Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,solute:sodium symporter activity (GO:0015370),0.8469689621446508,2.0573877026643226,0.0,0.0,0.0,4/27,2.82%,SLC4A10;SLC4A4;SLC5A6;SLC34A2
prerank,sulfate transmembrane transporter activity (GO:0015116),0.9221884521907461,2.0001370327425003,0.0,0.0005176546975926582,0.001,3/14,2.44%,SLC26A7;SLC26A2;SLC26A6
prerank,anion:anion antiporter activity (GO:0015301),0.8854588048094979,1.9976099138327208,0.0,0.0003451031317284388,0.001,4/17,4.19%,SLC26A7;SLC26A2;SLC26A6;SLC4A2
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.7687896618896738,-1.9327322631637862,0.0,0.12475448914909303,0.121,5/14,5.34%,SLC7A11;SLC1A3;SLC1A1;SLC1A2;SLC25A13
prerank,gap junction channel activity (GO:0005243),-0.6827695530463547,-1.9326107318238563,0.0,0.06282925359320266,0.122,5/22,4.94%,GJB6;GJB2;GJA1;GJC1;GJD3
prerank,wide pore channel activity (GO:0022829),-0.6736417224272363,-1.9220382231134912,0.0,0.046707598594467194,0.134,5/23,4.94%,GJB6;GJB2;GJA1;GJC1;GJD3
prerank,cAMP binding (GO:0030552),-0.8210010396598553,-1.9119248235932516,0.0,0.040680811679052076,0.157,6/11,7.74%,RAPGEF4;PDE4B;RAPGEF2;PDE4D;HCN1;PDE2A
prerank,chloride transmembrane transporter activity (GO:0015108),0.8633433598926014,1.9078342863593938,0.0,0.010611921300649495,0.039,3/16,2.44%,SLC26A7;SLC26A2;SLC26A6
prerank,outward rectifier potassium channel activity (GO:0015271),-0.7930553451425457,-1.9070787624286352,0.0,0.034171881810403745,0.164,6/11,13.10%,KCNK2;KCNT2;KCND2;KCND3;KCNQ1;KCNT1
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.8868205585791938,1.903425414997001,0.0,0.009524846435704911,0.043,3/15,2.44%,SLC26A7;SLC26A2;SLC26A6
prerank,glutamate receptor activity (GO:0008066),-0.670763257900435,-1.8553181898782378,0.003257328990228013,0.05710380602355828,0.291,8/19,5.80%,GRM7;GRID2;GRIK2;GRIA4;GRM5;GRM3;GRM1;GRIA1
prerank,symporter activity (GO:0015293),0.9041977460612436,1.8541455761348895,0.0,0.029506317762781516,0.146,2/10,0.41%,SLC4A4;SLC5A6
prerank,adenylate cyclase binding (GO:0008179),-0.7730747844459533,-1.8419647904805918,0.005376344086021506,0.057857154387985166,0.334,4/10,8.41%,ADCY5;AKAP6;CAP2;CALM1
prerank,carbohydrate:cation symporter activity (GO:0005402),0.8880007016391399,1.8412300063894627,0.0016181229773462784,0.035052618094131426,0.191,2/11,0.14%,SLC23A1;SLC23A2
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.748368059817791,1.8358893495382638,0.004087193460490463,0.035718174133893416,0.221,4/27,3.32%,SLC26A7;SLC26A2;SLC26A6;SLC39A14
prerank,organic anion transmembrane transporter activity (GO:0008514),0.6067269643383796,1.7853002019710418,0.0,0.08685095481832378,0.47,18/134,5.90%,SLC26A7;SLC38A2;SLC26A2;SLC23A1;SLC23A2;SLC38A1;SLC5A6;SLCO3A1;SLCO2A1;SLCO4A1;ABCG2;SLC16A1;SLC26A6;SFXN3;SLC38A6;SLC7A9;SLC6A7;SLC25A25
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.7302310243220573,1.7707564161304241,0.0026954177897574125,0.10166738260719807,0.56,3/29,2.44%,SLC26A7;SLC26A2;SLC26A6
prerank,solute:anion antiporter activity (GO:0140323),0.8137995077487297,1.7629503323857638,0.0030959752321981426,0.10494272505742071,0.595,4/14,4.19%,SLC26A7;SLC26A2;SLC26A6;SLC4A2
prerank,cell adhesion mediator activity (GO:0098631),-0.592537441008356,-1.7566699776585941,0.003278688524590164,0.13051760413695873,0.633,11/24,13.47%,LRRC4C;BSG;ESAM;CNTN4;DSCAML1;BCAM;SIRPA;JAM3;ROBO4;NEXN;PALLD
prerank,metalloendopeptidase activity (GO:0004222),0.6257354571042931,1.743250615115143,0.0023612750885478157,0.13450394559115902,0.708,16/76,10.89%,ADAMTSL3;ADAMTS17;ADAMTSL1;THSD4;ADAMTS2;TRABD2B;ADAM9;MMP28;ADAMTS3;ECE1;PHEX;ADAMTS6;ADAMTSL5;MMP16;IDE;MMEL1
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.72419375357498,1.7350090024154405,0.005420054200542005,0.14159846958765326,0.759,3/27,0.21%,SLC23A1;SLC9A2;SLC9B2
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.8030642080424539,1.728590548328238,0.0061068702290076335,0.14368615391750497,0.786,3/14,4.25%,CAPN5;CAPN2;CAPN12
prerank,chemoattractant activity (GO:0042056),0.7129834078828501,1.706914878083157,0.0027247956403269754,0.1834568248268381,0.875,6/26,4.14%,BMP4;PGF;DEFB130A;FGF2;VEGFA;CCL3
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.6875344379558567,1.7052891323960335,0.0013422818791946308,0.17587318350710562,0.881,6/32,5.58%,SLC38A2;SLC38A1;SFXN3;SLC38A6;SLC7A9;SLC6A7
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.6255325101699735,-1.6828315225648287,0.028037383177570093,0.23835942250466807,0.873,10/15,26.77%,ALDH1A2;ALDH1A1;ALDH1L1;ALDH4A1;ALDH3B1;ALDH7A1;ALDH1A3;ALDH1L2;ALDH2;ALDH9A1
prerank,retinoid binding (GO:0005501),-0.5860210247754076,-1.682730421116403,0.010638297872340425,0.21470428386166374,0.873,6/22,2.78%,ALDH1A2;PTGDS;NR2F2;CYP26B1;RBP4;ABCA4
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.687226632532195,-1.6787606220614295,0.014124293785310734,0.2011851050309484,0.878,7/11,17.33%,ITPR1;TRPC3;TRPC4;TRPC6;TRPC1;RPH3A;TRPC7
prerank,metal ion:proton antiporter activity (GO:0051139),0.7947254955473451,1.673705297764038,0.009419152276295133,0.24914416092371347,0.959,2/13,0.21%,SLC9A2;SLC9B2
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.7971007787398201,1.663878729319142,0.01263823064770932,0.26624706612849053,0.969,2/12,0.21%,SLC9A2;SLC9B2
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.8066991157680026,1.6619122048306336,0.00625,0.2587183688599938,0.974,5/12,11.92%,AOX1;FDX1;CISD2;XDH;FXN
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),-0.6440550670132568,-1.6615731890001657,0.005813953488372093,0.21229356909549768,0.916,6/15,14.91%,SLC1A3;SLC1A1;SLC1A2;SLC25A13;SLC1A5;SLC1A6
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.6832252881041319,1.645556736014058,0.0067842605156037995,0.2975996856460192,0.988,3/31,0.50%,KCNK5;SLC12A7;SLC12A2
prerank,sodium:proton antiporter activity (GO:0015385),0.807731261195991,1.6416586133949191,0.006379585326953748,0.2955068816543232,0.99,2/11,0.21%,SLC9A2;SLC9B2
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.6050849220306228,1.6221827597820726,0.003592814371257485,0.34871102810559973,0.999,7/55,4.02%,SLC38A2;SLC23A1;SLC23A2;SLC38A1;SLC16A9;SLC16A1;SLC38A6
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.774848304821256,1.6189698776230568,0.02723146747352496,0.34529819002028533,0.999,5/11,12.73%,UBE4B;UBR5;UBE4A;ANAPC11;UBE2K
prerank,aspartic-type peptidase activity (GO:0070001),0.7992289592813931,1.6034625972764744,0.02572347266881029,0.3878959200627652,0.999,5/10,13.94%,PGC;ASPRV1;BACE2;DDI2;CTSE
prerank,ligand-gated ion channel activity (GO:0015276),-0.5178221644521064,-1.5987860644552327,0.02459016393442623,0.31897928747318266,0.98,8/30,5.95%,GRID2;GRIK2;GRIA4;GRIN2A;GABRB1;GRIN2B;GRIA1;GRIN1
prerank,ligand-gated channel activity (GO:0022834),-0.520870996868595,-1.5964480685923865,0.028925619834710745,0.30226488804705204,0.982,8/29,5.95%,GRID2;GRIK2;GRIA4;GRIN2A;GABRB1;GRIN2B;GRIA1;GRIN1
prerank,gated channel activity (GO:0022836),0.7543150771019979,1.5957098468585387,0.024883359253499222,0.40256970522385843,0.999,2/14,2.42%,PIEZO2;TMC6
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.6654749655743815,-1.5933707092697311,0.036211699164345405,0.2882612181643053,0.983,6/12,8.54%,PDE8B;PDE4B;PDE7B;PDE4D;PDE2A;PDE8A
prerank,metallopeptidase activity (GO:0008237),0.5487639742950484,1.5913838096119268,0.005543237250554324,0.40389012289864096,0.999,28/113,16.30%,ADAMTSL3;ADAMTS17;ADAMTSL1;THSD4;ADAMTS2;TRABD2B;BMP1;ADAM9;MMP28;ADAMTS3;ECE1;MYSM1;PHEX;ADAMTS6;ADAMTSL5;MMP16;IDE;ADAM12;MMEL1;ECE2;DPEP1;COPS5;ADAMTS5;BRCC3;ADAM15;NLN;PRPF8;ADAMTS1
prerank,cation:chloride symporter activity (GO:0015377),0.8092332620909775,1.5883138962732914,0.03486529318541997,0.40039632238981754,0.999,2/10,0.50%,SLC12A7;SLC12A2
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.6215663726536755,-1.585445799623825,0.04,0.2868562234646492,0.985,5/16,14.91%,SLC13A3;SLC1A1;SLC25A13;SLC1A5;SLC1A6
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.5982615747360244,1.585339903902912,0.007272727272727273,0.3965604736915185,0.999,6/53,5.58%,SLC47A1;SLC38A2;SLC38A1;SLC38A6;SLC7A9;SLC6A7
prerank,metal ion transmembrane transporter activity (GO:0046873),0.6615000229303123,1.5815790650192165,0.02656042496679947,0.39645209770803236,1.0,5/27,5.90%,SLC23A1;SLC9B2;SLC12A2;CNNM2;ATP2B4
prerank,mechanosensitive ion channel activity (GO:0008381),0.7666727737560578,1.5807796847322355,0.03129890453834116,0.38617040440412304,1.0,2/12,2.42%,PIEZO2;TMC6
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.5734893270944789,-1.5753451078235965,0.019933554817275746,0.29088109788812394,0.988,10/18,29.80%,ALDH1A2;ALDH1A1;FAR2;ALDH3B1;ALDH1A3;HSD17B12;ALDH2;ALDH9A1;FAR1;ALDH8A1
prerank,amino acid transmembrane transporter activity (GO:0015171),0.596256435538352,1.5720904774784872,0.012269938650306749,0.40610845953075636,1.0,3/47,0.16%,SLC47A1;SLC38A2;SLC38A1
prerank,anion channel activity (GO:0005253),0.5800518095270369,1.5706442258820195,0.014251781472684086,0.39869117740214544,1.0,8/61,4.12%,SLC26A7;CLIC4;LRRC8D;ANO9;GABRA3;ANO6;CLIC1;GLRB
prerank,secondary active transmembrane transporter activity (GO:0015291),0.5878073729952142,1.5567654732763707,0.0175,0.438249604283142,1.0,5/51,1.29%,SLC4A4;SLC5A6;SLCO3A1;SLCO2A1;SLCO4A1
prerank,cyclic nucleotide binding (GO:0030551),-0.553860355184624,-1.5533480828546542,0.04318936877076412,0.32052461745149424,0.992,6/21,7.74%,RAPGEF4;PDE4B;RAPGEF2;PDE4D;HCN1;PDE2A
prerank,cation transmembrane transporter activity (GO:0008324),0.5937410300234852,1.5428856579412062,0.01616915422885572,0.48102301516889534,1.0,5/48,5.58%,SLC38A2;SLC38A1;SFXN3;SLC38A6;SLC6A7
prerank,histone deacetylase activity (GO:0004407),0.6695574147386716,1.5371232141024822,0.06876790830945559,0.4905887519756706,1.0,5/19,6.81%,HDAC4;HDAC9;HDAC8;SIRT6;MIER1
prerank,intracellular ligand-gated ion channel activity (GO:0005217),-0.6454825823986796,-1.535626115775825,0.03361344537815126,0.34209945727764257,0.994,3/11,10.97%,ITPR1;RYR2;RASA3
prerank,transmitter-gated ion channel activity (GO:0022824),-0.5043750898919523,-1.532870511462249,0.028112449799196786,0.33032819083390286,0.995,14/29,14.50%,GRID2;GRIK2;GRIA4;GABRG3;GABRB3;GABRB1;GABRA2;GABRB2;GLRA3;GABRG1;GABRA5;GABRA1;GABRG2;GRIK1
prerank,aspartic-type endopeptidase activity (GO:0004190),0.7481181251553415,1.528905981888015,0.05045871559633028,0.5103212560434289,1.0,6/12,13.94%,PGC;ASPRV1;BACE2;SPPL2A;DDI2;CTSE
prerank,insulin-like growth factor I binding (GO:0031994),-0.6044394792418055,-1.5248831643229397,0.0486322188449848,0.3308706016562902,0.997,6/13,4.29%,IGF1R;IGFBP2;ITGA6;IGFBP3;INSR;IGFBP4
prerank,endopeptidase activity (GO:0004175),0.5014677324276644,1.5226171251547997,0.0,0.5232509645936599,1.0,53/257,16.53%,ADAMTSL3;F3;ADAMTS17;HTRA3;PCSK5;ADAMTSL1;THSD4;ADAMTS2;TRABD2B;ADAM9;USP2;CASP6;USP46;HTRA4;PGC;ASPRV1;PRSS12;MMP28;PSMB2;ADAMTS3;USP24;USP15;USP25;USP13;ECE1;BACE2;CASP2;PHEX;ADAMTS6;ADAMTSL5;MMP16;USP1;USP34;TASP1;IDE;MMEL1;DDI2;PCSK7;ECE2;CTRC;USP40;CPNE1;CLPP;TYSND1;CTSE;ADAMTS5;PIDD1;ATG4B;USP28;NLN;GZMM;ADAMTS1;USP47
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.5773142087110313,1.5130109359035981,0.027160493827160494,0.5512205179839295,1.0,10/48,11.38%,PIEZO2;SLC12A7;SLC12A2;TRPM7;TRPM6;CALHM5;TRPM4;TRPM8;NALCN;RHCG
prerank,R-SMAD binding (GO:0070412),0.6824833674684557,1.508715657248796,0.040229885057471264,0.5549523822140779,1.0,9/18,18.27%,DDX5;SMAD6;PMEPA1;SMAD2;RANBP3;LDLRAD4;PAX6;SMAD4;SMURF1
prerank,Notch binding (GO:0005112),0.6401200202063767,1.5086548153438826,0.057931034482758624,0.541363282742402,1.0,8/22,12.02%,CCN3;TCIM;SNED1;NCOR2;CUL3;AAK1;GALNT11;JAG1
prerank,CoA hydrolase activity (GO:0016289),0.6862272125837564,1.508426354331397,0.054814814814814816,0.529144106734349,1.0,7/16,13.08%,ACOT12;ABCD1;HIBCH;ACOT9;ACOT11;ACOT8;ACOT13
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.6096289016462368,-1.5066076772981214,0.06936416184971098,0.35318341048631574,0.999,3/11,17.73%,PPP1R1A;PPP1R2;PPP1R14A
prerank,I-SMAD binding (GO:0070411),0.7187106744541154,1.4977935864217478,0.05692307692307692,0.5610144410719671,1.0,8/13,18.27%,SMAD6;SMAD9;TGFBR1;SMAD2;TGFB1I1;SMAD4;SMAD7;SMURF1
prerank,5'-nucleotidase activity (GO:0008253),0.7096883320173817,1.4922954493560674,0.06230529595015576,0.5706480924485392,1.0,4/13,9.77%,NT5C1A;NT5E;ACP3;NT5DC1
prerank,nucleotidase activity (GO:0008252),0.6907494624784988,1.492273554410753,0.05389221556886228,0.5577729366560892,1.0,4/15,9.77%,NT5C1A;NT5E;ACP3;NT5DC1
prerank,chloride channel activity (GO:0005254),0.5503428780722456,1.4914328353345447,0.027611044417767107,0.5491281032062918,1.0,7/59,4.12%,SLC26A7;CLIC4;ANO9;GABRA3;ANO6;CLIC1;GLRB
prerank,cytokine activity (GO:0005125),0.5139461417118898,1.4852003450327285,0.006493506493506494,0.5622855352155383,1.0,21/131,7.67%,BMP4;WNT9A;TNFRSF11B;BMP5;WNT11;FGF2;SLURP1;FAM3C;VEGFA;TGFB3;CXCL2;CLCF1;GDF10;CCL3;CCL1;TIMP1;IL33;BMP6;CTF1;INHBA;KITLG
prerank,phospholipase inhibitor activity (GO:0004859),0.7341526710744734,1.4832549989487986,0.06635071090047394,0.558384209756438,1.0,4/10,11.47%,ANXA2;ANXA4;ANXA1;ANGPTL3
prerank,leucine zipper domain binding (GO:0043522),0.7288614793099848,1.479632705357112,0.0804416403785489,0.5612455369191066,1.0,4/10,13.77%,ERC1;PAWR;MRTFA;AATF
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.6103405389335143,-1.4772019410731734,0.0581039755351682,0.40598270901732253,1.0,5/11,19.88%,KCNJ3;KCND3;KCNQ1;KCNJ8;KCNH2
prerank,glucose transmembrane transporter activity (GO:0005355),-0.5450959608755386,-1.4762427620578582,0.052941176470588235,0.39140214273799084,1.0,4/17,11.72%,SLC2A1;SLC5A3;MFSD4A;SLC5A11
prerank,translation initiation factor activity (GO:0003743),0.5776134671428446,1.4709760995027927,0.06068601583113457,0.5845272330163628,1.0,14/36,19.43%,EIF4G3;MTIF3;EIF4E3;AGO2;EIF4G2;EIF3E;EIF3A;EIF2S1;EIF5B;COPS5;EIF3L;EIF2S2;EIF2D;EIF4G1
prerank,sodium channel regulator activity (GO:0017080),0.5810019896770051,1.4654442078775916,0.059050064184852376,0.5954892579226903,1.0,9/37,5.90%,FXYD5;NEDD4;PTPN3;CAMK2D;FGF13;SNTA1;RANGRF;PRSS41;ATP2B4
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",-0.5671527530151449,-1.4604566089214803,0.0673854447439353,0.41317240377319914,1.0,9/14,32.26%,ALDH1L1;ALDH4A1;AASS;ALDH1L2;QDPR;PYCR1;BLVRB;NOXRED1;CRYM
prerank,nucleotidyltransferase activity (GO:0016779),0.636831128226417,1.4599251461341514,0.0641025641025641,0.6065695044732795,1.0,7/19,17.28%,PAPSS2;NUDT5;TUT7;TUT4;CGAS;TENT2;TENT4B
prerank,potassium ion antiporter activity (GO:0022821),0.6691381055020879,1.4588666203252323,0.08444444444444445,0.5989463949107667,1.0,2/15,0.76%,SLC9A2;SLC24A3
prerank,ligand-gated calcium channel activity (GO:0099604),-0.5258407673098152,-1.4527688922554363,0.0744336569579288,0.4130667032026826,1.0,5/19,5.95%,ITPR1;RYR2;GRIN2A;GRIN2B;GRIN1
prerank,pre-mRNA binding (GO:0036002),0.5943286309157654,1.4456403467612933,0.08495821727019498,0.6414425398056648,1.0,9/28,16.81%,DDX5;CELF3;U2AF2;SRSF6;CELF4;CELF1;ERI1;PRPF8;RNPC3
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.640262407070893,1.4451844864637846,0.08247422680412371,0.6313086623085574,1.0,5/18,8.31%,BAIAP2L1;ANXA2;KRT18;ANXA1;STXBP6
prerank,hexose transmembrane transporter activity (GO:0015149),-0.570514342198482,-1.4373427951457742,0.09137055837563451,0.43191972893808367,1.0,3/12,9.57%,SLC2A1;SLC5A3;MFSD4A
prerank,nucleoside-diphosphatase activity (GO:0017110),0.6964479815374577,1.43501067667639,0.08990536277602523,0.662240360582084,1.0,6/12,11.57%,ENTPD6;NUDT5;ENTPD2;ENTPD5;NUDT15;ENTPD7
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.5555939330361097,-1.4309181507973139,0.1069364161849711,0.43270177628782214,1.0,6/13,16.20%,ALDH1A2;ALDH1A1;ALDH1L1;ALDH4A1;ALDH7A1;ALDH1A3
prerank,transcription corepressor binding (GO:0001222),0.59689945325825,1.4242083681392699,0.09918478260869565,0.6972993653250817,1.0,14/27,20.09%,ESR1;ZBTB16;PER1;LCOR;EHMT1;RORA;EED;PER3;NR1D1;FAM89B;THAP7;SUZ12;ZBTB7A;NEK6
prerank,single-stranded DNA helicase activity (GO:0017116),0.6195923907559008,1.424057164483218,0.0936599423631124,0.6855746161626275,1.0,8/19,18.46%,CHTF18;MCM2;RAD51;CHTF8;DSCC1;HELB;MCM7;DHX9
prerank,potassium:proton antiporter activity (GO:0015386),0.713152934158675,1.42367260575548,0.09854604200323101,0.6756643314923206,1.0,3/10,11.18%,SLC9A2;SLC9A1;SLC9A8
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.688678386538934,1.4236076735312124,0.0899854862119013,0.6644756079234301,1.0,3/13,6.10%,BMP4;BMP5;BMP6
prerank,sequence-specific DNA binding (GO:0043565),0.46266180498359766,1.4216288985490695,0.0,0.6618387860288,1.0,118/590,15.35%,FOXP2;TBX15;FOXP1;KLF12;VSX1;SIX1;NR3C2;TCF7L1;KLF5;TCF7L2;TFCP2L1;PRRX2;NFIB;SLTM;FOXD1;HES1;HDAC4;ZIC4;CUX1;RARB;HOXA5;KLF3;MEOX2;NFAT5;HOXB6;PBX1;FOXL1;SOX9;DMRT3;DMBX1;SOX14;SP8;GRHL2;PITX2;JDP2;ZNF423;ESR1;NFE2L2;GRHL1;ZNF148;TELO2;FOXC2;ZIC1;GLIS1;HOXC4;RARA;ELF1;KLF4;GLI3;ABL1;ATOH7;HOXA6;SMG6;FOXO3;KLF10;NFIX;MEF2A;NFATC4;BHLHE40;GLI2;HOXB4;GLIS2;NR4A2;MBD1;RORA;TEN1;E2F3;POU3F4;NFATC3;MLX;EGR1;NFIC;GATA4;KDM1A;RUNX2;RXRA;HOXA2;STN1;FOXC1;ELF3;ARNT;SIX4;ATF7;ATF6;POU4F1;ERF;CREB3L1;MECP2;RFX2;HOXB5;TEAD1;RXRB;ZBTB32;NR2F1;ETV3;HSF2;NR1D1;CEBPD;BATF3;LMX1A;SREBF1;NR4A1;MBD3;E2F1;PRMT5;HOXA7;NFATC1;SIRT3;PRDM2;RFX7;SP3;NR3C1;BCL11B;POU2F1;FOSB;GMEB1;E2F2;MEF2D
prerank,calcium-activated potassium channel activity (GO:0015269),0.6854802856616026,1.420197802483469,0.11282843894899536,0.6570650479541695,1.0,2/11,1.57%,KCNMB3;KCNMB2
prerank,double-stranded DNA binding (GO:0003690),0.46244870508035046,1.4196725144508753,0.0,0.6489720053948732,1.0,100/531,13.64%,TBX15;FOXP1;KLF12;VSX1;SIX1;EGFR;NR3C2;TCF7L1;KLF5;TFCP2L1;PRRX2;NFIB;HES1;ZIC4;CUX1;RARB;HOXA5;KLF3;MEOX2;NFAT5;HOXB6;PBX1;SOX9;DMRT3;DMBX1;SOX14;SP8;PITX2;JDP2;ESR1;GRHL1;FOXC2;ZIC1;GLIS1;HOXC4;RARA;ELF1;KLF4;GLI3;ABL1;ATOH7;ERCC5;HOXA6;FOXO3;KLF10;RAD51;NFIX;NFATC4;BHLHE40;GLI2;HOXB4;GLIS2;NR4A2;MBD1;APEX1;E2F3;POU3F4;NFATC3;SMAD2;MLX;EGR1;NFIC;GATA4;RUNX2;RXRA;HOXA2;ELF3;TOP1;ARNT;NEIL3;SIX4;ATF7;ATF6;HDGFL3;POU4F1;KIN;CREB3L1;CGAS;WDR48;MECP2;RFX2;HOXB5;TEAD1;POLR3F;RAD50;RXRB;ZBTB32;NR2F1;ETV3;HSF2;NR1D1;CEBPD;BATF3;LMX1A;SREBF1;NR4A1;E2F1;HOXA7;NFATC1;DDX11
prerank,manganese ion binding (GO:0030145),0.5330906407726158,1.4180936406325664,0.06125,0.6452606889198643,1.0,17/48,22.23%,ME1;MPPED2;ABL1;LARGE1;XPNPEP3;XPNPEP1;B4GALT1;WRN;ARG1;PRIMPOL;MGAT1;MGAT5;NEK4;MPPE1;SOD2;LARGE2;TDP2
prerank,calcium channel inhibitor activity (GO:0019855),-0.59634873785294,-1.4151513097995365,0.1168091168091168,0.4570278774150057,1.0,3/11,11.27%,ITPR1;CALM1;SLC30A1
prerank,water transmembrane transporter activity (GO:0005372),-0.5917536625429773,-1.4150394769599541,0.07853403141361257,0.4420346863111221,1.0,3/11,13.89%,AQP11;PDPN;AQP4
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.704489450966675,1.4140392533707538,0.12786885245901639,0.6520507984551521,1.0,3/10,1.29%,SLCO3A1;SLCO2A1;SLCO4A1
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.5066567575843169,-1.4137297741565327,0.07420494699646643,0.4303709095049824,1.0,3/21,5.80%,GRM5;GRM1;GRIA1
prerank,androgen receptor binding (GO:0050681),0.5930017167207693,1.4132324864999792,0.08594815825375171,0.6453800212848282,1.0,5/25,10.44%,FOXP1;DDX5;KDM1A;NSD1;TGFB1I1
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.6180911348564144,1.4075863857416437,0.11396011396011396,0.6576253905205155,1.0,6/20,13.66%,DLG2;MAGI3;DLG1;AK4;AK3;AK1
prerank,insulin-like growth factor binding (GO:0005520),-0.5255336026515012,-1.4074985752373403,0.0672782874617737,0.4315556105619441,1.0,6/15,4.29%,IGF1R;IGFBP2;ITGA6;IGFBP3;INSR;IGFBP4
prerank,thiol-dependent deubiquitinase (GO:0004843),0.5039253558978252,1.4063184202387689,0.048368953880764905,0.6527702998538583,1.0,38/83,24.18%,TANK;USP2;USP46;OTUD1;USP24;USP15;USP25;USP13;MYSM1;ZC3H12A;USP1;USP34;DESI2;USP40;COPS5;ZRANB1;USP4;BRCC3;USP28;MINDY3;USP47;OTUD5;OTUD4;OTUD3;USP49;PSMD14;VCPIP1;USP21;USP16;USP19;USP10;USP32;USP30;USP36;USP9X;USP7;USP33;USP42
prerank,MHC class I protein binding (GO:0042288),-0.5552512552704443,-1.4039146426550047,0.11048158640226628,0.4266691191254115,1.0,7/13,20.57%,TAP2;ATP5F1A;ABCB9;ATP5F1B;TUBB4B;DERL1;TAPBP
prerank,GTPase inhibitor activity (GO:0005095),0.6688044310997168,1.4034475984820516,0.12442396313364056,0.6540567104083236,1.0,2/13,5.07%,SLIT2;PDE6D
prerank,ATPase binding (GO:0051117),0.506555525730129,1.4033184069931852,0.056976744186046514,0.645057771136405,1.0,13/71,9.02%,EGFR;SLC2A13;PPP3CA;PTPN3;ANK2;ATP1B1;EZR;ESR1;SNTA1;TCIRG1;USP25;ATP6V0A4;RDX
prerank,MAP kinase kinase kinase activity (GO:0004709),0.7007610459863438,1.3988323503357305,0.11128526645768025,0.651889955745543,1.0,2/11,0.92%,EGFR;MAP3K5
prerank,BMP receptor binding (GO:0070700),0.6886822092145493,1.3987408382595514,0.1037037037037037,0.643087534457223,1.0,3/12,6.10%,BMP4;BMP5;BMP6
prerank,death receptor activity (GO:0005035),-0.5968808936462613,-1.3963922784988319,0.1111111111111111,0.43174837911401803,1.0,3/11,9.95%,TNFRSF19;TNFRSF11A;FAS
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.4544295477958315,1.3952973164871894,0.0,0.6475860266884155,1.0,131/597,16.75%,BNC2;TBX15;FOXP1;KLF12;VSX1;SIX1;NR3C2;TCF7L1;KLF5;TCF7L2;TFCP2L1;PRRX2;NFIB;HES1;HDAC4;ZIC4;CUX1;RARB;HOXA5;KLF3;MEOX2;SMAD6;NFAT5;HOXB6;PBX1;SOX9;DMRT3;DMBX1;SOX14;SP8;PITX2;JDP2;ESR1;NFE2L2;GRHL1;FOXC2;ZIC1;GLIS1;HOXC4;RARA;ELF1;KLF4;GLI3;ABL1;ATOH7;HOXA6;ARID4B;STAT3;FOXO3;CDC45;KLF10;MCM2;NFIX;PER1;NFATC4;BHLHE40;GLI2;HOXB4;GLIS2;NR4A2;CRY2;NCOR1;E2F3;POU3F4;NFATC3;IRF1;CHD3;MLX;EGR1;NFIC;GATA4;PER3;RUNX2;RXRA;HOXA2;GABPB1;GABPB2;FOXC1;ELF3;MLH3;ARNT;SIX4;ATF7;ATF6;TBL1X;POU4F1;DHX36;BCOR;ARID4A;CREB3L1;RFX2;HOXB5;TEAD1;RXRB;ZBTB32;ZW10;ORC3;NR2F1;ETV3;HSF2;BRCA1;NR1D1;CEBPD;BATF3;LMX1A;SREBF1;NR4A1;E2F1;HOXA7;NFYA;NFATC1;DDX11;RFX7;HINFP;SP3;NR3C1;BCL11B;MCM7;FOSB;GMEB1;E2F2;MEF2D;HOXD3;KDM5B;PAX6;MZF1;PRDM5;SMAD4;FOXK1;ZFP1;MBNL2
prerank,calcium activated cation channel activity (GO:0005227),0.6298008130089625,1.3949769949969184,0.12663755458515283,0.6400764879932014,1.0,4/17,8.51%,KCNMB3;KCNMB2;ANO6;TRPM4
prerank,omega peptidase activity (GO:0008242),0.4915972260377399,1.386736171663681,0.05752212389380531,0.6631856209537077,1.0,41/89,24.18%,TANK;USP2;USP46;OTUD1;USP24;USP15;USP25;USP13;MYSM1;ZC3H12A;USP1;USP34;DESI2;USP40;COPS5;ZRANB1;USP4;BRCC3;USP28;MINDY3;ASRGL1;USP47;OTUD5;APEH;OTUD4;OTUD3;USP49;PSMD14;VCPIP1;USP21;USP16;USP19;USP10;USP32;USP30;USP36;GGH;USP9X;USP7;USP33;USP42
prerank,GABA-A receptor activity (GO:0004890),-0.5092970951946386,-1.3858100598254852,0.11935483870967742,0.4441311471881272,1.0,9/18,14.15%,GABRG3;GABRB3;GABRB1;GABRA2;GABRB2;GABRG1;GABRA5;GABRA1;GABRG2
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.4481284117308709,1.3836746970117977,0.0,0.6663251267412696,1.0,141/731,13.63%,FOXP2;TBX15;FOXP1;KLF12;ZBTB7C;SIX1;PBX3;NR3C2;PLAGL1;ZFHX3;TCF7L1;KLF5;TCF7L2;TFCP2L1;ZFHX4;PRRX2;NFIB;MKX;FOXD1;HES1;HDAC4;FOXP4;ZIC4;RARB;HOXA5;KLF3;MEOX2;NFAT5;HOXA3;NFIA;SKIL;HOXB6;PBX1;FOXL1;SMAD9;EHF;PRRX1;SOX9;DMRT3;SOX14;SP8;GRHL2;PITX2;JDP2;ZNF423;ESR1;HOXC6;NFE2L2;GRHL1;ZNF148;FOXC2;ZIC1;GLIS1;MLXIP;HOXC4;RARA;ELF1;KLF4;GLI3;ATOH7;HOXA6;KLF7;HOXB3;NR4A3;TWIST1;STAT3;FOXO3;KLF10;CC2D1B;SKI;NFIX;ZBTB16;PER1;MEF2A;NFIL3;NFATC4;BHLHE40;KLF9;GLI2;HOXB4;GLIS2;REL;NR4A2;NFE2L1;NRF1;RORA;ZNF691;E2F3;POU3F4;NFATC3;IRF1;SMAD2;FOXO6;MLX;MLXIPL;EGR1;NFIC;GATA4;THRAP3;DNMT3A;RUNX2;RXRA;HOXA2;HIF3A;MXD4;FOXC1;TOP1;MTA1;ARNT;HES3;SIX4;ATF7;ATF6;NSD1;POU4F1;DHX36;CREB3L1;RFX2;ATOH8;HOXB5;TEAD1;ZBTB1;RXRB;ZBTB32;MYNN;NR2F1;HSF2;NR1D1;CEBPD;BATF3;GTF2IRD1;SREBF1;NR4A1;ZBTB24;E2F1;PRMT5;HOXA7;NFYA;NFATC1;PATZ1;RBMX
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.4469060303796729,1.38054906510204,0.0,0.6707306406676239,1.0,139/732,13.63%,FOXP2;TBX15;FOXP1;KLF12;ZBTB7C;SIX1;PBX3;NR3C2;PLAGL1;ZFHX3;TCF7L1;KLF5;TCF7L2;TFCP2L1;ZFHX4;PRRX2;NFIB;MKX;FOXD1;HES1;HDAC4;FOXP4;ZIC4;RARB;HOXA5;KLF3;MEOX2;NFAT5;FOXN3;HOXA3;NFIA;SKIL;HOXB6;PBX1;FOXL1;SMAD9;EHF;PRRX1;SOX9;DMRT3;SOX14;SP8;GRHL2;PITX2;JDP2;ZNF423;ESR1;HOXC6;NFE2L2;GRHL1;ZNF148;FOXC2;ZIC1;GLIS1;MLXIP;HOXC4;RARA;ELF1;KLF4;GLI3;ATOH7;HOXA6;KLF7;HOXB3;NR4A3;STAT3;FOXO3;KLF10;CC2D1B;SKI;NFIX;ZBTB16;PER1;MEF2A;NFIL3;NFATC4;BHLHE40;KLF9;GLI2;HOXB4;GLIS2;REL;NR4A2;NFE2L1;NRF1;RORA;ZNF691;E2F3;POU3F4;NFATC3;IRF1;SMAD2;FOXO6;MLX;MLXIPL;EGR1;NFIC;GATA4;THRAP3;DNMT3A;RUNX2;RXRA;HOXA2;HIF3A;MXD4;FOXC1;TOP1;MTA1;ARNT;HES3;SIX4;ATF7;ATF6;NSD1;POU4F1;DHX36;RFX2;ATOH8;HOXB5;TEAD1;ZBTB1;RXRB;ZBTB32;MYNN;NR2F1;HSF2;NR1D1;CEBPD;BATF3;GTF2IRD1;SREBF1;NR4A1;ZBTB24;E2F1;HOXA7;NFYA;NFATC1;PATZ1;RBMX
prerank,telomeric DNA binding (GO:0042162),0.5541816113982118,1.3783003463992387,0.11186903137789904,0.6708670425035241,1.0,12/32,20.29%,TELO2;SMG6;TEN1;APEX1;WRN;KDM1A;STN1;RAD50;UPF2;HNRNPA2B1;XRCC5;ZBTB48
prerank,phosphotyrosine residue binding (GO:0001784),0.5358462796301069,1.376858824147884,0.09263959390862944,0.6679603846577674,1.0,10/37,12.16%,PTPN3;VAV2;CBLC;IRS1;PLCG2;ABL1;SHC1;NCK2;PIK3R3;BCAR3
prerank,RNA polymerase II complex binding (GO:0000993),0.550657258480441,1.3746223195516314,0.10317460317460317,0.6682463464543604,1.0,19/32,29.59%,ELOF1;ERCC5;AGO2;WAC;UVSSA;SCAF8;WDR43;SCAF1;URI1;RECQL5;DHX9;BRD4;ELP4;GTF2B;SMYD2;SUPT4H1;CTR9;AGO1;RTRAF
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.6798585021160606,1.3733747941200583,0.13692307692307693,0.6643839216252971,1.0,3/10,12.95%,DPYSL3;DPYSL2;DPEP1
prerank,metalloendopeptidase inhibitor activity (GO:0008191),-0.5246162747791585,-1.3699876744395467,0.09523809523809523,0.4684822362249355,1.0,5/14,3.22%,COL4A3;SPOCK3;SPOCK2;SPOCK1;TIMP3
prerank,protein phosphorylated amino acid binding (GO:0045309),0.5296800973142822,1.3674700565073203,0.07711757269279393,0.6791374000466247,1.0,9/42,6.74%,NEDD4;PTPN3;VAV2;CBLC;IRS1;PLCG2;ABL1;SHC1;NCK2
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.5798274380996179,1.3673855659289018,0.13186813186813187,0.6711330025667157,1.0,6/23,4.45%,PLCE1;PLCZ1;EDNRA;CASR;PLCB3;PLCG2
prerank,RNA polymerase core enzyme binding (GO:0043175),0.5382046971359358,1.3571368033039433,0.11710526315789474,0.7022266629005754,1.0,18/33,29.59%,ELOF1;ERCC5;AGO2;ERBB2;WAC;UVSSA;SCAF8;WDR43;URI1;RECQL5;DHX9;ELP4;GTF2B;SMYD2;SUPT4H1;CTR9;AGO1;RTRAF
prerank,nuclear receptor binding (GO:0016922),0.4658280460416401,1.3558731222632818,0.05849889624724062,0.6988708170856309,1.0,27/111,13.29%,FOXP1;TCF7L2;DDX5;TACC2;JMJD1C;ESR1;BCAS3;MED13;NR4A3;DNAAF4;LCOR;NR4A2;STRN;NCOR1;MED24;NCOR2;THRAP3;KDM1A;RXRA;TADA3;NSD1;TGFB1I1;GAS2L1;JUP;NCOA6;NR4A1;TRIP12
prerank,UDP-glycosyltransferase activity (GO:0008194),0.48922500933086843,1.3547534796326253,0.07646356033452807,0.6951432682590163,1.0,13/70,11.62%,EXT1;GXYLT2;B3GNT2;MGAT4C;HEXA;LARGE1;HAS1;B4GALNT3;B4GALT1;B4GAT1;B3GALT6;POGLUT3;B3GNT9
prerank,H4 histone acetyltransferase activity (GO:0010485),0.6748141144804966,1.3546539494060543,0.12398042414355628,0.6874333999217107,1.0,8/10,29.23%,MSL3;NAA40;ATF2;BRCA2;NAA60;KAT8;HAT1;NAA50
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.6756459654738755,1.3542011144792934,0.1539708265802269,0.6812097818159569,1.0,4/10,13.17%,DSE;RENBP;GLCE;RPE
prerank,protein kinase C binding (GO:0005080),0.5178829105545121,1.3539054644953175,0.10472541507024266,0.6746452495171225,1.0,8/43,5.88%,ADAM9;GRK5;HDAC9;IRS1;NELL1;DSP;ABL1;DACT1
prerank,deubiquitinase activity (GO:0101005),0.4811249316793583,1.3523161174841682,0.07862679955703211,0.6727998819026197,1.0,38/88,24.18%,TANK;USP2;USP46;OTUD1;USP24;USP15;USP25;USP13;MYSM1;ZC3H12A;USP1;USP34;DESI2;USP40;COPS5;ZRANB1;USP4;BRCC3;USP28;MINDY3;USP47;OTUD5;OTUD4;OTUD3;USP49;PSMD14;VCPIP1;USP21;USP16;USP19;USP10;USP32;USP30;USP36;USP9X;USP7;USP33;USP42
prerank,mannose binding (GO:0005537),0.6488233838221282,1.3504833225078567,0.14925373134328357,0.671938804350719,1.0,2/12,6.51%,COLEC11;LMAN2L
prerank,amino acid:sodium symporter activity (GO:0005283),0.6588971347534613,1.349070439802441,0.15562403697996918,0.6695948841058439,1.0,2/11,0.16%,SLC38A2;SLC38A1
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.6402993205320389,1.3484188000660677,0.1334355828220859,0.6643647909082123,1.0,2/13,6.37%,EXO1;SLX4
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.5463941920600259,-1.34462461018421,0.14030612244897958,0.5174159453016731,1.0,9/12,14.15%,GABRG3;GABRB3;GABRB1;GABRA2;GABRB2;GABRG1;GABRA5;GABRA1;GABRG2
prerank,serine-type peptidase activity (GO:0008236),0.4706448729435249,1.3423318235625878,0.07912087912087912,0.6793410809869758,1.0,5/96,3.68%,F3;HTRA3;PCSK5;PRSS12;HTRA1
prerank,flavin adenine dinucleotide binding (GO:0050660),0.5054490710352151,1.3412478241088468,0.10191846522781775,0.6757376310936671,1.0,17/53,17.42%,MICAL2;AOX1;MMACHC;GSR;AGPS;ACOX3;CRY2;KDM1A;MTO1;ETFDH;XDH;ETFA;GFER;ACOX1;ACADL;SQLE;PPOX
prerank,fibroblast growth factor binding (GO:0017134),0.5838326223761658,1.3398786528971516,0.13165266106442577,0.673245352698561,1.0,7/21,16.78%,THBS1;FGFR1;FGFBP3;ITGAV;FGFRL1;ITGB3;FGFR3
prerank,transmembrane receptor protein kinase activity (GO:0019199),-0.37457699246350995,-1.3391056606766738,0.0718232044198895,0.518240234863433,1.0,25/60,10.33%,FLT1;IGF1R;TEK;PDGFRB;KIT;MERTK;EPHB1;EPHA6;TIE1;KDR;EPHA7;ERBB4;INSR;ROR2;EPHA5;RYK;EPHA8;EPHA4;AXL;LMTK2;FGFR4;BMPR1B;NTRK2;ALK;FLT3
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.6232691832571096,1.3345540260225286,0.16149068322981366,0.6849542251708853,1.0,6/14,20.01%,RSAD1;ETFDH;ACO2;NUBPL;NFU1;IREB2
prerank,acylglycerol lipase activity (GO:0047372),0.6668486507575234,1.3336989872850267,0.15127388535031847,0.6808066503225835,1.0,2/11,9.44%,MGLL;ABHD6
prerank,transforming growth factor beta binding (GO:0050431),0.567701935335197,1.3323544242241403,0.1531791907514451,0.678687566070309,1.0,9/23,9.88%,THBS1;TGFB3;CD109;TGFBR1;LTBP3;TSKU;TGFBR2;LTBP4;ITGAV
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.5107477551205546,1.3315546997143688,0.12790697674418605,0.6746452495171225,1.0,13/42,19.87%,CCNA2;CCNL1;CCNL2;CCND1;CDKN2C;CCNB1;CCNYL1;CDKN1B;CCNG1;CCNT2;CDKN1A;HEXIM1;CCNT1
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.6409093212394199,1.3245016197352495,0.1472,0.6917005600172618,1.0,5/12,19.55%,CYFIP2;EIF4E3;AGO2;CYFIP1;GEMIN5
prerank,organic cation transmembrane transporter activity (GO:0015101),-0.49844904221231406,-1.3244630823062185,0.12680115273775217,0.5419240434441928,1.0,8/16,29.15%,SLC44A1;SLC22A4;SLC22A2;SLC44A2;SLC22A3;SLC5A7;SLC29A4;SLC25A17
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.5241419063587769,1.319498102456713,0.14848883048620237,0.7027905687455492,1.0,18/33,29.59%,ELOF1;ERCC5;AGO2;WAC;UVSSA;SCAF8;WDR43;URI1;RECQL5;DHX9;ELP4;TBP;GTF2B;SMYD2;SUPT4H1;CTR9;AGO1;RTRAF
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.42704429881419514,1.319240514955646,0.0,0.6966718721307311,1.0,155/831,14.23%,FOXP2;TBX15;FOXP1;KLF12;ZBTB7C;SIX1;PBX3;NR3C2;PLAGL1;ZFHX3;TCF7L1;KLF5;TCF7L2;TFCP2L1;ZFHX4;PRRX2;NFIB;MKX;FOXD1;HES1;HDAC4;FOXP4;ZIC4;CUX1;RARB;TWIST2;HOXA5;KLF3;MEOX2;NFAT5;HOXA3;NFIA;SKIL;HOXB6;PBX1;PURG;FOXL1;SMAD9;EHF;PRRX1;SOX9;DMRT3;DMBX1;SOX14;SP8;GRHL2;PITX2;JDP2;ZNF423;ESR1;HOXC6;NFE2L2;GRHL1;ZNF148;FOXC2;ZIC1;GLIS1;MLXIP;HOXC4;RARA;ELF1;KLF4;GLI3;ATOH7;HOXA6;KLF7;HOXB3;NR4A3;TWIST1;STAT3;FOXO3;KLF10;CC2D1B;SKI;NFIX;ZBTB16;PER1;MEF2A;NFIL3;NFATC4;BHLHE40;KLF9;GLI2;HOXB4;GLIS2;REL;NR4A2;NFE2L1;NRF1;RORA;ZNF691;E2F3;POU3F4;NFATC3;IRF1;SMAD2;FOXO6;MLX;MLXIPL;EGR1;NFIC;GATA4;THRAP3;DNMT3A;RUNX2;RXRA;HOXA2;HIF3A;MXD4;FOXC1;TOP1;MTA1;ARNT;HES3;SIX4;ATF7;ATF6;NSD1;POU4F1;DHX36;ZNF25;RFX2;ATOH8;HOXB5;TEAD1;ZBTB1;TFDP1;RXRB;ZBTB32;MYNN;ZBTB8B;NFXL1;NR2F1;HSF2;NR1D1;CEBPD;ZBTB8A;ZFP3;BATF3;GTF2IRD1;LMX1A;SREBF1;NR4A1;ZBTB24;E2F1;HOXA7;NFYA;NFATC1;PATZ1;RBMX;PRDM2;RFX7;RFXANK;HINFP;SP3
prerank,ligand-gated anion channel activity (GO:0099095),-0.4859137889958109,-1.3184221069280322,0.12912912912912913,0.5446030661278433,1.0,11/17,14.15%,GABRG3;GABRB3;GABRB1;GABRA2;GABRB2;GLRA3;GLRA1;GABRG1;GABRA5;GABRA1;GABRG2
prerank,O-acyltransferase activity (GO:0008374),0.5460168437117112,1.317856154987168,0.14323607427055704,0.6950946660703902,1.0,9/30,16.45%,SOAT1;MBOAT4;PLA2G15;MBOAT1;LPCAT1;SOAT2;MOGAT1;LPCAT2;LCAT
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.5387227905298573,-1.3168614016025608,0.16022099447513813,0.535465317954352,1.0,3/11,7.11%,SASH1;ROR2;DAB2IP
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.4373960118727985,1.3162476265661,0.021363173957273652,0.6939061672249276,1.0,62/254,16.42%,SIX1;PLAGL1;KLF5;TFCP2L1;NFIB;HOXA5;MEOX2;NFAT5;NFIA;EHF;PRRX1;SOX9;GRHL2;ESR1;GRHL1;FOXC2;MLXIP;HOXC4;ELF1;KLF4;KLF7;HOXB3;NR4A3;STAT3;FOXO3;KLF10;ZBTB16;MEF2A;GLIS2;REL;NR4A2;NRF1;E2F3;NFATC3;IRF1;SMAD2;EGR1;NFIC;GATA4;FOXC1;ELF3;ATF6;POU4F1;CREB3L1;TFDP1;RXRB;MDM4;HSF2;NR4A1;HOXA7;NFATC1;PRDM2;RFXANK;HINFP;NR3C1;PLSCR1;GMEB1;E2F2;HOXD3;MZF1;ATF1;SMAD4
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.5597229081277739,-1.3155297270813842,0.16071428571428573,0.525858682608953,1.0,4/10,13.98%,PRKAR2B;PRKAR1B;PRKAR1A;PRKAG2
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.5549144431738227,1.3117539600803605,0.15767634854771784,0.7028764784360503,1.0,10/27,18.58%,POLR1A;PRIM1;POLR1D;POLR3F;POLR3A;PRIMPOL;POLR3K;POLR1F;MED20;POLR2C
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.5482048412698605,1.3115926395377409,0.14758620689655172,0.6967143876108884,1.0,5/26,2.44%,SLC5A6;SLC16A9;ABCG2;SLC16A1;SLC26A6
prerank,calcium channel regulator activity (GO:0005246),-0.4112579477904605,-1.3108910546260877,0.09482758620689655,0.5243935326669746,1.0,9/37,11.27%,ITPR1;PRKG1;NRXN1;SGK1;CACNG7;REM1;CALM1;CACNG4;SLC30A1
prerank,inward rectifier potassium channel activity (GO:0005242),0.5575124212034083,1.3105530894896964,0.14783821478382148,0.6938314589714829,1.0,2/24,1.49%,KCNJ2;KCNJ15
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.604578800213301,1.3081433656256025,0.16323296354992076,0.6961017752905718,1.0,1/13,1.39%,EHHADH
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.5509758169348021,1.3080235027651348,0.15151515151515152,0.6901049487760033,1.0,2/25,1.17%,MICAL2;FMO1
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.47925058216578575,-1.3047307318218366,0.13312693498452013,0.5154710848754553,1.0,6/17,5.71%,EPHB1;EPHA6;EPHA7;EPHA5;EPHA8;EPHA4
prerank,ephrin receptor activity (GO:0005003),-0.47925058216578575,-1.3047307318218366,0.13312693498452013,0.5154710848754553,1.0,6/17,5.71%,EPHB1;EPHA6;EPHA7;EPHA5;EPHA8;EPHA4
prerank,phospholipase C activity (GO:0004629),0.5468878016481594,1.300025241163102,0.16346153846153846,0.7114928520821273,1.0,6/25,4.45%,PLCE1;PLCZ1;EDNRA;CASR;PLCB3;PLCG2
prerank,transforming growth factor beta receptor binding (GO:0005160),0.5729979384433581,1.2999567229974953,0.17567567567567569,0.7052882030245772,1.0,6/18,7.92%,SMAD6;TGFB3;TGFBR1;USP15;TGFBR2;SMAD2
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.43251444730192407,1.2933945935187223,0.06191950464396285,0.7217955251218772,1.0,34/188,10.85%,BNC2;VSX1;SIX1;TCF7L2;HDAC4;SMAD6;PBX1;PITX2;NFE2L2;GRHL1;FOXC2;KLF4;ARID4B;STAT3;FOXO3;PER1;GLIS2;CRY2;NCOR1;IRF1;CHD3;EGR1;GATA4;PER3;RXRA;GABPB1;GABPB2;FOXC1;ATF6;TBL1X;DHX36;BCOR;ARID4A;CREB3L1
prerank,diacylglycerol kinase activity (GO:0004143),-0.5387885418879216,-1.2927047426689804,0.1628498727735369,0.5332330740520385,1.0,4/11,7.53%,DGKB;DGKI;DGKD;DGKG
prerank,mRNA methyltransferase activity (GO:0008174),0.6120816675642665,1.2890372725331964,0.20512820512820512,0.7311391596918888,1.0,1/12,0.87%,RNMT
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.45088227258467634,1.2840949278083116,0.11060433295324971,0.7425075512364586,1.0,28/91,15.64%,KCNJ2;MARK1;VILL;ANXA2;PLCZ1;GSN;PLEKHA4;FZD7;GBF1;KIF16B;RLBP1;FLII;FCHO2;STXBP6;KRIT1;WDR45B;SLC9A1;RAB35;CGAS;SNX14;SNX18;TTPAL;PARD3;TIRAP;WIPI2;COMMD1;ANXA8;GSDME
prerank,acyl-CoA hydrolase activity (GO:0047617),0.5819326890402461,1.2836968584320145,0.1884272997032641,0.7375093996780548,1.0,6/17,13.08%,ACOT12;ABCD1;ACOT9;ACOT11;ACOT8;ACOT13
prerank,cysteine-type endopeptidase activity (GO:0004197),0.4625191653382257,1.2804467809749733,0.13529411764705881,0.7427720154785137,1.0,30/78,24.18%,CAPN5;USP2;CASP6;USP46;CAPN2;CAPN12;USP24;USP15;USP25;USP13;CASP2;USP1;USP34;USP40;USP28;USP47;PIGK;USP49;USP16;USP10;CAPN1;USP30;GPAA1;USP36;USP9X;CTSK;CTSO;USP7;USP33;USP42
prerank,histone deacetylase binding (GO:0042826),0.4550298836485525,1.2798648501384207,0.12430011198208286,0.7384676091093624,1.0,22/88,15.75%,HES1;HDAC4;HDAC9;GLI3;NIPBL;MEF2A;DACT1;LCOR;MIER1;NCOR1;CCND1;NCOR2;MTA1;BRMS1L;BRMS1;ANKRA2;DHX36;BCOR;KPNA2;THAP7;MEF2D;TRAF6
prerank,NAD binding (GO:0051287),0.5412836932791271,1.2792057818915983,0.1725067385444744,0.7345607896924158,1.0,6/26,13.62%,ME1;BDH2;SIRT6;CRYL1;SORD;SIRT3
prerank,retinoic acid binding (GO:0001972),-0.5161742777189224,-1.279011795824608,0.17073170731707318,0.5543361667093526,1.0,2/12,2.27%,NR2F2;CYP26B1
prerank,triglyceride lipase activity (GO:0004806),0.5616140382147905,1.2788787840552136,0.18220946915351507,0.7293972191054333,1.0,6/20,17.98%,PLA2G15;PNPLA3;PNPLA2;LCAT;CEL;DAGLB
prerank,glucuronosyltransferase activity (GO:0015020),0.5591349476324445,1.278117105141959,0.19133034379671152,0.7259416927473574,1.0,3/19,10.81%,EXT1;LARGE1;B4GAT1
prerank,G protein-coupled photoreceptor activity (GO:0008020),-0.5194601381042059,-1.2755386983022334,0.21680216802168023,0.5516205061424797,1.0,12/12,48.10%,OPN3;GPR88;ELOVL4;GPR52;RRH;OPN1MW3;OPN1MW;RHO;OPN5;OPN1SW;GNAT2;OPN4
prerank,protein kinase regulator activity (GO:0019887),0.4504130290623478,1.2750026324600083,0.11982082866741321,0.7305434005811363,1.0,30/95,19.87%,CCNA2;WNK1;WNT11;FGF13;ELP3;KIDINS220;PARVA;CCNL1;CCNL2;STRADA;CCND1;CCNB1;DUSP19;QARS1;DNAJC3;CCNYL1;CAB39;CDKN1C;CDKN1B;MARK2;CCNG1;CCNT2;NCK1;CDKN1A;SOCS3;NCKAP1L;ELP4;HEXIM1;ANKRD54;CCNT1
prerank,NF-kappaB binding (GO:0051059),0.5385983346053614,1.2739709660756442,0.18407310704960836,0.7280686029501985,1.0,9/24,19.98%,ANXA4;GSK3B;BRMS1;CPNE1;MTDH;PSMA6;COMMD7;HDAC2;HIF1AN
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.5551823932980938,1.271466700942289,0.18679775280898878,0.7306590842150941,1.0,10/21,30.87%,REV3L;POLE2;POLI;PRIMPOL;POLB;POLM;POLK;POLQ;POLA1;POLD1
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.6022083598515275,1.263702573870796,0.21386430678466076,0.7507746461649906,1.0,1/14,0.23%,KCNJ2
prerank,cation channel activity (GO:0005261),0.44200195025842304,1.262512338055431,0.12330316742081449,0.7490339237038341,1.0,14/94,11.52%,PIEZO2;KCNK5;SLC24A3;PKD1;ANXA2;ANO6;TRPM7;TRPM6;CALHM5;SEC61A1;TRPM4;TRPM8;NALCN;MCU
prerank,protease binding (GO:0002020),0.44612328350826796,1.2624353397888053,0.12111111111111111,0.7433521457430572,1.0,22/99,13.75%,F3;SLC2A13;ANXA2;CRADD;COL3A1;LDLR;GSK3B;TIMP1;SERPINB9;LCOR;FN1;ITGB1;ADRM1;TIMP2;VCP;LONP2;ITGAV;RIPK2;COL1A2;CARD16;ITGB3;TYSND1
prerank,kinase activator activity (GO:0019209),0.516709414607977,1.2612103472919147,0.20160213618157544,0.741729889289184,1.0,7/30,12.68%,WNK1;WNT11;FGF13;STRADA;DUSP19;CAB39;MARK2
prerank,phosphatase binding (GO:0019902),0.4431946095222292,1.254223803923089,0.1318082788671024,0.7605318110194136,1.0,25/105,13.52%,EGFR;MET;MAP3K5;WNK1;FCRL6;SHOC2;STAT3;ANAPC5;PPP1R3C;VRK3;ERBB2;STYXL1;CRY2;AP3B1;IKBKE;SMAD2;MAST2;VCP;PPP6R3;TRPC4AP;JUP;CDKN1B;TRAF2;DLG1;PDLIM4
prerank,transferrin receptor binding (GO:1990459),0.6299217736901127,1.253620016866399,0.2229299363057325,0.7566105265248103,1.0,4/10,19.76%,SNX2;IKBKG;IKBKB;CHUK
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.4780184283767114,1.253430599486993,0.17380352644836272,0.7514036672702291,1.0,9/46,15.47%,EXT1;B3GNT2;MGAT4C;HEXA;LARGE1;B4GAT1;B3GNT9;MGAT1;MGAT5
prerank,peptidoglycan binding (GO:0042834),-0.5372333536457281,-1.2531826717451848,0.19788918205804748,0.595987728108888,1.0,6/10,30.57%,NOD1;PGLYRP1;NOD2;JCHAIN;NLRP3;TLR2
prerank,glycerophospholipid flippase activity (GO:0140333),-0.5265877573854452,-1.2531497075875626,0.2111111111111111,0.5841583753504416,1.0,6/11,14.65%,ABCA4;ATP11C;ATP8A1;ATP8A2;ATP10B;ABCB4
prerank,phospholipase activity (GO:0004620),0.4592427188714693,1.2506969068943194,0.15795724465558195,0.7550171584704887,1.0,11/67,10.49%,PLCE1;MGLL;PLCB3;PLA2G4F;PLA2G15;LYPLA2;SMPDL3A;PNPLA3;ABHD6;LYPLAL1;SEC23IP
prerank,enoyl-CoA hydratase activity (GO:0004300),0.613593059301189,1.2490379760662544,0.22570532915360503,0.7552425172817008,1.0,7/10,26.31%,EHHADH;AUH;ECHDC1;ECHDC2;ECI1;HADHA;HSD17B4
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.4265740160791973,-1.2478067103992254,0.15181518151815182,0.5861582050557272,1.0,7/24,14.63%,OSBPL8;CERT1;PLEKHA5;GSDMD;DAB2IP;JPH2;SNX3
prerank,phospholipid transfer activity (GO:0120014),0.5366203108696872,1.2421958706462062,0.21897810218978103,0.7726521800549183,1.0,3/21,3.78%,TNFAIP8L3;PITPNC1;PITPNA
prerank,vitamin D receptor binding (GO:0042809),0.5721996828863549,1.240120130166499,0.2291350531107739,0.7744577847357146,1.0,4/14,8.76%,MED13;MED24;THRAP3;RXRA
prerank,miRNA binding (GO:0035198),0.5093744047764702,1.2394048404886895,0.20054945054945056,0.7712978304545779,1.0,15/30,29.21%,ZC3H7A;AGO2;TUT7;TUT4;ZC3H12A;DDX21;HNRNPA2B1;PUM2;PUM1;FMR1;TRIM71;RBM4;ZC3H10;AGO1;ELAVL1
prerank,protein tyrosine kinase activity (GO:0004713),-0.3063345880886148,-1.239356568733069,0.09090909090909091,0.596582364777073,1.0,31/108,10.33%,FLT1;IGF1R;LYN;TEK;PEAK1;PDGFRB;KIT;MERTK;EPHB1;EPHA6;TEC;TIE1;KDR;EPHA7;ERBB4;INSR;ROR2;EPHA5;RYK;EPHA8;EPHA4;AXL;DYRK1A;LMTK2;FGFR4;NTRK2;BMX;ALK;AATK;TNK2;FLT3
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.4288231993718487,-1.2388329896866226,0.1737704918032787,0.5864689089982589,1.0,8/23,10.44%,PDE8B;PDE4B;PDE7B;PDE1A;PDE4D;PDE2A;PDE8A;PDE1C
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.5764745128986606,1.237975320267023,0.22255192878338279,0.7706127556265764,1.0,2/15,5.86%,PLA2G4F;PLA2G2C
prerank,voltage-gated ion channel activity (GO:0005244),-0.4889823490379011,-1.2373713497141818,0.23098591549295774,0.5794085976181038,1.0,3/14,6.28%,KCND2;CACNA1E;HCN1
prerank,nuclear export signal receptor activity (GO:0005049),0.60044230029569,1.236705165891722,0.23529411764705882,0.7695522747438418,1.0,5/11,16.18%,NUP214;XPO1;XPO4;XPO7;CSE1L
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.4456654859736438,1.2359141397026387,0.16587677725118483,0.7667891497326147,1.0,21/72,15.64%,KCNJ2;MARK1;VILL;ANXA2;PLCZ1;GSN;PLEKHA4;FZD7;FLII;FCHO2;STXBP6;KRIT1;SLC9A1;RAB35;CGAS;SNX18;PARD3;TIRAP;COMMD1;ANXA8;GSDME
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.4490058843172535,-1.235182083158784,0.20625,0.5736898464783655,1.0,7/17,9.79%,GRIK2;GRIA4;GRIN2A;GRIN2B;GRIA1;GRIN1;GRIA3
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.4158881989086293,1.2345982938271391,0.09801876955161627,0.7654139186102435,1.0,37/181,13.59%,ZFPM2;TCF7L2;HES1;HDAC4;ANXA4;TACC2;PRRX1;PITX2;NFE2L2;ID2;WWP2;GSK3B;BCAS3;KLF4;MDFIC;STAT3;MEF2A;DACT1;BHLHE40;MIER1;CREBBP;NCOR1;NCOR2;GATA4;KDM1A;RXRA;MTA1;TADA3;ARNT;BRMS1;ZFPM1;JUP;CPNE1;MTDH;HIRA;NFATC1;DMAP1
prerank,FAD binding (GO:0071949),0.5279005441596467,1.2343334582041365,0.21297602256699577,0.7607897139848213,1.0,4/24,7.14%,MICAL2;MMACHC;AGPS;CRY2
prerank,transcription cis-regulatory region binding (GO:0000976),0.4053915849915458,1.2338069384093489,0.06030150753768844,0.7570755021941307,1.0,93/406,17.32%,BNC2;FOXP1;VSX1;SIX1;PLAGL1;TCF7L2;HDAC4;CUX1;TWIST2;SMAD6;FOXN3;PBX1;PURG;SOX9;DMBX1;GRHL2;PITX2;NFE2L2;GRHL1;FOXC2;MLXIP;RARA;KLF4;GLI3;TWIST1;ARID4B;STAT3;FOXO3;KLF10;PER1;MEF2A;NFIL3;PRDX5;AGO2;GLIS2;RORA;CRY2;NCOR1;E2F3;IRF1;SMAD2;CHD3;MLX;EGR1;GATA4;PER3;RXRA;HIF3A;GABPB1;GABPB2;FOXC1;ARNT;ATF6;TBL1X;DHX36;BCOR;ARID4A;ZNF25;CREB3L1;TEAD1;TFDP1;RXRB;ZBTB8B;NFXL1;HSF2;BRCA1;NR1D1;ZBTB8A;ZFP3;LMX1A;SREBF1;E2F1;NFYA;PRDM2;RFXANK;HINFP;SP3;TAF4;NR3C1;E2F2;MEF2D;HOXD3;PAX6;MZF1;ATF1;PRDM5;SMAD4;FOXK1;YAP1;E4F1;KMT2D;RB1;ZBTB7B
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.4396717176766465,1.2332492071617702,0.17109826589595376,0.753617748760106,1.0,11/75,13.96%,ME1;EHHADH;ADH7;BDH2;RDH12;CBR3;CRYL1;SORD;DHRS3;KDSR;ADH5
prerank,SUMO transferase activity (GO:0019789),0.5593653722567526,1.232611045244245,0.21936459909228442,0.7502952346240552,1.0,8/16,29.29%,HDAC4;RANBP2;PIAS2;PIAS1;TOPORS;PIAS3;UBE2I;PIAS4
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.4416967773923234,-1.2311995319794344,0.19269102990033224,0.5728407152504614,1.0,8/21,10.44%,PDE8B;PDE4B;PDE7B;PDE1A;PDE4D;PDE2A;PDE8A;PDE1C
prerank,chemorepellent activity (GO:0045499),-0.4041880099895294,-1.2306934119288426,0.17938931297709923,0.5643610147319255,1.0,15/25,20.82%,SEMA6A;NRG3;SEMA7A;DPP4;EPHA7;SEMA6D;SEMA3B;SEMA5A;SEMA3G;SEMA5B;SEMA6B;SEMA4G;SEMA3A;SEMA3F;SEMA4D
prerank,N-methyltransferase activity (GO:0008170),0.5462891298623281,1.2305242126117502,0.23198847262247838,0.7520588101706226,1.0,4/20,15.93%,RNMT;NNMT;METTL15;TRMT11
prerank,histone acetyltransferase activity (GO:0004402),0.5042142879097283,1.2277995356931999,0.21372031662269128,0.7556687575133653,1.0,17/30,29.23%,SRCAP;CREBBP;TADA3;NAA40;KAT6B;ATF2;BRCA2;NAA60;EPC1;BAZ1A;KAT6A;EPC2;TADA2A;KAT8;HAT1;KAT2B;NAA50
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.5314042331157656,-1.2259018843377116,0.23733333333333334,0.5661802621615197,1.0,3/10,3.02%,SLC6A13;SLC6A12;SLC6A1
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.5203112459160874,1.223012227112765,0.23529411764705882,0.7658594883479763,1.0,6/24,13.66%,IP6K1;IP6K2;PPIP5K1;AK4;AK3;AK1
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.4112339216168294,1.222750988787185,0.12937433722163308,0.7616003541983304,1.0,35/173,16.48%,FOXP2;FOXP1;KLF12;PLAGL1;ZFHX3;HES1;FOXP4;SKIL;JDP2;ZNF148;FOXO3;SKI;ZBTB16;NFIL3;NFATC4;BHLHE40;NFATC3;MLX;ERF;ZNF25;CREB3L1;ZBTB1;ZBTB32;NR2F1;NR1D1;BATF3;GTF2IRD1;PATZ1;PRDM2;ZBTB34;NR3C1;ZNF219;MZF1;PRDM5;FOXK1
prerank,BMP binding (GO:0036122),-0.5061748342271646,-1.2224077831024849,0.23872679045092837,0.5644749914336266,1.0,2/11,1.89%,ENG;GREM2
prerank,receptor ligand activity (GO:0048018),0.4053713470722911,1.2194801545893819,0.08952187182095625,0.7669963738222895,1.0,28/245,6.79%,BMP4;WNT9A;OSGIN2;PGF;SEMA3E;DEFB130A;TNFRSF11B;BMP5;WNT11;FGF2;EDA;SLURP1;NGF;FAM3C;VEGFA;TGFB3;CLCF1;GDF10;CCL3;TIMP1;SEMA3C;PTHLH;IL33;SEMA3D;NBL1;BMP6;CTF1;INHBA
prerank,endodeoxyribonuclease activity (GO:0004520),0.5253142111001213,1.2184164927818706,0.2263083451202263,0.7656356170877505,1.0,8/20,23.71%,EXO1;ERCC5;APEX1;RAD50;APLF;ERCC4;EXOG;RBBP8
prerank,death receptor binding (GO:0005123),0.5639655571619693,1.2182008098140829,0.2541856925418569,0.7613182147808397,1.0,5/15,14.67%,EDA;NGF;FEM1B;MYD88;PIDD1
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.46413031720585535,-1.217681171514673,0.19736842105263158,0.5571566903730283,1.0,6/16,7.45%,PTPRG;PTPRB;PTPRM;PTPRT;PTPRN2;PTPRO
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.46413031720585535,-1.217681171514673,0.19736842105263158,0.5571566903730283,1.0,6/16,7.45%,PTPRG;PTPRB;PTPRM;PTPRT;PTPRN2;PTPRO
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.5271904520826766,-1.21654967800721,0.2133676092544987,0.5508094415727136,1.0,4/10,9.48%,DPP10;DPP4;PRCP;DPP6
prerank,RNA cap binding (GO:0000339),0.5536042828249116,1.2106294205252723,0.2530487804878049,0.7806369966769496,1.0,8/16,28.66%,CYFIP2;EIF4E3;AGO2;CYFIP1;GEMIN5;LSM1;SNUPN;NCBP3
prerank,frizzled binding (GO:0005109),0.48803740829288716,1.2056983105539378,0.24025974025974026,0.7914122976669229,1.0,6/34,6.17%,WNT9A;LRP6;WNT11;FZD1;FZD7;MYOC
prerank,MAP kinase activity (GO:0004707),-0.4595704246327552,-1.2046493430762568,0.254601226993865,0.570220139154205,1.0,4/14,12.82%,MAPK4;MAPK6;MAPK1;MAPK10
prerank,low-density lipoprotein particle binding (GO:0030169),0.5390724402855996,1.2042865845730637,0.25595238095238093,0.7909222440969969,1.0,2/16,3.46%,THBS1;LDLR
prerank,potassium ion leak channel activity (GO:0022841),0.5569162577642898,1.203603650676466,0.2656716417910448,0.7879107864657083,1.0,1/15,0.18%,KCNK5
prerank,cysteine-type peptidase activity (GO:0008234),0.4374395837437445,1.2023455007449393,0.20521945432977462,0.7871891493598394,1.0,31/73,24.18%,USP2;CASP6;USP46;CAPN2;USP24;USP15;USP25;USP13;CASP2;TINAGL1;USP1;USP34;USP40;ATG4C;ATG4B;USP28;ATG4A;USP47;USP49;USP21;USP16;USP10;USP30;USP36;GGH;USP9X;CTSK;CTSO;USP7;USP33;USP42
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.5235651572531768,1.201179854435394,0.2569832402234637,0.7861648438734448,1.0,9/22,15.79%,TAB3;IKBKG;IKBKE;UIMC1;WDR81;TAB2;ZBTB1;ZRANB1;PRPF8
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.5763088044617177,1.200525815733725,0.2719869706840391,0.7834918163704013,1.0,6/11,30.27%,SLC25A25;SLC19A1;SLC35B3;LRRC8A;SLC17A9;SLC25A24
prerank,DNA-binding transcription factor binding (GO:0140297),0.4002239353970462,1.1984218447070927,0.15163934426229508,0.7853280443858239,1.0,53/189,20.09%,ZFPM2;TCF7L2;HES1;HDAC4;HDAC9;PRRX1;PITX2;NFE2L2;ID2;WWP2;GSK3B;TXLNG;KLF4;TLE2;TWIST1;STAT3;SKI;MEF2A;DACT1;BHLHE40;MIER1;CREBBP;NCOR1;SMAD2;CBX5;GATA4;KDM1A;MTA1;CRTC2;ZFPM1;CRTC1;MTDH;HIRA;NFATC1;DMAP1;MEF2D;ZMYND8;MAP3K10;PRDM5;SIK1;YAP1;HCFC1;RB1;TLE6;ATF2;DHX9;MKKS;PIAS2;PPARG;HDAC2;ZBTB7A;TCF12;NEK6
prerank,protein tyrosine phosphatase activity (GO:0004725),0.43650323825362414,1.198171716478065,0.20094562647754138,0.7812353536750583,1.0,13/71,8.48%,EYA2;UBASH3B;PTP4A2;PTPN3;PTPRU;PTPRF;EYA4;PTPDC1;PTPN2;ACP4;CDC14A;PTPRA;DUSP11
prerank,iron ion binding (GO:0005506),0.4584050792780222,1.1976187742144164,0.24936061381074168,0.778196777574763,1.0,18/48,25.31%,AOX1;EGLN3;FDX1;ALKBH8;TYW5;ACO2;FXN;AGMO;ALOX5;FTO;SCD;NFU1;HIF1AN;PHF8;JMJD6;ALKBH1;KDM3A;HEPH
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.5662697649391986,1.1975892372974979,0.272,0.7734854365867739,1.0,7/12,31.95%,SLC25A25;SLC19A1;SLC35B3;LRRC8A;SLC17A9;SLC25A24;SLC25A5
prerank,DNA polymerase activity (GO:0034061),0.5158905733721736,1.1971156834481032,0.2538141470180305,0.7701615464393683,1.0,8/22,25.86%,REV3L;POLE2;POLI;PRIMPOL;POLB;POLM;POLK;POLQ
prerank,nuclease activity (GO:0004518),0.4408412625574007,1.1962830285044266,0.2340686274509804,0.7682440323671753,1.0,15/52,20.84%,N4BP2;EXO1;STK31;ERCC5;APEX1;WRN;ZC3H12A;RNASE3;RNASEH2A;MAP1S;PLSCR1;ERN2;DIS3;EXOG;REXO1
prerank,protein phosphatase 2A binding (GO:0051721),-0.406822792540615,-1.1943769108925202,0.22857142857142856,0.586057943251344,1.0,8/23,11.75%,MFHAS1;CTTNBP2NL;FOXO1;DAB2IP;MAPT;SPHK1;ANKLE2;SMG7
prerank,ion channel inhibitor activity (GO:0008200),0.48352240562482385,1.1936961082948707,0.2617801047120419,0.7717852769376589,1.0,4/35,1.67%,NEDD4;KCNMB2;WNK1;CAMK2D
prerank,endonuclease activity (GO:0004519),0.45229313057994547,1.1934778111947442,0.23325062034739455,0.7678921157101468,1.0,15/49,20.59%,N4BP2;ERCC5;SMG6;AGO2;APEX1;ZC3H12C;ZC3H12A;ZC3H12B;CPSF3;ERN2;APLF;DIS3;ERCC4;EXOG;YBEY
prerank,3'-5' exonuclease activity (GO:0008408),0.4582370870300051,1.192758129035571,0.22014925373134328,0.7653244047746106,1.0,20/45,28.21%,REV3L;ERI3;CNOT8;APEX1;WRN;ANGEL2;RAD50;EXOSC3;REXO2;ERI1;APLF;DIS3;EXOSC2;EXOSC7;TATDN1;RAD9A;ANGEL1;PARN;ERI2;EXD1
prerank,5'-3' RNA polymerase activity (GO:0034062),0.5000644408738195,1.1905967672870774,0.25761772853185594,0.7677718086630271,1.0,9/27,18.58%,POLR1A;POLR1D;POLR3F;POLR3A;TENT2;POLR3K;POLR1F;MED20;POLR2C
prerank,clathrin adaptor activity (GO:0035615),0.5451984559128754,1.1895438567764636,0.28421052631578947,0.7665849815754897,1.0,7/15,23.60%,STON2;AP2A2;STON1;AP2B1;AP2A1;AP1M1;DAB2
prerank,carboxypeptidase activity (GO:0004180),-0.3672482663196851,-1.1895428080060597,0.1774193548387097,0.5883905705620435,1.0,9/35,17.80%,AEBP1;AGBL4;CTSA;ACE2;MINDY1;PEPD;FOLH1;CTSZ;CPXM1
prerank,single-stranded RNA binding (GO:0003727),0.4646196470736351,1.188270722517916,0.2506265664160401,0.7661105741638468,1.0,11/43,18.46%,STRBP;U2AF2;AGO2;ZFR;IFIH1;TLR8;ZFR2;DDX11;SRA1;EIF4B;DHX9
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.5249303154089022,1.185419511992755,0.2793696275071633,0.7708426552128603,1.0,13/20,27.40%,USP25;SENP5;DESI2;COPS5;USP47;OTUD5;USP21;COPS2;USP9X;SENP1;USP7;SENP2;SENP3
prerank,Wnt-activated receptor activity (GO:0042813),0.551960054673459,1.1835510666980757,0.2595307917888563,0.772153121140113,1.0,4/15,7.13%,PKD1;FZD1;FZD7;ROR1
prerank,ADP binding (GO:0043531),0.5014590669943735,1.182699962247561,0.2749326145552561,0.7702461130551966,1.0,4/25,10.01%,ME1;GCLC;ABCD1;MIEF1
prerank,delayed rectifier potassium channel activity (GO:0005251),0.48551447557984334,1.1807289576327356,0.264,0.7721193842555185,1.0,3/32,3.07%,KCNB2;KCNB1;KCNS3
prerank,DNA binding (GO:0003677),0.38139246187371845,1.1804954934715077,0.048,0.7684792237652848,1.0,159/694,19.88%,FOXP2;KLF12;SIX1;EGFR;PLAGL1;TCF7L1;TCF7L2;NFIB;SLTM;FOXD1;HES1;HDAC4;ZIC4;CUX1;RARB;HOXA5;MEOX2;PBX1;FOXL1;EHF;SOX9;DMBX1;SOX14;GRHL2;ZNF423;NFE2L2;GRHL1;ZNF148;EXO1;MPG;COLEC11;FOXC2;ABL1;CHTF18;ERCC5;NR4A3;CCDC25;C1D;STAT3;FOXO3;NABP1;CDC45;MCM2;RAD51;ZBTB16;MEF2A;GLI2;NR4A2;MBD1;CREBBP;RORA;CRY2;APEX1;E2F3;WRN;ZMYM4;IRF1;SMAD2;CHD3;ZC3H12A;MLX;MLXIPL;EGR1;GATA4;THRAP3;DNMT3A;RXRA;STN1;FOXC1;TOP1;SMC6;ILF2;ARNT;NEIL3;CLSPN;ATF6;HDGFL3;POU4F1;DHX36;RAD23B;ARID4A;ERF;KIN;CGAS;DENND4A;WDR48;MECP2;RFX2;TLR8;TEAD1;POLR3F;RAD50;ZBTB32;RNF138;NR2F1;BRCA1;EZH1;SREBF1;NR4A1;MBD3;E2F1;HOXA7;NFYA;PATZ1;SIRT3;DDX11;MAP1S;PRDM2;DNTTIP1;HINFP;TAF4;BRIP1;KHDRBS1;MSL3;RTF2;MCM7;POU2F1;FOSB;DNASE2;E2F2;PRKDC;ZNF219;SMC1A;FAM111A;KDM5B;PAX6;SMARCA5;PRDM5;SMAD4;RNF11;TSHZ2;CHD8;ESR2;POLG2;KMT2D;CAMTA2;PCID2;POU6F1;NUP35;MCM9;BRCA2;MTERF2;DHX9;BCLAF3;RBM6;PPARG;RFC1;MBD5;AIFM1;HDAC2;PARP4;CARF;DEDD;MAFF;CEBPG;XRCC5;LIN9;CCNT1;ZBTB7A
prerank,CARD domain binding (GO:0050700),0.5450483123485512,1.1796955936629372,0.28708133971291866,0.7663596785309182,1.0,4/14,13.46%,CARD14;MAVS;RIPK2;CARD16
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.5494813853811314,1.1785331648795427,0.283987915407855,0.7657524762934304,1.0,3/14,11.78%,ADH7;RDH12;DHRS3
prerank,protein phosphatase binding (GO:0019903),0.4098651619169444,1.1773995209166015,0.20877944325481798,0.7650936430419489,1.0,26/117,13.52%,EGFR;MET;MAP3K5;PPP1R3B;FCRL6;SHOC2;STAT3;ANAPC5;PPP1R3C;ATP2B4;VRK3;ERBB2;STRN;STYXL1;AP3B1;IKBKE;VCP;PTPA;SLC9A1;PPP6R3;IGBP1;JUP;CDKN1B;TRAF2;STRN3;PDLIM4
prerank,thyroid hormone receptor binding (GO:0046966),0.48734052146224505,1.1761776886884008,0.2792297111416781,0.7644887431706047,1.0,9/28,13.29%,JMJD1C;MED13;NCOR1;MED24;THRAP3;NSD1;GAS2L1;NCOA6;TRIP12
prerank,histone methyltransferase activity (GO:0042054),0.48586767103845574,1.1746590229564289,0.27055702917771884,0.7646540703378478,1.0,21/32,32.86%,KMT2C;PRMT8;SETD2;EHMT1;EED;KMT5B;PRMT5;KMT5A;SMYD3;KMT2E;PRMT6;SUZ12;SMYD2;SETD7;CARM1;DOT1L;NTMT1;SETDB1;MEN1;EHMT2;PRDM9
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.44073233458828354,1.170494985595791,0.24231242312423124,0.7725306155306968,1.0,7/54,6.81%,ACER3;HDAC4;HDAC9;VNN1;HDAC8;SIRT6;MIER1
prerank,GTPase regulator activity (GO:0030695),-0.27650774205646994,-1.1690808819169942,0.1111111111111111,0.6298266271468594,1.0,46/212,10.25%,PLCB1;RANBP3L;PREX2;ARHGAP28;ASAP1;ARHGAP29;TBC1D4;CHN2;ERRFI1;ARHGAP24;RASGRP3;RGS3;ADGRB3;ALDH1A1;CPEB2;ARHGAP32;RGS7;RIMS1;RAPGEF2;ARHGAP26;RALGAPA2;RGS5;ARAP3;RALGAPA1;USP6NL;RGS12;SIRPA;ARHGAP22;SIPA1;VAV3;IQGAP2;HACD3;TBC1D8;ELMOD1;OPHN1;ARHGAP25;ARHGAP39;TBC1D30;ABR;EVI5L;TBC1D9;STXBP5L;ARHGEF10L;RHOH;SYDE2;TNK2
prerank,protein kinase inhibitor activity (GO:0004860),0.456681087066658,1.1686226790448757,0.2633587786259542,0.7738966328717289,1.0,14/42,17.39%,CIT;SPRED2;PARVA;IBTK;CEP43;CIB1;DUSP19;QARS1;DNAJC3;CDKN1C;CDKN1B;NCK1;CDKN1A;SOCS3
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.5823774369442059,1.167666352698183,0.29549248747913187,0.7723920054266892,1.0,5/10,26.31%,EXO1;APEX1;DCLRE1A;TATDN1;MGME1
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.5433324598750021,1.1646129135025884,0.3106508875739645,0.7769968723723855,1.0,7/14,23.82%,USP15;USP13;DESI2;MINDY3;OTUD5;USP9X;USP7
prerank,sialyltransferase activity (GO:0008373),-0.4220156970429655,-1.1645195234991768,0.24734982332155478,0.631746694402951,1.0,8/20,7.51%,ST6GALNAC3;ST6GAL1;ST8SIA4;ST3GAL1;ST3GAL6;ST3GAL3;ST8SIA1;ST8SIA6
prerank,actin monomer binding (GO:0003785),0.49775705342927146,1.1637303754874766,0.2913165266106443,0.7752835632304305,1.0,5/22,6.04%,COBL;PRKCE;ABL1;MRTFA;LIMA1
prerank,SUMO binding (GO:0032183),0.5504298501721672,1.1620508026826064,0.31345565749235477,0.7759895748928992,1.0,6/13,24.99%,HERC2;USP25;RNF111;SERBP1;PML;TDG
prerank,receptor antagonist activity (GO:0048019),0.526211271765873,1.1617209612524455,0.29185185185185186,0.7728528973262946,1.0,4/17,16.97%,ADH7;DKK3;WFIKKN1;ESR2
prerank,protein phosphatase 1 binding (GO:0008157),0.5008902154824586,1.1613942151486787,0.29445234708392604,0.7696335024219059,1.0,3/21,5.50%,PPP1R3B;SHOC2;PPP1R3C
prerank,transition metal ion binding (GO:0046914),0.3767507426563025,1.1612538202832006,0.11711711711711711,0.7660298270695101,1.0,90/397,16.08%,AOX1;ME1;ZFPM2;ACER3;HDAC4;ADH7;MPPED2;TES;CBLC;TNP2;FDX1;ADAMTS3;KLF4;ADA;LIMS1;TIMP1;S100B;ABL1;PLA2G15;LARGE1;KLF7;CLIP1;SKI;EEA1;TAB3;ECE1;XPNPEP3;XPNPEP1;GLI2;MNAT1;SIRT6;PLSCR3;MBD1;NPEPPS;B4GALT1;ZFYVE1;SEC24B;SMPDL3A;WRN;ZMYM2;ZDHHC20;TIMP2;CHD3;PHEX;AOC3;ARG1;SEC23A;EGR1;MMP16;RXRA;NUDT12;ARIH1;EPRS1;ALKBH8;IFIH1;CUTC;TYW5;SEC24D;NSD1;SORD;CDADC1;TAB2;IDE;TK1;ACO2;CHORDC1;ESCO1;ZBTB32;AGMO;SCO2;UBA5;MDM4;ZDHHC15;DPEP1;SIRT3;PRDM2;ADH5;RNF8;COMMD1;PRIMPOL;MGAT1;TIMM9;PLSCR1;MGAT5;ZMYND8;CCS;ALOX5;KDM5B;DPP3;HHIP
prerank,small GTPase binding (GO:0031267),0.3932251415705445,1.1610507295739914,0.21480709071949947,0.7625793202250702,1.0,50/170,18.27%,PLCE1;CDC42EP5;EXOC4;UNC13B;SGSM2;SRGAP2;AKAP13;ERC1;YBX3;ARHGDIB;NDRG1;HPS4;MLPH;PDE6D;RANGRF;DOCK7;SIKE1;RAB11FIP3;ARFIP2;RGP1;CIB1;TNPO3;KIF3B;FGD1;RAF1;AP3M1;OCRL;STRN3;RANBP2;EHD1;FGD3;NUTF2;SORL1;PARD6A;ANKRD27;PIH1D2;EVI5;BICD1;CYFIP1;RNF41;FGD6;RABGAP1;AFDN;CDC42EP2;IQGAP1;ANKFY1;GOLGA4;LRRK2;MTSS2;MYCBP2
prerank,FMN binding (GO:0010181),0.5661081719926949,1.1571802093026027,0.3044189852700491,0.7700413321515712,1.0,2/11,4.72%,IYD;PNPO
prerank,regulatory RNA binding (GO:0061980),0.4528440623263255,1.1555464490349565,0.266839378238342,0.7708176572896751,1.0,18/38,30.07%,ZC3H7A;AGO2;TUT7;TUT4;ZC3H12A;DDX21;HNRNPA2B1;DHX9;PUM2;PUM1;FMR1;TRIM71;RBM4;ZC3H10;DICER1;AGO1;ELAVL1;PIWIL2
prerank,GTPase activator activity (GO:0005096),-0.26421246279733024,-1.1544989502260719,0.0,0.6473300922471906,1.0,62/313,9.23%,PLCB1;RANBP3L;PREX2;ARHGAP28;ASAP1;ARHGAP29;RAPGEF5;TBC1D4;DOCK10;RAPGEF4;CHN2;ERRFI1;ARHGAP24;DENND2A;RASGRP3;DOCK11;ELMO1;RGS3;ADGRB3;SBF2;ALDH1A1;FGD5;RAPGEF3;RASGRF1;RASGRF2;ARHGAP32;RGS7;RAPGEF2;ARHGAP26;RALGAPA2;RGS5;RASGRP2;RALGPS1;ARAP3;RALGAPA1;USP6NL;ARHGAP22;DOCK2;SIPA1;VAV3;IQGAP2;HACD3;EPS8L2;TBC1D8;ELMOD1;NGEF;OPHN1;ARHGEF15;ARHGAP25;ARHGAP39;TBC1D30;SPATA13;ABR;CYTH1;DENND5A;RGL1;EEF1B2;EVI5L;TBC1D9;STXBP5L;ARHGEF10L;DENND4C
prerank,potassium channel activity (GO:0005267),0.410520700539101,1.1532739442805116,0.268348623853211,0.7735540620057288,1.0,7/89,3.64%,KCNK5;KCNB2;KCNMB3;KCNMB2;KCNB1;KCNS3;GRIK4
prerank,calcium ion binding (GO:0005509),0.37575426828851377,1.1532419037668724,0.1659959758551308,0.7696372029265186,1.0,38/323,10.25%,SLIT3;SLIT2;SMOC2;THBS1;CDH11;ACER3;ESYT3;CDH1;PPP3CA;ANXA2;GSN;ANXA4;CASR;SLIT1;S100G;DSPP;COLEC11;DSG2;PLA2G4F;DSG3;S100B;LRP1;ANXA1;PLA2G2C;PLSCR3;CRACR2A;LTBP4;PCLO;AOC3;TRPM4;ANXA3;TKT;MAN1B1;S100A10;CIB1;ANXA7;RCN1;C2CD5
prerank,adenylyltransferase activity (GO:0070566),0.49120766974493996,1.1503610326828284,0.3124128312412831,0.7743527244885804,1.0,6/21,17.28%,NMNAT2;ABL1;NMNAT1;TENT2;FLAD1;TENT4B
prerank,nuclear localization sequence binding (GO:0008139),0.5216060135220246,1.1481804843172294,0.31334332833583206,0.7768430773575647,1.0,10/18,28.28%,NUP214;NUP153;TNPO2;KPNA1;KPNA2;KPNA4;BRAP;IPO4;POM121;IPO5
prerank,protein serine/threonine kinase activity (GO:0004674),0.3745415044552143,1.1467887858265684,0.17087967644084934,0.7769838545142047,1.0,88/335,18.03%,STK39;EGFR;MAP3K5;MARK1;CIT;GRK5;WNK1;PRKCD;CAMK2D;ULK2;PRKCE;PTK2B;TLK1;BMPR1A;CLK2;CLK1;GSK3B;CDK10;ALPK1;CDK12;HIPK1;TGFBR1;IRAK3;CHEK2;STK16;NEK7;FAM20A;BCR;VRK3;MAPK12;TGFBR2;NRBP2;AURKA;IRAK4;LIMK2;CDK11B;IKBKE;CSNK1A1;NLK;MAST2;TOP1;MAK;GAK;CDK16;RIPK2;CDK13;TTK;AAK1;PLK4;MAP3K7;EIF2AK2;PDK3;CSNK1G3;ULK3;SGK3;CLK4;MAP3K1;RPS6KA3;TRIO;RAF1;MARK2;CDKL2;CSNK1G1;ACVR1;HTATIP2;STK35;PIM2;PRKCA;MARK3;CDK7;PRKDC;CDK2;CDC7;MAP3K10;SIK1;IKBKB;PLK3;CPNE3;ERN2;RPS6KB1;MAP3K14;NEK4;MAP3K4;LRRK2;STK24;STK3;PBK;MAPKAPK2
prerank,monocarboxylic acid binding (GO:0033293),-0.4329160749510656,-1.1463709811503482,0.26174496644295303,0.6579679106351031,1.0,2/18,2.27%,NR2F2;CYP26B1
prerank,leak channel activity (GO:0022840),0.51255072228794,1.1460155265218772,0.30869565217391304,0.7754414816161614,1.0,1/18,0.18%,KCNK5
prerank,CoA-ligase activity (GO:0016405),-0.44693146846799126,-1.145498005120706,0.2920353982300885,0.6509059014082232,1.0,5/14,11.53%,ACSS3;ACSL1;ACSS2;ACSS1;ACSBG1
prerank,ribonuclease P RNA binding (GO:0033204),-0.481951391656518,-1.1447559666463465,0.3100558659217877,0.6436481099179222,1.0,7/10,38.78%,POP4;RPP14;POP7;RPP40;RPP21;POP1;RPP25
prerank,RNA polymerase binding (GO:0070063),0.5087697313904999,1.1394278082183944,0.3103953147877013,0.7913528540652854,1.0,8/18,21.38%,NEDD4;STOM;SCAF8;BRCA1;CCNT2;DHX9;CCNT1;TCERG1
prerank,lysine N-methyltransferase activity (GO:0016278),0.505156067814959,1.1391798082028897,0.31512605042016806,0.7881461854040903,1.0,9/20,26.83%,SETD2;EHMT1;ETFBKMT;EEF1AKMT4;EEF2KMT;KMT5A;SETD6;SMYD2;SETD7
prerank,SH3 domain binding (GO:0017124),0.42181744321427755,1.1390071293647497,0.2819277108433735,0.7846402844230477,1.0,8/62,7.04%,AFAP1L1;DPYSL3;ADAM9;ABI1;CBLC;ABL1;RUFY1;SHANK1
prerank,lipid phosphatase activity (GO:0042577),0.5301783059332634,1.1381787384203228,0.33178294573643413,0.7830956646149473,1.0,2/14,2.48%,PLPP3;PLPPR2
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.5552651959660113,1.137097333067164,0.3208137715179969,0.7826067727614945,1.0,2/10,7.15%,CASP6;CASP2
prerank,kinase binding (GO:0019900),0.3662595647330737,1.135959389856992,0.15678391959798996,0.7822450986873095,1.0,90/434,17.25%,SLC12A7;EGFR;SLC12A2;TCF7L2;PKD1;CIT;CCNA2;WNK1;PRKCD;ANK2;RHOBTB1;GSN;UNC5C;ESR1;TTC28;NBEA;TELO2;DLG2;GSK3B;AP2A2;LIMS1;PLCG2;IRAK3;PTPN2;NR4A3;TAX1BP1;SPRED2;STAT3;CNTLN;SHC1;FOXO3;IBTK;SKI;CHEK2;ACSL3;PER1;TSKS;FAM83E;STRADA;TIAM1;SIKE1;AURKA;IRAK4;BARD1;CEP43;CCND1;BECN1;RND3;CDKN2C;MAVS;LRBA;ATP1A4;CCNB1;ANKRA2;RHOA;PARP1;QARS1;DNAJC3;TOM1L1;CHP1;CAB39;FBXO5;NSF;RB1CC1;MAP3K1;BCAR3;RNF138;CDKN1B;PIP5K1A;TRAF2;DLG1;LYST;NBEAL2;CARD16;CD160;SRCIN1;PPP1R12A;BICD1;NR3C1;DVL1;PTN;TRAF6;PAX6;CDKN1A;LCK;SIK1;IKBKB;IQGAP1;RB1;PTPN23
prerank,lipoprotein particle binding (GO:0071813),0.4949359956130986,1.1347951783934842,0.3196480938416422,0.7818463700689426,1.0,2/20,3.46%,THBS1;LDLR
prerank,acetyltransferase activity (GO:0016407),0.4576005811963647,1.1340436080430032,0.3119891008174387,0.7805172278853438,1.0,16/31,29.87%,ELP3;CREBBP;PAFAH1B2;NAA15;ESCO1;NAT10;PAFAH1B3;KAT6B;LCAT;NAA80;KAT6A;GTF2B;KAT8;KAT2B;NAA50;SMARCE1
prerank,serine-type endopeptidase activity (GO:0004252),0.405572032342888,1.13117459516569,0.30248306997742663,0.785357562854508,1.0,3/80,3.42%,F3;PCSK5;PRSS12
prerank,phospholipase A2 activity (GO:0004623),0.47030020711743636,1.128653673486353,0.3274695534506089,0.7887707187753175,1.0,4/26,8.80%,PLA2G4F;PLA2G15;PLA2G2C;PNPLA3
prerank,store-operated calcium channel activity (GO:0015279),-0.48060506592601004,-1.1244574797059566,0.314070351758794,0.6866016993386679,1.0,7/10,17.33%,TRPC3;TRPC4;TRPC6;TRPC1;ORAI1;ORAI2;TRPC7
prerank,copper ion binding (GO:0005507),-0.33665533407532416,-1.1234938796245173,0.2688679245283019,0.6796853421627924,1.0,16/42,25.69%,PAM;MOXD1;SOD3;LOXL3;LACC1;ATOX1;RNF7;ATP13A2;MT3;SOD1;PRNP;SNCA;S100A13;ACR;GPC1;TYR
prerank,kinase inhibitor activity (GO:0019210),0.4562725617754442,1.1212099563323368,0.34190231362467866,0.806530906094438,1.0,11/33,19.68%,LRP6;PARVA;DUSP19;QARS1;DNAJC3;CDKN1C;CDKN1B;NCK1;CDKN1A;SOCS3;HEXIM1
prerank,cardiolipin binding (GO:1901612),-0.48426563292287494,-1.1209213693440399,0.34048257372654156,0.6773416226861988,1.0,2/10,6.15%,MME;GSDMD
prerank,acid-thiol ligase activity (GO:0016878),-0.44209610221440937,-1.1205827875191323,0.31412103746397696,0.6691059369232176,1.0,4/13,9.08%,ACSS3;ACSL1;ACSS2;ACSS1
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.4463337872561536,1.119741428157225,0.330718954248366,0.8072292493359502,1.0,11/35,23.63%,FOXP1;KLF10;AGO2;TAF4;NR3C1;POU2F1;UBTF;ZBTB17;TBP;TP53;GTF2B
prerank,exonuclease activity (GO:0004527),0.42545726806801776,1.1184885895093297,0.3016069221260816,0.8069447928311305,1.0,20/46,24.90%,REV3L;EXO1;APEX2;APEX1;WRN;ZC3H12A;RAD50;EXOSC3;REXO2;ERI1;EXOSC1;CPSF3;APLF;EXOG;EXOSC2;REXO1;EXOSC7;EXOSC8;AEN;RAD9A
prerank,calcium-release channel activity (GO:0015278),-0.4146090349843639,-1.1172021426086096,0.31329113924050633,0.6682596491605689,1.0,2/17,2.87%,ITPR1;RYR2
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.42629877642263636,1.117169802163928,0.3268529769137303,0.8071193537991158,1.0,16/49,15.83%,TAB3;IKBKG;IKBKE;ZFAND6;UIMC1;WDR81;VCP;TAB2;RAD23B;ZBTB1;ZRANB1;BRCC3;ABRAXAS2;PSMD4;PRPF8;TNIP1
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.40547052142421847,-1.116459899941706,0.3269230769230769,0.6614476909628038,1.0,9/19,14.50%,GRID2;GRIK2;GABRG3;GABRA2;GABRG1;GABRA5;GABRA1;GABRG2;GRIK1
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.48413570011588464,-1.1138594757085043,0.32189973614775724,0.6597129577160464,1.0,7/10,37.29%,NOX1;NOX4;NCF2;NCF1;NOX3;NCF4;DUOX1
prerank,active ion transmembrane transporter activity (GO:0022853),0.4454215506151279,1.1118625463952818,0.3302872062663185,0.818480446382354,1.0,3/37,1.29%,SLCO3A1;SLCO2A1;SLCO4A1
prerank,cholesterol binding (GO:0015485),-0.3274929601135219,-1.1106030777193796,0.2864321608040201,0.6598416211075951,1.0,13/47,13.38%,OSBPL8;APOD;SIDT1;OSBPL10;PROM1;ABCG1;PTCH1;NR1H3;GRAMD1B;OSBPL1A;CD81;SYP;OSBP2
prerank,lysine-acetylated histone binding (GO:0070577),0.4922890914814437,1.1104177722046251,0.3606102635228849,0.8152239045041463,1.0,12/20,31.62%,MLLT3;BRD3;THAP7;ZMYND8;BRD4;BRD9;BAZ2A;SMARCA4;BRDT;CARM1;PSME4;PHIP
prerank,acetylation-dependent protein binding (GO:0140033),0.4922890914814437,1.1104177722046251,0.3606102635228849,0.8152239045041463,1.0,12/20,31.62%,MLLT3;BRD3;THAP7;ZMYND8;BRD4;BRD9;BAZ2A;SMARCA4;BRDT;CARM1;PSME4;PHIP
prerank,sulfuric ester hydrolase activity (GO:0008484),0.5359895598799767,1.1075473403544376,0.3660436137071651,0.8202491491463796,1.0,3/12,7.77%,ARSI;SULF1;ARSB
prerank,snoRNA binding (GO:0030515),0.45577074723526284,1.1069372662198584,0.3302139037433155,0.8181292840499373,1.0,15/30,29.37%,NUDT5;BMS1;NOP56;NUDT1;DDX21;BYSL;PRKDC;XRCC5;NOP14;NUDT4;IMP4;TBL3;IMP3;NUDT16L1;GAR1
prerank,cadherin binding (GO:0045296),0.36031392013391417,1.1055657105637458,0.2530241935483871,0.818371523300172,1.0,80/315,16.29%,EGFR;CDH11;FXYD5;BAIAP2L1;FMNL2;CDH1;CTNND2;ANXA2;ABI1;EZR;MPP7;AHNAK;SNX2;ERC1;TES;PKP1;PLCB3;GIPC1;CLIC1;NDRG1;KRT18;PHLDB2;EMD;SPTAN1;CAST;PAICS;HDLBP;LYPLA2;CTNNA1;ANXA1;PARVA;PCMT1;CALD1;LIMA1;BAG3;BZW1;ARFIP2;VCL;ITGB1;ARGLU1;PDXDC1;STXBP6;EIF4G2;SHTN1;EIF3E;TXNDC9;RDX;GOLGA3;NOP56;CLINT1;PFKP;KTN1;CD46;JUP;STX5;PLIN3;SH3GLB1;NIBAN2;CTTN;MARK2;FLNB;EHD1;DLG1;DBN1;ACVR1;UNC45A;TNKS1BP1;PLEC;CAPZA1;RAB11B;EPS15L1;AFDN;NCK1;CCS;CHMP2B;KIF5B;RAB1A;ADD1;GAPVD1;SCRIB
prerank,protein tyrosine kinase binding (GO:1990782),-0.29582775834349445,-1.1054654903159837,0.2459016393442623,0.6642837540425212,1.0,31/71,24.88%,NRG3;GRM5;PTPN14;NEDD9;CBLB;SIRPA;EPHA4;GRB14;FLT3LG;PITPNM2;SHC4;GAS6;RACK1;SHC3;CDH5;ANGPT2;BLNK;NOX4;SH2B3;SOCS5;HYAL2;DOCK4;TJP2;ARHGEF16;CD247;PCNA;BANK1;TREM2;NRG1;ANGPT4;PHYHIP
prerank,metal ion binding (GO:0046872),0.3574783083413834,1.1049868602007014,0.2092092092092092,0.816327210726624,1.0,54/477,10.67%,SLIT3;SLIT2;SMOC2;THBS1;CDH11;EYA2;ACER3;ESYT3;MAP3K5;MARK1;CDH1;PPP3CA;ANXA2;GSN;GCLC;ANXA4;CASR;SLIT1;S100G;DSPP;COLEC11;NUDT5;DSG2;PLA2G4F;DSG3;S100B;ABL1;IRAK3;LRP1;ANXA1;PLA2G2C;MAPK12;PLSCR3;CRACR2A;APEX1;LTBP4;WRN;PCLO;AOC3;TRPM4;ANXA3;NLK;MAST2;NUDT12;TKT;MAN1B1;S100A10;CIB1;YDJC;ANXA7;RCN1;C2CD5;DHX36;CALU
prerank,endopeptidase inhibitor activity (GO:0004866),-0.29398443233852267,-1.1045732306553668,0.2605042016806723,0.6582255776119216,1.0,16/82,11.47%,COL4A3;SPOCK3;SPOCK2;SPOCK1;APP;TIMP3;PROS1;SERPINI1;CST3;ITIH2;SERPIND1;BST2;BIN1;GAPDH;TFPI;A2M
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.5626567983811718,1.1044651190831487,0.3707692307692308,0.8141171975080297,1.0,8/10,33.99%,SETD2;NSD1;ASH1L;SMYD2;SETD5;SETMAR;PRDM9;NSD3
prerank,myosin II binding (GO:0045159),0.5414093252899604,1.1044444066043506,0.36550632911392406,0.8104919600208249,1.0,2/10,4.64%,GSN;SHROOM4
prerank,low-density lipoprotein particle receptor binding (GO:0050750),-0.3839527905359217,-1.103503914303538,0.3079584775086505,0.6526238506679798,1.0,4/22,6.77%,APOE;PICALM;SYT1;HSPG2
prerank,pseudouridine synthase activity (GO:0009982),0.5235681574351199,1.098895019190433,0.3666146645865835,0.8228320516195914,1.0,4/13,17.69%,PUS7L;RPUSD4;RPUSD2;PUSL1
prerank,metallocarboxypeptidase activity (GO:0004181),-0.36178903162190046,-1.098296531901115,0.3076923076923077,0.6567636582155718,1.0,2/26,0.96%,AEBP1;AGBL4
prerank,single-stranded telomeric DNA binding (GO:0043047),0.5307657651962473,1.0980475733540918,0.38975155279503104,0.8215599770820561,1.0,3/11,17.73%,STN1;RAD50;HNRNPA2B1
prerank,GTPase binding (GO:0051020),0.36911941608034055,1.0971624869292922,0.3154639175257732,0.8206150110106537,1.0,53/195,18.27%,PLCE1;CDC42EP5;EXOC4;UNC13B;SGSM2;SRGAP2;AKAP13;ERC1;YBX3;ARHGDIB;NDRG1;HPS4;MLPH;PDE6D;RANGRF;RRAGB;DOCK7;SIKE1;RAB11FIP3;ARFIP2;BECN1;EPRS1;RGP1;CIB1;TNPO3;KIF3B;FGD1;RAF1;AP3M1;OCRL;STRN3;RANBP2;EHD1;FGD3;NUTF2;SORL1;PARD6A;ANKRD27;PIH1D2;EVI5;BICD1;CYFIP1;RNF41;FGD6;RABGAP1;AFDN;CDC42EP2;IQGAP1;ANKFY1;GOLGA4;LRRK2;MTSS2;MYCBP2
prerank,magnesium ion binding (GO:0000287),0.37542991704821543,1.0970033213198807,0.29449838187702265,0.8174553400868347,1.0,27/135,20.17%,EYA2;MAP3K5;MARK1;GCLC;NUDT5;ABL1;IRAK3;MAPK12;PLSCR3;WRN;NLK;MAST2;NUDT12;TKT;YDJC;DHX36;MARK2;RHEB;PLSCR1;SIK1;ERN2;LRRK2;STK3;SRR;CDC42BPA;NEK6;FOXK2
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.4320639822710234,-1.0948142102656404,0.34560906515580736,0.6575009282328061,1.0,7/14,20.39%,NOD1;CTSH;MAL;ATP2A3;RACK1;PYCARD;CASP1
prerank,neurexin family protein binding (GO:0042043),0.54185121501713,1.0942699267934255,0.38925081433224756,0.8217917868973864,1.0,4/10,16.98%,SYTL4;SYTL5;NLGN1;CEL
prerank,GABA receptor binding (GO:0050811),-0.4638278131885453,-1.0936338442365985,0.3710144927536232,0.6522543316739623,1.0,7/11,33.04%,PLCL2;JAKMIP1;GABARAPL1;GABARAPL2;SHISA7;AKAP5;GABARAP
prerank,transcription coregulator binding (GO:0001221),0.41655606401885004,1.0933446937645124,0.3448275862068966,0.820583478014868,1.0,18/50,20.09%,CIT;ESR1;ZBTB16;PER1;LCOR;EHMT1;RORA;EED;PER3;NR1D1;FAM89B;THAP7;CCNT2;SMAD4;MED25;SUZ12;ZBTB7A;NEK6
prerank,filamin binding (GO:0031005),0.5415571676132276,1.090189623540893,0.3863275039745628,0.8258895647944611,1.0,1/11,0.80%,DPYSL3
prerank,"DNA binding, bending (GO:0008301)",0.5133476919578883,1.0897836044389162,0.38814814814814813,0.823502348086987,1.0,3/14,9.04%,FOXD1;FOXL1;FOXC1
prerank,carboxy-lyase activity (GO:0016831),0.46668068227980003,1.0890128089393651,0.37202797202797205,0.8219181137322731,1.0,10/23,28.25%,CSAD;ECHDC1;ODC1;AZIN1;GGCX;PPCDC;UMPS;MVD;GAD1;PISD
prerank,GABA receptor activity (GO:0016917),-0.3842314474968186,-1.0886467678742677,0.3079584775086505,0.656138393848773,1.0,10/21,14.15%,GABRG3;GABRB3;GABRB1;GABRA2;GABRB2;GABBR2;GABRG1;GABRA5;GABRA1;GABRG2
prerank,ribosome binding (GO:0043022),0.41727011240638195,1.0882668295716906,0.3566958698372966,0.82062673873065,1.0,16/46,24.00%,RPSA;MTIF3;SEC61A1;ZC3H12A;MRPS27;EIF6;ETF1;EIF2S1;NAA15;SRP19;ERI1;SERBP1;GEMIN5;FMR1;SRP72;SEC61B
prerank,estrogen receptor binding (GO:0030331),-0.34436773006837024,-1.0849660942078747,0.3229571984435798,0.6562859220529373,1.0,4/32,2.48%,TACC1;LEF1;NCOA1;PPARGC1B
prerank,CCR chemokine receptor binding (GO:0048020),0.4484204693248096,1.0826833848763826,0.38191632928475033,0.8329400223679891,1.0,4/28,9.92%,DEFB130A;CCL3;CCL1;CCL7
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.45674803606215486,1.082107570465375,0.3616133518776078,0.8310589166610408,1.0,5/28,13.33%,EXO1;DBR1;AGO2;APEX1;RNASEH2A
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.518765863000389,1.0820071640750097,0.3874425727411945,0.8277365265326038,1.0,2/11,7.15%,CASP6;CASP2
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.5143690199152563,1.0811365569623983,0.38977635782747605,0.8266370348668537,1.0,7/12,25.37%,JMJD1C;KDM1A;HR;KDM3B;PHF8;KDM3A;KDM4D
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.36174272932594,-1.0800824233527915,0.33935018050541516,0.6600256236281354,1.0,9/28,14.50%,GRID2;GRIK2;GABRG3;GABRA2;GABRG1;GABRA5;GABRA1;GABRG2;GRIK1
prerank,voltage-gated potassium channel activity (GO:0005249),0.3893445628042249,1.0797526639427937,0.35930232558139535,0.8269522780112979,1.0,5/80,3.07%,KCNJ2;KCNB2;KCNJ15;KCNB1;KCNS3
prerank,methylation-dependent protein binding (GO:0140034),0.4103860734038566,1.079444686103511,0.37605804111245467,0.8243256237783563,1.0,23/57,27.20%,TDRD3;ZCWPW2;CBX5;MORC4;PYGO1;RRP8;MORC3;MSL3;ATRX;CHD1;THAP7;MBTD1;ZMYND8;CHD8;KMT2E;SUZ12;CBX8;FMR1;PHF8;ING1;ZCWPW1;SGF29;KAT8
prerank,mRNA 5'-UTR binding (GO:0048027),-0.3740141403768337,-1.0782368366096113,0.347682119205298,0.656611662763786,1.0,8/24,11.94%,RPS13;RPS14;MYH10;RPL26;RPL41;DDX3X;UTP23;RPS7
prerank,growth factor activity (GO:0008083),0.39279306516638096,1.0759853444411183,0.3798358733880422,0.8304710287311616,1.0,13/74,16.35%,OSGIN2;PGF;FGF2;NGF;VEGFA;CLCF1;INHBA;ANGPTL3;JAG1;CLEC11A;CNTF;PTN;GDNF
prerank,zinc ion binding (GO:0008270),0.35310424433095794,1.0746122614856246,0.3420787083753784,0.8308836400704477,1.0,67/293,16.08%,ZFPM2;ACER3;HDAC4;ADH7;TES;CBLC;TNP2;ADAMTS3;KLF4;ADA;LIMS1;TIMP1;S100B;PLA2G15;KLF7;CLIP1;SKI;EEA1;TAB3;ECE1;GLI2;MNAT1;SIRT6;MBD1;NPEPPS;ZFYVE1;SEC24B;SMPDL3A;ZMYM2;ZDHHC20;TIMP2;CHD3;PHEX;SEC23A;EGR1;MMP16;RXRA;NUDT12;ARIH1;EPRS1;ALKBH8;IFIH1;SEC24D;NSD1;SORD;CDADC1;TAB2;IDE;TK1;CHORDC1;ESCO1;ZBTB32;UBA5;MDM4;ZDHHC15;DPEP1;SIRT3;PRDM2;ADH5;RNF8;PRIMPOL;TIMM9;PLSCR1;ZMYND8;KDM5B;DPP3;HHIP
prerank,actinin binding (GO:0042805),0.4653455826579582,1.0723051889262254,0.38950276243093923,0.8339568792564299,1.0,3/21,4.08%,CACNA1C;CSRP3;RARA
prerank,protein homodimerization activity (GO:0042803),0.34784818637414544,1.0720151838877003,0.2665330661322645,0.8312369720268508,1.0,101/589,14.43%,SLIT2;FOXP2;AOX1;EXT1;LRP6;ABCD3;MAP3K5;MGLL;HES1;PRPS2;CAMK2D;ABCG2;CASR;CPQ;SRGAP2;ADRB2;SNX2;CLTRN;MMACHC;VEGFA;SRM;BMPR1A;GRHL1;NPR3;MID1;NECTIN3;NUDT5;HPS4;S100B;IRAK3;ERCC5;PNPO;NOG;SCARB2;NR4A3;HSPB8;PDGFC;FGFR1;STAT3;CISD2;ACP3;EEA1;CHEK2;ZBTB16;CEACAM5;ECE1;BHLHE40;XPNPEP3;XPNPEP1;PRMT8;CRYL1;SPPL2A;NRF1;RAB11FIP3;TENM1;BARD1;DGCR8;ZDHHC2;IKBKG;WRN;ABCD1;SLC51A;PAFAH1B2;KNSTRN;SLC39A13;CEP43;MLX;MLXIPL;PHETA2;TKT;EPRS1;S100A10;PTPA;ARNT;TYW5;RIPK2;XDH;CDADC1;IDE;EIF2AK1;ODC1;MCL1;MAD2L1;ZBTB1;JUP;SH3GLB1;UBA5;GLCE;SLC8B1;PAFAH1B3;RPE;PDCD6IP;PDLIM4;ACVR1;PIP4K2A;DNTTIP1;ACOX1;GTF2A2;RNF8;COMMD1;TIMM9
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),-0.4375909925401563,-1.06939726626655,0.3743016759776536,0.669555937012902,1.0,5/12,11.59%,CDK19;CDK8;CDK6;MAPK1;CDK4
prerank,adrenergic receptor binding (GO:0031690),0.4970901595309699,1.0685566952234358,0.3952451708766716,0.8375309335880683,1.0,2/16,2.20%,NEDD4;GNAS
prerank,protein kinase binding (GO:0019901),0.3443957859885055,1.068398678902502,0.30823293172690763,0.8345192664513179,1.0,94/479,16.73%,SLC12A7;SLC12A2;TCF7L2;PKD1;CIT;ADAM9;GRK5;CCNA2;WNK1;PRKCD;ANK2;RHOBTB1;EZR;HDAC9;UNC5C;SOX9;IRS1;NELL1;ESR1;NBEA;DSP;TELO2;GSK3B;RARA;AP2A2;LIMS1;PLCG2;ABL1;IRAK3;PTPN2;NR4A3;SPRED2;STAT3;CNTLN;SHC1;FOXO3;IBTK;SKI;CHEK2;ACSL3;DACT1;TSKS;FAM83E;SIKE1;AURKA;IRAK4;ITGB1;CEP43;CCND1;BECN1;RND3;CDKN2C;MAVS;LRBA;ITGAV;ATF7;CCNB1;ANKRA2;RHOA;DUSP19;PARP1;QARS1;DNAJC3;TOM1L1;FBXO5;NSF;RB1CC1;MAP3K1;RNF138;DUSP5;CDKN1B;TRAF2;DLG1;LYST;TIRAP;NBEAL2;ACVR1;PARD6A;SRCIN1;PPP1R12A;BICD1;NBR1;KHDRBS1;NR3C1;DVL1;PTN;TRAF6;TNIP1;PAX6;CDKN1A;LCK;PIN1;SIK1;IKBKB
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.44665535870608675,1.067517288039158,0.3912429378531073,0.8335263159039511,1.0,10/28,21.71%,EDA;FEM1B;MYD88;TRAF2;PIDD1;TRAF6;TRAF5;TRAF4;TRAF3;TMBIM1
prerank,poly-purine tract binding (GO:0070717),-0.34721485309200134,-1.0675130853742725,0.3563636363636364,0.6666785325932859,1.0,6/27,10.58%,RBPMS;ATXN1;RBMS1;KHDRBS2;ELAVL4;DDX3X
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.5215287829254541,1.0666527425975245,0.40498442367601245,0.8326857687194164,1.0,2/12,3.17%,PGF;VEGFA
prerank,microtubule plus-end binding (GO:0051010),0.46751828514470045,1.0658343525883285,0.39745403111739747,0.8316069894918137,1.0,4/20,8.07%,CLIP4;CLIP1;PAFAH1B1;KNSTRN
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.42717181024315437,-1.0644645588500787,0.391304347826087,0.6663988614613414,1.0,3/13,1.51%,PDGFD;PDGFRB;IL1R1
prerank,peptide hormone receptor binding (GO:0051428),0.5063367214360048,1.058931919926555,0.4050235478806907,0.8472744827158663,1.0,2/11,12.10%,PTHLH;GNRH1
prerank,transaminase activity (GO:0008483),-0.4402857032364804,-1.0581365618785166,0.388268156424581,0.6734837171735827,1.0,9/11,46.52%,GOT2;GOT1;AGXT;GOT1L1;AADAT;BCAT1;BCAT2;PSAT1;AGXT2
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.4540109597935171,1.0580975836090243,0.38342696629213485,0.8459944796268548,1.0,7/23,14.28%,PLEKHA4;GBF1;KIF16B;WDR45B;SNX14;WIPI2;COMMD1
prerank,double-stranded RNA binding (GO:0003725),0.3843691167504411,1.0555187767339085,0.3894736842105263,0.8497093129250585,1.0,12/70,11.46%,STRBP;MBNL1;SIDT2;AGO2;DGCR8;ZFR;ILF2;IFIH1;DHX36;EIF2AK2;TLR8;ZFR2
prerank,phosphatidylinositol binding (GO:0035091),0.37505972555200734,1.054930044092407,0.40266963292547275,0.8478976053114894,1.0,25/91,18.12%,TNFAIP8L3;ESYT3;PITPNC1;SNX2;PITPNA;BCAS3;EEA1;CEACAM5;ZFYVE1;FCHO2;PLEKHF1;SNX22;PIGU;PHF12;SNX24;PARD3;DPEP1;RUBCN;SNX8;GRAMD2A;SNX12;ANKFY1;PIGK;ITPR2;MYO1E
prerank,translation elongation factor activity (GO:0003746),-0.4162270951533752,-1.0543306745372116,0.36797752808988765,0.6749071681325857,1.0,7/14,23.73%,EEF1A1;EEF1B2;EEF2;GTPBP1;EIF5A;EIF5AL1;EEFSEC
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.45026274992718773,-1.0541816114085405,0.436046511627907,0.668126425449807,1.0,2/10,5.08%,MECOM;PRDM16
prerank,NADP binding (GO:0050661),0.4274508427792033,1.0512204659613473,0.41611624834874505,0.8546147758248329,1.0,8/32,19.14%,ME1;CBR3;GMDS;DECR1;LBR;CAT;HMGCR;CRYZL1
prerank,chloride channel inhibitor activity (GO:0019869),0.5271018301679151,1.0509997210997761,0.4294573643410853,0.8516925304997804,1.0,1/10,1.59%,WNK1
prerank,damaged DNA binding (GO:0003684),0.4039662422753801,1.0503037826194024,0.3913612565445026,0.8502149738310146,1.0,7/44,9.58%,MPG;ERCC5;CREBBP;CRY2;APEX1;SMC6;NEIL3
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.42520703979416824,1.0499762078778359,0.40660736975857686,0.8478447362808321,1.0,11/34,17.21%,CYTH3;ARAP1;GAB2;GBF1;KIF16B;ZFYVE1;PARD3;COMMD1;ANXA8;FCHSD2;IQGAP1
prerank,C-C chemokine receptor activity (GO:0016493),-0.3671012399701194,-1.0487412624923063,0.391304347826087,0.6734934377976399,1.0,12/21,40.12%,CCR9;CCR5;GPR75;CCRL2;CXCR6;CCR1;CCR2;ACKR3;CCR10;ACKR4;CCR6;CXCR2
prerank,histone acetyltransferase binding (GO:0035035),0.4628117350547571,1.0483465036999153,0.4178885630498534,0.848790663202324,1.0,10/21,25.52%,BCAS3;GLI3;MEF2A;EGR1;PAX6;ZBTB7A;KANSL1;TP53;TAF7;TRIM68
prerank,poly(A) binding (GO:0008143),-0.36617679686610605,-1.0474964942731182,0.37012987012987014,0.6695138944787499,1.0,6/21,14.01%,RBPMS;RBMS1;KHDRBS2;ELAVL4;DDX3X;PABPC4L
prerank,platelet-derived growth factor binding (GO:0048407),0.5092568779802523,1.04704027252605,0.4369230769230769,0.8491120454888702,1.0,2/11,2.53%,COL6A1;COL3A1
prerank,ubiquitin protein ligase activity (GO:0061630),0.3466916638520412,1.0450619485776638,0.3936605316973415,0.8509353509411814,1.0,57/228,19.40%,WWP1;NEDD4;RNF144A;MKRN3;CBLC;SH3RF3;WWP2;RNF126;UBE4B;TRIM55;TRAF3IP2;RNF114;HERC2;UBR5;FANCL;RNFT2;RNF115;TRIM39;RNF185;ARIH1;CUL3;UBE4A;ANAPC11;ANKIB1;DTX2;UBR4;FBXO27;NSMCE1;UBE3C;TRIM44;TRIM41;RNF138;RNF130;UBE2K;UBR3;TRIP12;COP1;RNF122;RNF8;RNF41;KCMF1;NHLRC1;UBE2D3;MKRN2;RNF111;TRAF6;UBE2O;RNF11;FBXO17;TMEM129;AREL1;RNF14;SMURF1;MYCBP2;TRIM35;NFX1;LRSAM1
prerank,voltage-gated calcium channel activity (GO:0005245),0.42061675644745744,1.0449654608329701,0.4305912596401028,0.8478781102445101,1.0,5/37,2.89%,CACNA1C;CACNA1G;CACHD1;CACNG6;CACNA1F
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.40939732315188815,1.0425005684348985,0.4175257731958763,0.8512691052962305,1.0,16/37,27.32%,WARS2;NARS2;EPRS1;EARS2;QARS1;CARS2;YARS1;VARS1;VARS2;FARSA;RARS2;LARS1;YARS2;CARS1;NARS1;FARS2
prerank,phosphoric diester hydrolase activity (GO:0008081),0.4086373443118471,1.0380631851820437,0.43799472295514513,0.8597824806988978,1.0,6/35,7.46%,PLCE1;MPPED2;PLCB3;APEX2;APEX1;SMPDL3A
prerank,phosphatase activator activity (GO:0019211),-0.39978147011951426,-1.0376405743349877,0.3904494382022472,0.685005830762596,1.0,5/14,15.31%,FRS2;CALM1;BMP2;PPP2R5E;PPP2R5A
prerank,sterol binding (GO:0032934),-0.2962160445625193,-1.0366880374796017,0.37222222222222223,0.6802233498531868,1.0,14/56,13.38%,OSBPL8;APOD;SIDT1;OSBPL10;PROM1;ABCG1;PTCH1;INSIG2;NR1H3;GRAMD1B;OSBPL1A;CD81;SYP;OSBP2
prerank,actin binding (GO:0003779),0.34923619360527425,1.0361518000156136,0.4222689075630252,0.8616163343469183,1.0,28/170,9.43%,MICAL2;FXYD5;COBL;PRKCE;GSN;EZR;PAWR;GIPC1;PDLIM7;MYOZ3;PHACTR1;MLPH;ABL1;EMD;PARVA;CALD1;MRTFA;LIMA1;ALKBH4;FLII;VCL;ITGB1;DMTN;PHACTR2;GC;SLC6A2;RDX;MAP1B
prerank,myosin binding (GO:0017022),0.3874134455351459,1.032903212051202,0.41133896260554886,0.8670101345764175,1.0,8/55,6.17%,GSN;GIPC1;RAB25;MLPH;SHROOM4;CALD1;RAB6A;MYOC
prerank,calcium channel activity (GO:0005262),0.36853422937594715,1.0323359686179803,0.43184421534937,0.865285512182879,1.0,14/84,11.52%,SLC24A3;CACNA1C;PKD1;ANXA2;CACHD1;CACNG6;CACNA1F;ORAI3;TRPM7;SEC61A1;TRPM4;ITGAV;TRPM8;MCU
prerank,ribonuclease P activity (GO:0004526),-0.4247529998927778,-1.0321155235472574,0.4301994301994302,0.6838625246856116,1.0,7/11,38.78%,POP4;RPP14;POP7;RPP40;RPP21;POP1;RPP25
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.4733402886939715,1.031353397288064,0.4635958395245171,0.8646329334094618,1.0,5/17,17.04%,BDH2;DECR1;TECR;LBR;PECR
prerank,deoxyribonuclease activity (GO:0004536),0.4806793168686368,1.0302092740907103,0.4463452566096423,0.8643382447993535,1.0,5/14,20.10%,ERCC5;APEX1;MAP1S;APLF;ERCC4
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.4958898378322865,1.029924420806554,0.4681528662420382,0.8618306088313209,1.0,5/13,25.44%,PNPLA3;LPCAT1;LPCAT2;AGPAT2;LCLAT1
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.4938953894611299,1.0281674723105763,0.4501557632398754,0.8599427183813796,1.0,7/11,30.37%,BAG3;BAG5;BAG2;HSPH1;GRPEL2;GRPEL1;SIL1
prerank,adenyl nucleotide binding (GO:0030554),0.4938953894611299,1.0281674723105763,0.4501557632398754,0.8599427183813796,1.0,7/11,30.37%,BAG3;BAG5;BAG2;HSPH1;GRPEL2;GRPEL1;SIL1
prerank,E-box binding (GO:0070888),-0.31525841214475736,-1.027007101546824,0.40082644628099173,0.6886200762437561,1.0,4/34,5.11%,TCF4;ZEB1;MITF;AHR
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.4875068489084484,1.0262790435687117,0.4391785150078989,0.8615126251107187,1.0,3/13,3.75%,EZR;SOX9;GSK3B
prerank,sulfotransferase activity (GO:0008146),0.41687428561526485,1.0259399110075071,0.44063324538258575,0.8591913359894797,1.0,9/33,16.84%,UST;CHST13;HS3ST1;CHST11;GAL3ST4;CHST5;SULT1A1;HS2ST1;CHST12
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.3836085593542289,1.0245908207859242,0.44512946979038226,0.8595905494676783,1.0,11/60,7.13%,EGFR;CRIM1;MET;NTRK3;DDR2;NRP1;IGF2R;EPHB3;FGFR1;ERBB2;ROR1
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.3736466880652164,-1.023182351500902,0.42249240121580545,0.6903861670046711,1.0,3/18,1.78%,LTBP1;ENG;TGFBR3
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.4086048405926572,-1.023143253840148,0.43455497382198954,0.6838062649223186,1.0,3/12,1.78%,LTBP1;ENG;TGFBR3
prerank,methylated histone binding (GO:0035064),0.3852439540930278,1.0211344192609715,0.45126353790613716,0.8655415763541537,1.0,24/62,27.20%,TDRD3;ZCWPW2;CBX5;MORC4;PYGO1;RRP8;MORC3;MSL3;ATRX;CHD1;THAP7;MBTD1;ZMYND8;CHD8;KMT2E;SUZ12;CBX8;FMR1;PHF8;TAF7;ING1;ZCWPW1;SGF29;KAT8
prerank,hexosyltransferase activity (GO:0016758),0.35371610783965524,1.0203302338044995,0.4608501118568233,0.8644452821343279,1.0,15/101,12.67%,EXT1;TMTC1;B3GNT2;MGAT4C;HEXA;LARGE1;HAS1;B4GALNT3;B4GALT1;DPY19L3;ALG12;B4GAT1;POGLUT3;B3GNT9;POFUT1
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.4184622279152427,-1.019454416338222,0.4246987951807229,0.6856542188957154,1.0,2/11,6.84%,LEF1;GATA2
prerank,cholesterol transfer activity (GO:0120020),-0.37215948805759724,-1.0144245101057268,0.42857142857142855,0.690325392682835,1.0,3/16,10.96%,PLTP;ABCG1;GRAMD1B
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.4918134825545831,1.0141150047420533,0.45454545454545453,0.8775441711959232,1.0,3/12,11.62%,B3GNT2;B4GAT1;B3GNT9
prerank,sodium channel activity (GO:0005272),-0.3027351080545807,-1.0077876182487482,0.45147679324894513,0.6988315282585338,1.0,14/37,22.15%,SHROOM2;GRIK2;SCN7A;HCN1;SCN1A;SCN9A;HCN2;GRIK1;SCN3A;PKD2L1;SCN2A;CACNA1I;SCN5A;CACNA1H
prerank,protein heterodimerization activity (GO:0046982),0.34091465875150667,1.0075182547658268,0.47713097713097713,0.8915487508108064,1.0,35/178,13.30%,KCNB2;EXT1;ADRA1B;ATP1B1;SNX2;KCNB1;HEXA;IRAK3;KATNB1;MEF2A;BMP6;BHLHE40;ERBB2;NR4A2;AURKA;SAE1;TENM1;BARD1;PAFAH1B1;IKBKG;SLC51A;ITGB1;PAFAH1B2;AOC3;MLX;MLXIPL;TLR4;ARNT;ATP1A1;ATF6;MCL1;ZBTB1;PAFAH1B3;NR4A1;PRMT5
prerank,nuclear import signal receptor activity (GO:0061608),0.46903293968655513,1.006221996611818,0.47470238095238093,0.8918192777740687,1.0,5/15,15.61%,TNPO2;KPNA1;TNPO3;KPNA2;KPNA4
prerank,RNA binding (GO:0003723),0.3216313024351641,1.0039766938707395,0.491,0.894233485607329,1.0,356/1321,23.29%,STRBP;MSI2;RNMT;SLTM;MBNL1;SPATS2L;RPSA;FNDC3A;DDX5;ZCCHC24;ANXA2;RBFOX2;SAMD4A;TCF20;EZR;AHNAK;MKRN3;HOXB6;PURG;SIDT2;GPATCH8;TES;YBX3;EIF4G3;DDX17;DSP;ERI3;NUDT5;CELF3;PRR3;SREK1;SRSF11;KRT18;ZCCHC7;U2AF2;FASTKD1;SON;LUC7L2;RBM14;ABCF1;TDRD3;FNDC3B;SMG6;POLR1G;CAST;C1D;LRP1;HDLBP;G3BP2;RBM27;ZC3H18;DDX18;SNTB2;THOC2;KMT2C;STAT3;CISD2;CTNNA1;ZC3H7A;DDX49;EWSR1;STAU1;DBR1;ALG13;LARP1B;ANKHD1;PNISR;DIAPH1;SRSF5;AGO2;TRMT10A;BZW1;TUT7;GOLGB1;MRPL40;PCDH20;RBM39;NQO1;BARD1;DGCR8;SRSF6;ZC3H14;TDRD7;CDK11B;APEX1;DDX24;URB1;MEX3A;DDX43;BMS1;GLRX3;RBM33;NUFIP2;TUT4;SRRM2;CHD3;DAZAP1;ZC3H12C;ZC3H12A;CKAP4;MRPL42;ZFR;DUSP11;THRAP3;NOA1;EIF4G2;EIF3E;KDM1A;HELB;MRPS27;RDX;EPRS1;PSMC1;VCP;TOP1;PPRC1;MRPL11;ILF2;NOL6;ATXN2;ALKBH8;IFIH1;NOP56;GSPT1;TYW5;ANXA7;SCAF8;MTO1;RPUSD4;SUCLG1;CDK13;PABPC1;RRBP1;EIF3A;SEC23IP;PARP1;DHX36;WDR43;EIF2AK2;ETF1;KIN;PARP12;ANKRD17;MECP2;TLR8;NPM3;ZFR2;EIF2S1;RBM3;KTN1;NAA15;UBAP2L;RRP36;FAM133B;YARS1;EXOSC3;CDC40;NAT10;SRSF2;EIF5B;RBM47;CELF4;KPNA2;FYTTD1;GANAB;EBNA1BP2;RBM25;BRCA1;MARK2;CELF1;TIA1;MTHFSD;FUS;RPL22L1;HNRNPH1;FLNB;RPUSD2;NUDT1;SNRNP35;RRP1B;KIF1C;ELP5;U2SURP;RRP8;MTDH;RBMX;DDX11;NELFE;AATF;DCP1A;SCAF11;SRBD1;SPATS2;DDX56;DDX21;ARCN1;GDI2;KHDRBS1;SRSF1;CHERP;ZC3H12B;PLEC;WBP4;NGDN;NMD3;FAM120C;NKAP;DIDO1;BYSL;MRPL15;PSTK;EIF3L;YLPM1;SRP19;HNRNPM;SNRNP70;LSM8;CIRBP;MKRN2;PRKDC;ERI1;RNPS1;PSMD4;PRPF8;SMC1A;MEX3D;KNOP1;MRM3;RBMS3;UBE2O;ADD1;MOV10;EXOSC1;KRI1;FASTKD5;NCOA5;PCDHGA9;LBR;MBNL2;SSB;CNOT4;CPSF3;CPNE3;CHTOP;CS;SYF2;STXBP1;TENT4B;NAF1;UBTF;PABPC4;LARP4;PCID2;PCBP4;PSMA6;EIF4B;GPKOW;HNRNPA2B1;APEH;OTUD4;DDX19B;DEK;VIRMA;DHX9;MRPL23;PUM2;ZNF106;CCDC9;NONO;EIF2S2;TASOR;SERBP1;FARSA;ESF1;SYNCRIP;IGF2BP3;RBM6;NFX1;CSTF3;SARNP;HDAC2;EIF4G1;MRPL44;FBRSL1;GEMIN5;SNRNP40;RSRC2;HEXIM1;XRCC5;FASTKD3;THUMPD1;PDCD11;IREB2;USP10;LGALS3;LARP4B;EXOSC2;SPTBN1;MRPS21;DHX8;UTP4;PPP1CC;SLPI;PUM3;CAPRIN1;PNN;LSM4;DHX30;IBA57;YY1;EXOSC7;SAMD4B;TCERG1;ZC3H15;DDX51;LUC7L3;NAP1L1;PUM1;MRPS30;PES1;RARS2;HNRNPH2;GTPBP4;PKM;FMR1;TARDBP;DHX38;SRSF3;NOP14;TPD52L2;METAP2;USP36;KCTD12;NUDT4;SRRM1;PTCD1;SUGP1;RPL15;RPL10;DDX59;IMP4;PPHLN1;MTIF2;CCAR1;SRPK2;SRP72;JMJD6;KHDC4;TSFM;YWHAE;MAZ;ALKBH1;CNOT1;LARP7;ZC3H11A;YARS2
prerank,kinase activity (GO:0016301),0.3493468092618708,1.0031186085079822,0.46813186813186813,0.8931356259309691,1.0,19/109,12.48%,STK39;PIK3C2B;PAPSS2;GSK3B;CCL3;RFK;ABL1;CHKB;IP6K1;NADK;DGKA;IP6K2;PPIP5K1;ETNK1;HYKK;PI4KB;CKB;ADPGK;AGK
prerank,C-C chemokine binding (GO:0019957),-0.34755513968484,-1.0027700099838648,0.4470198675496689,0.7040526269654761,1.0,12/22,40.12%,CCR9;CCR5;ZFP36;CCRL2;CXCR6;CCR1;CCR2;ACKR3;CCR10;ACKR4;CCR6;CXCR2
prerank,PDZ domain binding (GO:0030165),0.3718659659797783,1.0022790208551546,0.47313084112149534,0.8920791817362974,1.0,9/61,6.12%,CRIM1;CIT;SLC26A6;ERC1;FZD1;FZD7;KIDINS220;ATP2B4;SNTG2
prerank,tau-protein kinase activity (GO:0050321),0.44093204719768475,1.0015340529260202,0.4711111111111111,0.8907668447865406,1.0,4/20,14.90%,MARK1;GSK3B;MARK2;MARK3
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.35436848739687976,1.0010455565546996,0.4783092324805339,0.8888279059008111,1.0,26/100,17.34%,CYTH3;ARAP1;PLCZ1;GAB2;PLEKHA4;GBF1;KIF16B;RLBP1;ARFIP2;ZFYVE1;WDR45B;PLEKHF1;SNX22;SNX24;TTPAL;PARD3;WIPI2;COMMD1;RUBCN;ANXA8;FCHSD2;GOLPH3;ZFYVE19;SNX12;IQGAP1;ANKFY1
prerank,single-stranded DNA binding (GO:0003697),0.3508911446053919,1.0003193423132288,0.4668911335578002,0.8876212204308559,1.0,28/93,23.71%,ERCC5;NABP1;CDC45;MCM2;RAD51;CRY2;STN1;TOP1;SMC6;NEIL3;POU4F1;DHX36;RAD23B;WDR48;RNF138;DDX11;MCM7;FAM111A;NUP35;MCM9;BRCA2;DHX9;ERCC4;TDP2;SPRTN;RAD52;RAD51D;RBBP8
prerank,chemokine activity (GO:0008009),0.4113919020327017,0.9995287916680117,0.45718050065876153,0.8865883019599193,1.0,4/31,9.92%,CXCL2;CCL3;CCL1;CCL7
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.47953454278849794,0.9995080926076971,0.48619631901840493,0.8835140144983047,1.0,4/12,10.90%,GAB2;IRS1;SHC1;TRAT1
prerank,lipase activity (GO:0016298),0.3870485346968039,0.9991342931878664,0.4714828897338403,0.8813909681306883,1.0,9/43,17.98%,MGLL;PLA2G15;PNPLA3;ABHD6;SEC23IP;PNPLA2;LCAT;CEL;DAGLB
prerank,phosphatidate phosphatase activity (GO:0008195),0.4714823967951473,0.9982506811685103,0.4827586206896552,0.8805033956210278,1.0,3/13,10.75%,PLPP3;PLPPR2;LPIN2
prerank,high voltage-gated calcium channel activity (GO:0008331),0.5053657596198573,0.9979297805272883,0.4919093851132686,0.8781523249665215,1.0,2/10,2.89%,CACNA1C;CACNA1F
prerank,pyridoxal phosphate binding (GO:0030170),0.4363788486491704,0.9977076266010617,0.476056338028169,0.8756516999884282,1.0,2/20,4.72%,PYGB;PNPO
prerank,solute:proton symporter activity (GO:0015295),0.44978846618516083,0.9976626975493988,0.4739970282317979,0.8727011133040227,1.0,1/16,1.45%,SLC2A13
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.3653520786544033,0.9969810087754069,0.47863247863247865,0.8714940733063056,1.0,7/55,7.28%,SLC24A3;PKD1;ATP2C2;ANXA2;TRPM7;ATP2B4;SEC61A1
prerank,epidermal growth factor receptor binding (GO:0005154),0.41138744379972253,0.9959711996654097,0.46685082872928174,0.8708237225171501,1.0,10/25,21.00%,SNX2;CBLC;SHC1;AGR2;ATXN2;ARF4;PLSCR1;EFEMP1;FER;EGF
prerank,mRNA 3'-UTR binding (GO:0003730),0.3508420091851108,0.9952749092813958,0.4618055555555556,0.8695922944350178,1.0,34/79,26.21%,DDX5;YBX3;AUH;DAZAP1;ZC3H12A;PABPC1;DHX36;ANGEL2;CELF1;CIRBP;RNPS1;MEX3D;CCT5;RBMS3;RNF20;PABPC4;LARP4;PCBP4;HNRNPA2B1;PUM2;SERBP1;IGF2BP3;GEMIN5;LARP4B;PUM1;FMR1;TARDBP;TP53;RSL1D1;EXOSC8;RBM4;PARN;PABPC1L;SECISBP2
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.4957802305350419,0.994992471232868,0.45304777594728174,0.8671460756502328,1.0,4/10,19.68%,CDKN2C;CDKN1B;CDKN1A;HEXIM1
prerank,ubiquitin protein ligase binding (GO:0031625),0.32965415491911715,0.9945393790251419,0.5065989847715736,0.8652783777917415,1.0,53/254,18.45%,EGFR;SNCAIP;TANK;SMAD6;USP2;FHIT;MID1;GSK3B;HERC2;SKI;CHEK2;USP25;FANCL;USP13;PER1;UBE2A;VCL;IKBKG;IKBKE;SMAD2;HSPA1L;BECN1;GPI;NLK;ARIH1;CUL3;VCP;SMC6;CUL1;ANKRA2;SLC22A18;CKB;DET1;CLU;TRAF2;BRCA1;UBE2K;PATZ1;SPOPL;RNF8;PSMD1;UBE2B;TRAF6;CDKN1A;TRAF5;GLMN;RB1;SMAD7;RNF20;TRAF4;BAG5;RALB;SPOP
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.4088797616369047,0.9938761201317678,0.4708171206225681,0.8639762546637301,1.0,21/34,35.72%,SETD2;EHMT1;ETFBKMT;EEF1AKMT4;EEF2KMT;KMT5B;KMT5A;SMYD3;KMT2E;SETD6;SMYD2;SETD7;DOT1L;SETDB1;MEN1;EHMT2;EEF1AKMT3;PRDM9;NSD3;EEF1AKMT1;METTL21A
prerank,endoribonuclease activity (GO:0004521),0.4055647083316012,0.9923394393600063,0.4688741721854305,0.8647149735223909,1.0,14/32,30.07%,SMG6;AGO2;ZC3H12C;ZC3H12A;ZC3H12B;CPSF3;ERN2;EXOG;YBEY;DICER1;AGO1;SND1;TSNAX;PIWIL2
prerank,lysophospholipase activity (GO:0004622),0.4335282467079606,0.991936612463279,0.48637015781922527,0.8627729858775581,1.0,3/20,10.38%,MGLL;LYPLA2;LYPLAL1
prerank,poly-pyrimidine tract binding (GO:0008187),0.4239806195664766,0.991782590246053,0.4916897506925208,0.8602131294608774,1.0,15/23,29.36%,U2AF2;DAZAP1;PABPC1;HNRNPH1;KHDRBS1;RBMS3;SSB;PABPC4;FMR1;RBM11;PABPC1L;PATL1;MCRS1;PTBP1;HNRNPC
prerank,metalloaminopeptidase activity (GO:0070006),0.4438100850924168,0.9906911398615899,0.4823196605374823,0.8598279268940066,1.0,4/16,8.49%,XPNPEP3;XPNPEP1;NPEPPS;MMP16
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.3272611940055423,0.9883938883494442,0.5280898876404494,0.862520065959438,1.0,55/232,19.40%,WWP1;NEDD4;RNF144A;MKRN3;CBLC;SH3RF3;WWP2;RNF126;TRIM55;TRAF3IP2;RNF114;HERC2;UBR5;FANCL;RNFT2;RNF115;TRIM39;RNF185;ARIH1;CUL3;ANAPC11;ANKIB1;DTX2;UBR4;FBXO27;NSMCE1;UBE3C;TRIM44;TRIM41;RNF138;RNF130;UBR3;TRIP12;COP1;RNF122;RNF8;RNF41;KCMF1;NHLRC1;UBE2D3;MKRN2;RNF111;TRAF6;UBE2O;RNF11;FBXO17;TMEM129;AREL1;RNF14;SMURF1;MYCBP2;PIAS2;TRIM35;NFX1;LRSAM1
prerank,voltage-gated cation channel activity (GO:0022843),0.35184738409530397,0.988278122763307,0.5204081632653061,0.8599141795156546,1.0,8/97,3.07%,KCNB2;CACNA1C;PTK2B;CACHD1;CACNG6;CACNA1F;KCNB1;KCNS3
prerank,phosphatidic acid binding (GO:0070300),0.43930019503797485,0.9881241366702228,0.48914616497829233,0.8574597510097445,1.0,2/19,1.42%,MARK1;PITPNC1
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.39332475424694224,0.9878474405022097,0.47240915208613726,0.8554226736834651,1.0,15/34,25.79%,FAM20A;STRADA;CCNB1;CAB39;CCNT2;MLST8;IQGAP1;STK3;CCNT1;MAP2K2;IGF2;TAOK1;CALM2;MTCP1;CAB39L
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.3905957131127619,0.9869733746487174,0.5,0.8546256961179913,1.0,10/38,17.02%,PLCZ1;PLEKHA4;KIF16B;ZFYVE1;WDR45B;PLEKHF1;PARD3;WIPI2;ZFYVE19;SNX12
prerank,tRNA-specific ribonuclease activity (GO:0004549),-0.38307718397824986,-0.9860447233693983,0.48942598187311176,0.7358372002226562,1.0,7/14,38.78%,POP4;RPP14;POP7;RPP40;RPP21;POP1;RPP25
prerank,Hsp90 protein binding (GO:0051879),0.3963667657088174,0.9859905525621073,0.4900662251655629,0.8538271505799534,1.0,7/33,16.31%,SLC12A2;TELO2;HDAC8;CHORDC1;UNC45A;NR3C1;PPP5C
prerank,chemokine receptor binding (GO:0042379),0.3970810824924423,0.9859771787331557,0.4725848563968668,0.8510480840415638,1.0,4/35,9.92%,CXCL2;CCL3;CCL1;CCL7
prerank,N-acyltransferase activity (GO:0016410),-0.31101611045226557,-0.9853937157349564,0.4524714828897338,0.7307368551694681,1.0,7/32,15.10%,CERS4;TGM2;PLAAT3;NMT2;CERS2;CERS1;SAT2
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.4079701302377972,0.9842409910976636,0.5006784260515604,0.8522795508998914,1.0,9/29,21.74%,ACER3;GANAB;IDUA;GBA2;GALC;LCT;NEU3;ENGASE;GANC
prerank,1-phosphatidylinositol binding (GO:0005545),-0.37019635095289755,-0.9833610689289893,0.4559748427672956,0.7286878481484507,1.0,3/15,6.04%,EPB41;PICALM;SNAP91
prerank,ion channel activity (GO:0005216),0.34947815283651423,0.981959462139603,0.49886363636363634,0.8549463581081298,1.0,11/80,11.26%,PIEZO2;TMC6;TMEM120A;GRIK4;TRPM7;TRPM6;CALHM5;TRPM4;TMC8;TRPM8;NALCN
prerank,carboxylic acid binding (GO:0031406),-0.30019558588161444,-0.9788581129073654,0.4641350210970464,0.7332889371665289,1.0,7/38,10.12%,GRM7;NOS3;GRIN2B;GRIN1;MAG;GLRA3;GLRA1
prerank,calcium-dependent phospholipid binding (GO:0005544),0.37791821000981635,0.9785436777080251,0.5199501246882793,0.8601471465388656,1.0,10/49,12.86%,ESYT3;ANXA2;ANXA4;PLA2G4F;ANXA1;PCLO;ANXA3;C2CD5;CPNE8;CPNE1
prerank,phosphatidylinositol kinase activity (GO:0052742),0.45311642449486417,0.9783079065136887,0.4924698795180723,0.8580302514680016,1.0,3/15,10.88%,PIK3C2B;PIK3R3;PI4KB
prerank,P-type ion transporter activity (GO:0015662),0.46417079296911323,0.9762425868808006,0.517799352750809,0.8600649116577065,1.0,2/12,5.90%,ATP2C2;ATP2B4
prerank,ubiquitin-protein transferase activity (GO:0004842),0.31792869573581106,0.9758623210497142,0.5649546827794562,0.8581083691219261,1.0,85/346,20.07%,WWP1;NEDD4;RNF144A;MKRN3;FBXO10;CBLC;SH3RF3;WWP2;RNF126;TRIM55;TRAF3IP2;RNF114;HERC2;UBR5;FANCL;RNFT2;TRIM47;UBE2A;RNF115;BARD1;TRIM39;RNF214;TSPAN17;RNF185;ARIH1;CUL3;CUL1;ANAPC11;ANKIB1;FBXW8;DTX2;UBR4;BCOR;FBXO27;NSMCE1;UBE3C;TRIM44;TRIM41;RNF138;RNF130;RNF146;TRAF2;BRCA1;UBE2K;RNF123;UBE2M;UBR3;TRIP12;COP1;MIB1;RNF122;RNF8;RNF41;SEL1L;UBE2B;KCMF1;NHLRC1;UBE2D3;MKRN2;RNF111;TRAF6;RNF141;UBE2O;TRAF5;RNF11;FBXO17;CNOT4;TMEM129;RNF20;AREL1;RNF14;UBE2S;DTL;RBCK1;SMURF1;MYCBP2;CHFR;RMND5A;TRIM35;NFX1;FBXL6;LRSAM1;TRAF7;UBE2Z;BRAP
prerank,ubiquitin binding (GO:0043130),0.3559793003616395,0.9737704861165793,0.5132641291810842,0.860036823859392,1.0,20/73,23.91%,NEDD4;USP25;USP13;MVB12B;IKBKG;ADRM1;RNF185;RAD23B;TOM1L1;WDR48;DDI2;NBR1;ASCC2;RBCK1;UBXN2B;USP16;DNAJB2;BUB3;SPRTN;USP33
prerank,hydro-lyase activity (GO:0016836),0.3782361085749619,0.9732970011540024,0.5127551020408163,0.8583574887500804,1.0,8/41,11.33%,EHHADH;UROC1;CYP2S1;GMDS;AUH;ECHDC1;UROS;ACO2
prerank,exoribonuclease activity (GO:0004532),0.4789453869432981,0.9729068994760774,0.5256609642301711,0.8564679400762503,1.0,6/12,24.31%,ZC3H12A;EXOSC3;EXOSC1;EXOSC2;EXOSC7;EXOSC8
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),-0.37767911047409025,-0.9722954310486697,0.5135135135135135,0.7417790859731915,1.0,4/15,16.91%,PIK3R1;PIK3R6;PIK3R5;SOCS5
prerank,exopeptidase activity (GO:0008238),-0.2767230515448188,-0.9717509031405264,0.48677248677248675,0.7363986929072537,1.0,13/50,12.38%,DPP10;DPP4;CTSH;ACE;MME;CTSA;LTA4H;PRCP;ENPEP;DPP6;ACE2;ZMPSTE24;RNPEP
prerank,protein kinase activator activity (GO:0030295),0.3615493508284263,0.9716975250975683,0.4987745098039216,0.8565591197359558,1.0,21/60,24.27%,WNK1;WNT11;ABI1;FGF13;FAM20A;STRADA;DUSP19;CAB39;MARK2;MLST8;CDKN1A;IQGAP1;STK3;NCKAP1L;MAP2K2;IGF2;SPDYA;TAOK1;CALM2;MTCP1;PAK2
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.42067719564931505,-0.9700731634463435,0.4878640776699029,0.7338643967279758,1.0,7/10,18.97%,GABRG3;GABRA2;GABRG1;GABRA5;GABRA1;GABRG2;GABRA4
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.39468185737664324,-0.968592130318431,0.4918918918918919,0.7306352387821867,1.0,6/12,20.39%,NOD1;CTSH;ATP2A3;RACK1;PYCARD;CASP1
prerank,sterol transfer activity (GO:0120015),-0.3519401705644181,-0.9681741540579786,0.48307692307692307,0.7253731625768448,1.0,3/17,10.96%,PLTP;ABCG1;GRAMD1B
prerank,alpha-actinin binding (GO:0051393),0.41151368843568714,0.9664010651493149,0.5067750677506775,0.8659249150236682,1.0,3/24,4.08%,CACNA1C;PDLIM7;RARA
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.4656132514432538,0.9632533456835981,0.5144157814871017,0.8705972225437357,1.0,4/11,17.13%,SGMS2;DPAGT1;PIGO;GNPTAB
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.31828116956310903,0.962975945183327,0.59026369168357,0.8684910992736798,1.0,54/269,18.45%,EGFR;SNCAIP;TANK;SMAD6;USP2;FHIT;MID1;GSK3B;HERC2;SKI;CHEK2;USP25;FANCL;USP13;PER1;UBE2A;VCL;IKBKG;IKBKE;SMAD2;HSPA1L;BECN1;GPI;NLK;ARIH1;CUL3;VCP;SMC6;CUL1;CCNB1;ANKRA2;SLC22A18;CKB;DET1;CLU;TRAF2;BRCA1;UBE2K;PATZ1;SPOPL;RNF8;PSMD1;UBE2B;TRAF6;CDKN1A;TRAF5;GLMN;RB1;SMAD7;RNF20;TRAF4;BAG5;RALB;SPOP
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.47526674498742216,0.9617441099856416,0.520259319286872,0.8684136261006464,1.0,4/10,18.07%,DSP;DSG2;JUP;CXADR
prerank,ATPase regulator activity (GO:0060590),0.3740055070543398,0.9615653107346924,0.5084745762711864,0.8660816038585566,1.0,13/38,22.61%,ATP1B1;KATNB1;BAG3;DNAJC1;DNAJA2;FXYD2;BAG5;ATP5IF1;BAG2;TOR1AIP1;DNAJB2;HSPH1;GRPEL2
prerank,cytochrome-c oxidase activity (GO:0004129),-0.3751824933785165,-0.9587897699722696,0.49206349206349204,0.7396644674689414,1.0,6/15,25.08%,NDUFA4;COX4I1;COX5B;NDUFA4L2;COX6B1;COX4I2
prerank,steroid hydroxylase activity (GO:0008395),0.43398214310783356,0.9583422942203178,0.5274888558692422,0.8706435971442376,1.0,2/16,4.91%,CYP1B1;CYP2S1
prerank,potassium channel regulator activity (GO:0015459),0.36800604175907,0.9581138632146202,0.5256570713391739,0.8685088336840001,1.0,5/49,3.07%,KCNMB3;KCNMB2;WNK1;ADRB2;KCNS3
prerank,glycine binding (GO:0016594),-0.40455273218261834,-0.9572717117443669,0.5361111111111111,0.7369432461452687,1.0,4/11,10.12%,GRIN2B;GRIN1;GLRA3;GLRA1
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.39244394737500743,0.9570476018739067,0.519893899204244,0.8682367421988166,1.0,13/32,24.36%,EGLN3;TMLHE;ALKBH4;TYW5;JMJD4;FTO;KDM2A;RIOX2;HIF1AN;PHYHD1;PHF8;ALKBH1;HSPBAP1
prerank,lipoprotein particle receptor binding (GO:0070325),-0.30416949713905744,-0.9550550801245661,0.5507246376811594,0.7356275850848419,1.0,4/27,6.77%,APOE;PICALM;SYT1;HSPG2
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.43131939458416413,0.9537663996720653,0.532448377581121,0.873002279694443,1.0,2/15,10.46%,PLCZ1;PLEKHF1
prerank,fatty acid synthase activity (GO:0004312),-0.4033961814934644,-0.951212525882313,0.5297297297297298,0.7380026582435144,1.0,6/10,29.64%,ELOVL7;ELOVL6;CBR4;ELOVL4;OXSM;ELOVL1
prerank,phosphatase inhibitor activity (GO:0019212),0.41863005380614343,0.9506545642722437,0.5363128491620112,0.8772160577568338,1.0,9/20,23.24%,STYXL1;URI1;MGAT5;PTN;ARPP19;LGALS3;CABIN1;BOD1L1;STYX
prerank,snRNA binding (GO:0017069),0.3685141833165473,0.9506236679334891,0.5175438596491229,0.8745887268677137,1.0,14/42,23.25%,LSM11;SNRNP35;DDX21;CCNT2;SNRNP70;LSM8;PRPF8;RNPC3;GEMIN5;HEXIM1;CCNT1;SF3B3;LSM4;LARP7
prerank,cytokine receptor activity (GO:0004896),0.3374045767253601,0.9498879905266542,0.5477560414269275,0.8735035176613385,1.0,8/83,7.91%,F3;IL22RA1;CMKLR1;IL20RB;IL17RE;IL17RA;CD44;IL17RD
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.4438893718873795,0.9488885636885162,0.533625730994152,0.873078306818427,1.0,3/15,17.23%,KMT2C;WDR82;KMT2D
prerank,DNA replication origin binding (GO:0003688),0.40855225622830277,0.9487945479069064,0.5389972144846796,0.8706133835870978,1.0,7/23,18.46%,CDC45;MCM2;ORC3;DDX11;MCM7;MCM9;DHX9
prerank,ligand-gated cation channel activity (GO:0099094),0.3376812758829388,0.9483366140310443,0.5543981481481481,0.8689194888730486,1.0,4/75,3.64%,KCNJ2;KCNJ15;PTK2B;GRIK4
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.3833123936478399,-0.9457169564260146,0.5325779036827195,0.7441413267300763,1.0,8/13,14.15%,GABRG3;GABRA2;GLRA3;GLRA1;GABRG1;GABRA5;GABRA1;GABRG2
prerank,pyrophosphatase activity (GO:0016462),0.3569074735343349,0.9447817926035963,0.5533980582524272,0.8743015812077957,1.0,15/50,22.62%,ALPL;ENTPD6;NUDT5;ENTPD2;ENTPD5;NUDT15;ENTPD7;NUDT1;DHX9;FITM2;LHPP;RNGTT;NUDT4;PLPP1;TRPM2
prerank,semaphorin receptor binding (GO:0030215),-0.32010608322571055,-0.9433762418333419,0.5222222222222223,0.7427916073463638,1.0,13/23,20.82%,SEMA6A;SEMA7A;RIT2;SEMA6D;SEMA3B;SEMA5A;SEMA3G;SEMA5B;SEMA6B;SEMA4G;SEMA3A;SEMA3F;SEMA4D
prerank,phosphatidylglycerol binding (GO:1901611),0.4533123602373731,0.941274533585195,0.5590062111801242,0.8791523070127263,1.0,2/13,3.78%,PITPNC1;PITPNA
prerank,bHLH transcription factor binding (GO:0043425),0.4139696837270209,0.9412461279024525,0.5445544554455446,0.8765619545902346,1.0,4/19,8.64%,TWIST1;BHLHE40;CREBBP;KDM1A
prerank,nucleotide diphosphatase activity (GO:0004551),0.44890370174845934,0.9400034946968739,0.5568862275449101,0.8765443894607754,1.0,3/14,8.86%,FHIT;NUDT17;NUDT12
prerank,peptidase inhibitor activity (GO:0030414),0.3795086082812181,0.9399554240673416,0.5555555555555556,0.8740360056977028,1.0,5/33,7.88%,GPC3;TIMP1;CAST;RENBP;TIMP2
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.36651352090760086,0.932281393272666,0.5366795366795367,0.8876730429207057,1.0,11/40,19.65%,PCMT1;NNMT;PRMT8;DNMT3A;RRP8;METTL2A;METTL2B;LRTOMT;TARBP1;TPMT;ASMT
prerank,sequence-specific mRNA binding (GO:1990825),0.45851978818713524,0.9294178533469152,0.543171114599686,0.8910050838777653,1.0,4/10,22.05%,ETF1;SSB;DHX9;FMR1
prerank,tRNA methyltransferase activity (GO:0008175),0.42328017686455655,0.9280097057386993,0.5766312594840668,0.8913799479357223,1.0,8/16,28.89%,ALKBH8;METTL2A;METTL2B;TARBP1;TRDMT1;FTSJ1;TRMT44;THUMPD2
prerank,acetylcholine receptor activity (GO:0015464),-0.325355192307882,-0.9276282850792688,0.5606557377049181,0.7704732589548382,1.0,13/22,43.87%,CHRM2;CHRM3;ANXA9;CHRNA4;CHRM1;CHRNB2;CHRM5;CHRNA5;CHRNA3;CHRNE;CHRNB4;CHRNB3;HRH4
prerank,GTPase activity (GO:0003924),0.30954089803454554,0.9275025679415938,0.6277145811789038,0.88977665592642,1.0,32/192,16.15%,RHOJ;RHOBTB1;GNAS;ATL3;NRAS;KRAS;ARHGDIB;ATL2;MRAS;RRAGB;RAB43;RAB6A;RAB24;GNG8;BMS1;RHOQ;RND3;GSPT1;RAB35;RHOA;RAP1A;GPN1;ENTPD7;DRG1;RAB21;RAP2C;GNA13;RAB11B;ATL1;RHEB;RAB28;RAB1A
prerank,ribonuclease activity (GO:0004540),0.34404310735764343,0.9254237961942751,0.566150178784267,0.8914866500282786,1.0,22/56,30.07%,SMG6;AGO2;ZC3H12C;ZC3H12A;EXOSC3;RNASE3;RNASEH2A;ZC3H12B;EXOSC1;CPSF3;ERN2;EXOG;EXOSC2;YBEY;EXOSC7;EXOSC8;DICER1;RNASE12;AGO1;SND1;TSNAX;PIWIL2
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.46184379758107014,0.9245300364273388,0.5537974683544303,0.8906545091630163,1.0,6/11,26.51%,APEX2;APEX1;NEIL3;APLF;ALKBH1;NEIL1
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.38915259469088437,0.9235100230454377,0.5674232309746329,0.8902268277184994,1.0,9/27,17.58%,RNF144A;DCUN1D5;ZMYM2;ARIH1;ANKIB1;DCUN1D2;TRAF6;DCUN1D1;RNF14
prerank,signaling receptor complex adaptor activity (GO:0030159),0.36401889559816386,0.9234713239901501,0.5669191919191919,0.887700837305586,1.0,11/38,17.95%,GAB2;IRS1;G3BP2;SHC1;NCK2;SHANK1;TRAT1;NCK1;DLG5;LRRK2;LAT
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.4319603974406918,0.9221119460930278,0.566066066066066,0.8879674124525038,1.0,3/15,3.67%,HS3ST4;HS6ST2;HS3ST1
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.4582494763383363,0.9212920635264106,0.5805946791862285,0.8845821114752876,1.0,6/10,32.17%,DUSP5;DUSP7;DUSP10;DUSP16;DUSP4;DUSP1
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.4582494763383363,0.9212920635264106,0.5805946791862285,0.8845821114752876,1.0,6/10,32.17%,DUSP5;DUSP7;DUSP10;DUSP16;DUSP4;DUSP1
prerank,chloride channel regulator activity (GO:0017081),0.43046249545545157,0.918881882153181,0.5806451612903226,0.8870453324333166,1.0,4/14,21.86%,WNK1;SGK3;VTI1B;STX8
prerank,N-acetyltransferase activity (GO:0008080),0.40257299372725025,0.917835077925599,0.5795620437956205,0.8866710963282798,1.0,8/19,29.87%,NAT1;ESCO1;NAT10;ATAT1;NAA80;KAT2B;NAA50;SMARCE1
prerank,transcription coactivator binding (GO:0001223),0.3994021467996554,0.9160416548206233,0.5817655571635311,0.8878564186893814,1.0,6/20,19.08%,CIT;ESR1;RORA;CCNT2;SMAD4;MED25
prerank,hexosaminidase activity (GO:0015929),0.4418651757391439,0.914716502766362,0.5916666666666667,0.8880114904920363,1.0,2/12,3.41%,SPAM1;HEXA
prerank,mRNA binding (GO:0003729),0.2982048196105365,0.9138491875441231,0.6718106995884774,0.887221806881402,1.0,70/249,22.06%,DDX5;RBFOX2;SAMD4A;YBX3;EIF4G3;CELF3;LUC7L2;RBM14;HDLBP;G3BP2;THOC2;AUH;SRSF5;AGO2;SRSF6;TDRD7;SRRM2;DAZAP1;ZC3H12C;ZC3H12A;EIF4G2;SCAF8;PABPC1;EIF3A;DHX36;ANGEL2;ETF1;RBM47;CELF4;FYTTD1;RBM25;CELF1;SNRNP35;RBMX;DCP1A;SRBD1;KHDRBS1;SRSF1;ZC3H12B;HNRNPM;SNRNP70;CIRBP;RNPS1;CCT5;RBMS3;SSB;RNF20;PABPC4;LARP4;PCBP4;HNRNPA2B1;DHX9;PUM2;EIF2S2;SERBP1;SYNCRIP;IGF2BP3;CSTF3;EIF4G1;GEMIN5;IREB2;LARP4B;SLPI;PUM3;SAMD4B;LUC7L3;PUM1;PKM;FMR1;TARDBP
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.41030426207723636,0.9136959005441881,0.5604229607250756,0.88506306042892,1.0,1/15,2.28%,CMKLR1
prerank,hormone receptor binding (GO:0051427),0.429300545436807,0.9130148574687057,0.5975232198142415,0.883943055566296,1.0,5/14,27.99%,PTHLH;NCOA6;JAK2;CCK;SOCS2
prerank,GDP binding (GO:0019003),0.3347805435253876,0.9107824055140513,0.6019300361881785,0.8857422828147734,1.0,15/63,19.41%,NRAS;KRAS;MRAS;RAB35;MIEF1;ARL3;RAP1A;RAB21;RAP2C;RAB11B;RHEB;RAB28;RAB5B;RALB;RAP2B
prerank,voltage-gated chloride channel activity (GO:0005247),0.4467630157296276,0.9097709207631598,0.5698234349919743,0.8852391110798347,1.0,2/10,8.61%,ANO6;CLCN5
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),-0.2503382428487054,-0.9074787201844845,0.6807228915662651,0.807769278210683,1.0,23/57,28.62%,NDUFB9;NDUFA4;UQCRH;NDUFA13;COX4I1;COX5B;NDUFC1;NDUFV3;UQCR10;UQCRC1;CYB561A3;NDUFA7;NDUFA4L2;COX6B1;NDUFB6;NDUFB8;NDUFA3;COX4I2;CYB561D2;NDUFA1;UQCRQ;NDUFB10;NDUFA2
prerank,mannosyltransferase activity (GO:0000030),0.3946605674174036,0.9072044175691588,0.5718562874251497,0.8880511745824972,1.0,9/21,24.43%,TMTC1;DPY19L3;ALG12;TMTC3;DPM1;ALG8;POMT2;POMT1;PIGB
prerank,amyloid-beta binding (GO:0001540),0.32999430013469966,0.9050615334505688,0.6299303944315545,0.889667173516964,1.0,12/79,13.58%,COL25A1;ADRB2;LDLR;ITM2C;LRP1;TLR4;ATP1A3;NLGN1;EPHB2;CLU;APBB3;SORL1
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.44336453292607403,0.9042318329668928,0.5955414012738853,0.8888073319152244,1.0,6/11,29.31%,PRMT8;PRMT5;PRMT6;NDUFAF7;FBXO11;CARM1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.3911272462955824,-0.9008348744629292,0.6108108108108108,0.8159232876122623,1.0,4/10,10.30%,APOBEC1;ADARB2;LACC1;GDA
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),-0.30632092141849937,-0.9007404658233161,0.6153846153846154,0.8096988220860216,1.0,8/28,12.82%,PRKAA2;PAK3;SGK1;MAP2K6;RPS6KA1;TNK2;MAP2K1;MAPK10
prerank,voltage-gated anion channel activity (GO:0008308),0.4098006556600219,0.8971637660299753,0.5944272445820433,0.9003183158559864,1.0,2/15,8.61%,ANO6;CLCN5
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.42479620150904046,0.8952252318747367,0.6015625,0.9014841524198899,1.0,6/13,27.41%,ARHGDIB;ITGB1BP1;GDI2;GPSM1;GPSM2;GDI1
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.39420070190444795,0.8937484120949782,0.6127167630057804,0.9018978778594834,1.0,6/20,19.11%,PLA2G15;PNPLA3;LPCAT1;MOGAT1;LPCAT2;AGPAT2
prerank,protein kinase C activity (GO:0004697),0.42668553112196983,0.8929452158445643,0.6251968503937008,0.90094225152621,1.0,3/14,4.14%,PRKCD;PRKCE;CCL3
prerank,nucleoside-triphosphatase activity (GO:0017111),0.2938837080863931,0.8916581608022556,0.7183673469387755,0.9010129392869941,1.0,47/248,18.46%,RHOJ;RHOBTB1;GNAS;ATL3;NRAS;KRAS;ARHGDIB;ATL2;MRAS;RRAGB;RAB43;RAB6A;VWA8;RAB24;GNG8;ABCD1;BMS1;RHOQ;CHD3;CHD1L;RND3;VCP;GSPT1;RAB35;RHOA;RAP1A;GPN1;ENTPD7;CLU;DRG1;KIF1C;RAB21;RAP2C;TOR1B;GNA13;RAB11B;ATL1;RHEB;KLC1;RAB28;RAB1A;PIN1;RAB5B;LRRK2;MYO1E;RALB;DHX9
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.4504255847846004,0.8893880332541008,0.5957095709570958,0.9030258658977508,1.0,2/10,9.83%,PIK3C2B;PIK3R3
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.3782948093763334,0.8870722947387489,0.6439716312056738,0.9050305992377504,1.0,7/25,15.86%,GAB2;PLEKHA4;KIF16B;ZFYVE1;COMMD1;ANXA8;FCHSD2
prerank,3'-5' DNA helicase activity (GO:0043138),0.4000222952742624,0.8867990749100888,0.6044117647058823,0.9031150947339628,1.0,5/16,18.46%,MCM2;WRN;MCM7;RECQL5;DHX9
prerank,AMP binding (GO:0016208),0.44824115896537586,0.8860528778047165,0.6234567901234568,0.9019942687611539,1.0,2/11,10.28%,MPPED2;PFKP
prerank,peptidase activator activity (GO:0016504),0.3800199309593514,0.8811413286723324,0.6302521008403361,0.9091366893286016,1.0,3/22,9.12%,TANK;ADRM1;VCP
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.3599365777970915,0.8810876202311064,0.617948717948718,0.9067458528921416,1.0,10/33,17.58%,RNF144A;DCUN1D5;ZMYM2;RNF185;ARIH1;ANKIB1;DCUN1D2;TRAF6;DCUN1D1;RNF14
prerank,SH2 domain binding (GO:0042169),0.36207535543759617,0.8803818033908574,0.6537433155080213,0.9057558141121268,1.0,10/31,19.41%,IRS1;ABL1;RUFY1;ARHGAP5;NLK;INPPL1;KHDRBS1;LCK;JAK2;AFAP1
prerank,histone demethylase activity (GO:0032452),0.3670763737883348,0.8799684227925929,0.6315068493150685,0.9040455587143543,1.0,11/27,25.37%,JMJD1C;KDM1A;HR;KDM5B;KDM3B;KDM2A;RIOX2;PHF8;JMJD6;KDM3A;KDM4D
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.34367544385230353,0.8797164729613146,0.6148825065274152,0.902057839991559,1.0,5/35,5.74%,PTK2B;SRMS;CLK1;ABL1;FRK
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),-0.3647383543099304,-0.8788875081664267,0.6138328530259366,0.8484600784050065,1.0,4/11,28.13%,HCN1;HCN2;CNGB3;AQP1
prerank,tRNA binding (GO:0000049),0.3419603766870614,0.8768092029700618,0.6278481012658228,0.9048271038511027,1.0,16/43,27.32%,TRMT10A;MRPS27;ALKBH8;TYW5;RPUSD4;NAT10;ELP5;PSTK;SSB;PTCD1;ALKBH1;YARS2;CARS1;DALRD3;TRNAU1AP;FARS2
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.35634239423669495,0.8745487789178888,0.6419098143236074,0.9067123418341563,1.0,13/34,25.90%,ERI3;CNOT8;ANGEL2;EXOSC3;REXO2;ERI1;DIS3;EXOSC2;EXOSC7;CNOT1;PAN3;ANGEL1;PARN
prerank,phosphatidylcholine transporter activity (GO:0008525),0.39381915700459025,0.8725604056519011,0.6233183856502242,0.9079359705019304,1.0,5/17,15.78%,PITPNC1;PITPNA;ABCA7;ATP10A;PCTP
prerank,calcium:sodium antiporter activity (GO:0005432),0.43829423047451366,0.8717814120326632,0.6283891547049442,0.9070136346553572,1.0,1/10,0.76%,SLC24A3
prerank,DNA secondary structure binding (GO:0000217),0.3502364256489624,0.8705346986108387,0.6553079947575361,0.9067799903501483,1.0,5/31,9.61%,ABL1;ERCC5;WRN;NEIL3;CLSPN
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.34280498466494275,0.86968294495574,0.6394640682095006,0.9059285877520783,1.0,12/44,18.45%,KMT2C;SETD2;EHMT1;EED;WDR82;NSD1;KMT5B;KMT5A;SMYD3;KMT2D;ASH1L;KMT2E
prerank,titin binding (GO:0031432),0.40678795229339487,0.8695532123801918,0.6215384615384615,0.9037568098203178,1.0,1/13,1.67%,CAMK2D
prerank,poly(U) RNA binding (GO:0008266),0.3837003750110123,0.8686862378733293,0.6391304347826087,0.9028851500458892,1.0,12/20,26.69%,DAZAP1;PABPC1;HNRNPH1;KHDRBS1;RBMS3;SSB;PABPC4;FMR1;RBM11;PABPC1L;PATL1;MCRS1
prerank,ATPase activator activity (GO:0001671),0.3817678361071215,0.8682451361980686,0.6426470588235295,0.9013387290398401,1.0,6/20,20.86%,ATP1B1;DNAJC1;DNAJA2;FXYD2;TOR1AIP1;DNAJB2
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.37339203725278286,0.8680161585987589,0.638095238095238,0.8993748977378957,1.0,3/24,5.36%,CAMK2D;PTK2B;PHKA2
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.4319672619523399,0.8676871345558801,0.6159874608150471,0.8975645887872533,1.0,3/10,17.87%,DESI2;OTUD5;OTUD4
prerank,voltage-gated sodium channel activity (GO:0005248),-0.29587791298849125,-0.8664543405849822,0.6579804560260586,0.8685494546295948,1.0,11/22,22.15%,SCN7A;HCN1;SCN1A;SCN9A;HCN2;SCN3A;SCN2B;SCN2A;CACNA1I;SCN5A;CACNA1H
prerank,Toll-like receptor binding (GO:0035325),0.4246029065107273,0.8656145560349627,0.6198083067092651,0.8988291949413687,1.0,3/11,13.32%,TLR1;MYD88;TIRAP
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.3882192033646532,0.8631049629618809,0.6404657933042213,0.9009934635730666,1.0,4/17,19.70%,AK4;AK3;AK1;CLP1
prerank,purinergic nucleotide receptor activity (GO:0001614),-0.33099965743366566,-0.8627968576268347,0.6594427244582043,0.8692448783886755,1.0,3/15,10.41%,P2RY14;P2RY1;P2RX7
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.29469553159733985,0.8620384202404248,0.7491961414790996,0.9006574843913049,1.0,21/147,11.72%,ARHGEF28;PLCE1;DOCK5;CYTH3;VAV2;AKAP13;HPS4;RANGRF;HERC2;DNMBP;BCR;WDR41;TIAM1;RASGEF1B;FARP1;RGP1;SERGEF;DENND4A;RAP1A;SBF1;FGD1
prerank,guanyl ribonucleotide binding (GO:0032561),0.2848038270875018,0.8615223060377941,0.7484472049689441,0.8992932825770295,1.0,31/196,16.10%,RHOJ;RHOBTB1;ATL3;MPPED2;NRAS;KRAS;PDE5A;ATL2;MRAS;RRAGB;RAB6A;ARFIP2;BMS1;RHOQ;NOA1;RND3;RAB35;MIEF1;ARL3;RHOA;RAP1A;ARF4;NMUR2;DRG1;RAB21;RAP2C;RAB11B;ATL1;RHEB;TUBE1;RAB28
prerank,endopeptidase regulator activity (GO:0061135),-0.2603394976190263,-0.8601285282281079,0.6728110599078341,0.867899039729192,1.0,15/40,26.01%,PROS1;CST3;ITIH2;SERPIND1;TFPI;A2M;APH1B;ABCA2;UCHL5;PSME2;ITIH3;VSIR;HRG;NLRC4;AHSG
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.3510728347843523,0.8599527226103147,0.6643356643356644,0.8997052110015077,1.0,7/29,16.26%,CIT;SPRED2;CDKN2C;CIB1;CDKN1B;PKIG;CDKN1A
prerank,galactosyltransferase activity (GO:0008378),0.4183603248009662,0.8595242582092958,0.6352,0.8981615071562815,1.0,3/11,15.85%,B4GALT1;B3GALT6;A3GALT2
prerank,G protein-coupled peptide receptor activity (GO:0008528),-0.22573777613778134,-0.8590887057445815,0.8129496402877698,0.8633234238311198,1.0,10/73,12.08%,LGR4;SORCS3;NPR1;CALCRL;BDKRB2;LGR5;HCRTR2;CYSLTR2;SORCS1;CYSLTR1
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.40424963810138365,0.8580660513384711,0.6666666666666666,0.898417601386544,1.0,5/15,25.44%,PNPLA3;LPCAT1;LPCAT2;AGPAT2;LCLAT1
prerank,rRNA binding (GO:0019843),-0.2509720325038638,-0.8574714995128642,0.7477477477477478,0.8598923690213369,1.0,7/42,10.64%,RPS13;RPS9;RPS3;RPS14;RPL11;RPS5;UTP23
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.3856162428600237,0.8573492382902416,0.6473988439306358,0.8974146568670021,1.0,4/18,12.95%,SERPINB9;PRDX5;RPS6KA3;DPEP1
prerank,signal sequence binding (GO:0005048),0.3459287021110718,0.8568420908974926,0.668,0.8959678431940356,1.0,17/35,28.28%,SEC61A1;NUP214;NUP153;TNPO2;KPNA1;KPNA2;KPNA4;AP2B1;KDELR2;CAT;BRAP;KDELR3;IPO4;KCNIP2;TOMM20;POM121;IPO5
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.408349550837804,0.8562475194305877,0.6434108527131783,0.8948102705710201,1.0,6/13,30.55%,TRMT10A;TARBP1;TRMT11;FTSJ1;THUMPD2;WDR4
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),-0.2944130952998038,-0.8555516098199178,0.7010309278350515,0.8569955051158301,1.0,8/22,21.43%,CPEB2;CPEB3;ELAVL4;HNRNPA0;EXOSC9;ZFP36;RBM24;ZFP36L1
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.31152977533159365,0.8555408386646521,0.6802325581395349,0.8936979892834711,1.0,13/74,12.48%,PIK3C2B;PAPSS2;RFK;CHKB;FAM20A;NADK;DGKA;ETNK1;HYKK;PI4KB;GALK2;ADPGK;AGK
prerank,CXCR chemokine receptor binding (GO:0045236),0.4283522056986239,0.8541607925743665,0.6377049180327868,0.8938075007096971,1.0,2/11,11.96%,CXCL2;YARS1
prerank,5'-3' exonuclease activity (GO:0008409),0.39669662352945695,0.8540957947565933,0.655436447166922,0.8916157715030553,1.0,5/14,27.80%,EXO1;CPSF3;EXOG;DCLRE1A;DXO
prerank,insulin-like growth factor receptor binding (GO:0005159),0.4075481276847943,0.8490761324345445,0.6446153846153846,0.8978505583585707,1.0,3/12,5.34%,GNAS;IRS1;SHC1
prerank,GTP binding (GO:0005525),0.2824863835656732,0.8450979834256583,0.768025078369906,0.902438619816797,1.0,28/172,16.10%,RHOJ;RHOBTB1;ATL3;NRAS;KRAS;ATL2;MRAS;RRAGB;RAB6A;ARFIP2;BMS1;RHOQ;NOA1;RND3;RAB35;ARL3;RHOA;RAP1A;ARF4;NMUR2;DRG1;RAB21;RAP2C;RAB11B;ATL1;RHEB;TUBE1;RAB28
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),-0.34261099477192547,-0.8443369142923527,0.6428571428571429,0.8721277890855885,1.0,5/12,19.18%,STAT1;TBPL1;H3-3A;GTF2A1;TAF1
prerank,MAP kinase phosphatase activity (GO:0033549),0.4009272964340215,0.8350893674520375,0.6676691729323309,0.9170246480952968,1.0,6/12,32.17%,DUSP5;DUSP7;DUSP10;DUSP16;DUSP4;DUSP1
prerank,dynactin binding (GO:0034452),0.40581969358855063,0.8350363769362505,0.6646706586826348,0.9147993815857457,1.0,4/12,14.35%,GSK3B;PAFAH1B1;HOOK3;BICD1
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.35880179534333495,0.8340018197528265,0.6890156918687589,0.9141859414054564,1.0,3/22,7.53%,ATP2C2;TCIRG1;ATP6V0A4
prerank,MHC class II protein complex binding (GO:0023026),0.40563320189062274,0.8298274941831866,0.6768982229402262,0.9185589454043813,1.0,1/11,1.98%,ATP1B1
prerank,myosin V binding (GO:0031489),0.3790301428843313,0.8292036736895474,0.6861861861861862,0.9173226592233411,1.0,4/15,20.15%,RAB25;RAB6A;RAB11B;RAB11A
prerank,ionotropic glutamate receptor binding (GO:0035255),0.4071914125773307,0.8271100727288845,0.6651305683563749,0.9184219394100871,1.0,3/10,11.83%,GNAS;SHANK1;NSF
prerank,ankyrin binding (GO:0030506),-0.29256947618789764,-0.825300146676926,0.6869300911854104,0.9017479475741285,1.0,6/19,12.37%,CACNA1D;SLC8A1;FLNC;SPTB;SPTBN4;KCNQ2
prerank,serotonin receptor activity (GO:0099589),-0.2915779984486177,-0.8252153743469074,0.6907216494845361,0.8823347061274596,1.0,10/22,34.49%,HTR2C;CHRM2;CHRM3;HTR2A;HTR1F;CHRM1;HRH1;HTR1A;CHRM5;HTR1D
prerank,G protein-coupled amine receptor activity (GO:0008227),-0.2915779984486177,-0.8252153743469074,0.6907216494845361,0.8823347061274596,1.0,10/22,34.49%,HTR2C;CHRM2;CHRM3;HTR2A;HTR1F;CHRM1;HRH1;HTR1A;CHRM5;HTR1D
prerank,G protein-coupled serotonin receptor activity (GO:0004993),-0.2915779984486177,-0.8252153743469074,0.6907216494845361,0.8823347061274596,1.0,10/22,34.49%,HTR2C;CHRM2;CHRM3;HTR2A;HTR1F;CHRM1;HRH1;HTR1A;CHRM5;HTR1D
prerank,microtubule binding (GO:0008017),0.27491523653045735,0.8237322939326807,0.8385093167701864,0.9217040005398086,1.0,46/222,17.76%,EZR;FGF13;MAP7D3;MTUS1;MID1;CLIP4;NDRG1;KIF13A;KATNB1;FMN1;NDEL1;CLIP1;FAM161A;KIF16B;KIF1B;MACO1;PAFAH1B1;KIF9;KNSTRN;TOGARAM1;MAST2;KRIT1;HOOK3;MAP1B;HDGFL3;ARL3;EML6;GAS2L1;CHP1;KIF3B;TUBGCP6;KIF7;DRG1;KIF1C;MAP6;MAP1S;ABRAXAS2;KIF5B;RMDN3;CCDC66;TUBGCP2;CAMSAP3;CRIPT;POLB;CEP57L1;LRRK2
prerank,hyaluronic acid binding (GO:0005540),-0.34443053663436074,-0.8234088109646105,0.6572890025575447,0.878991696250559,1.0,2/10,5.23%,CEMIP;LAYN
prerank,adenyl ribonucleotide binding (GO:0032559),0.26913164844629084,0.8230755961223505,0.8622448979591837,0.9205303035924931,1.0,32/291,10.80%,ME1;ABCD3;MAP3K5;MARK1;SMC4;WNK1;PRPS2;GCLC;N4BP2;MPPED2;TLK1;BMPR1A;TGFBR1;ABL1;IRAK3;ABCF1;RAD51;CDK11B;ABCD1;PPIP5K1;HSPA1L;NLK;MAST2;TOP1;PTPA;ATP1A3;ATP1A1;MIEF1;PFKP;DHX36;IDE;PDK3
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.4025160764231799,0.8223354109701768,0.6953748006379585,0.9194793870532197,1.0,2/11,12.07%,RDH12;DHRS13
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.3777484910442949,0.8217871099596402,0.6923076923076923,0.915909618017844,1.0,2/16,3.59%,ANO9;ANO6
prerank,intracellular chloride channel activity (GO:0061778),0.3777484910442949,0.8217871099596402,0.6923076923076923,0.915909618017844,1.0,2/16,3.59%,ANO9;ANO6
prerank,vinculin binding (GO:0017166),0.4058923284591345,0.8217213872639333,0.6944444444444444,0.9137640721905603,1.0,2/11,5.31%,SORBS3;CTNNA1
prerank,acetylgalactosaminyltransferase activity (GO:0008376),-0.2714949902500287,-0.821393659741783,0.7435897435897436,0.8763421708271226,1.0,4/26,7.63%,CHSY3;CSGALNACT1;CHSY1;B3GALT1
prerank,MHC protein binding (GO:0042287),-0.28831132327479086,-0.8203214938756022,0.7368421052631579,0.8720440092833583,1.0,9/20,20.57%,CD81;TAP2;ATP5F1A;ABCB9;CD74;ATP5F1B;TUBB4B;DERL1;TAPBP
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.3393443751017881,0.8182882014555973,0.6954177897574124,0.9169717680149616,1.0,10/30,21.06%,CAST;SERPINB9;PRDX5;RPS6KA3;DPEP1;CARD16;UBE2O;CST7;UBE2Z;BIRC6
prerank,NAD+ binding (GO:0070403),0.398983908982555,0.8176852517658693,0.6620583717357911,0.9158015208740949,1.0,3/12,13.62%,SIRT6;CRYL1;SIRT3
prerank,tumor necrosis factor receptor binding (GO:0005164),0.39541946173264286,0.8171582796041662,0.682615629984051,0.9144288761895993,1.0,5/12,21.02%,TRAF2;TRAF6;TRAF5;TRAF4;TRAF3
prerank,ribosomal small subunit binding (GO:0043024),-0.3006372457365523,-0.8169409677361167,0.7594202898550725,0.8718553674214121,1.0,5/17,16.31%,CPEB2;NPM1;DDX3X;NME1;PIM1
prerank,protein tyrosine kinase activator activity (GO:0030296),0.3558035579239178,0.8163385907405304,0.6908831908831908,0.9135330031371421,1.0,2/19,2.18%,ABI1;EFNA5
prerank,heme binding (GO:0020037),0.300719213837278,0.8158098180644447,0.7553444180522565,0.9122173449013677,1.0,11/65,12.71%,CYP1B1;PTGIS;CYP2S1;PTGES2;DGCR8;RSAD1;COX15;TDO2;EIF2AK1;HMOX2;NR1D1
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.39091810010534467,0.8149883448316331,0.6900763358778625,0.9112937642442599,1.0,4/11,19.23%,NAA15;NAA40;NAA80;NAA60
prerank,ephrin receptor binding (GO:0046875),0.34694627202856454,0.8140293497201166,0.6892265193370166,0.9106501991847055,1.0,3/21,5.34%,EFNA5;ABL1;SHC1
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.3036052713311966,0.8122936738894145,0.7601918465227818,0.9111143736475716,1.0,18/60,22.26%,PPP3CA;PPM1H;PHLPP2;PPP1R3C;CDC14A;CTDSPL2;PPTC7;ILKAP;CDKN3;UBLCP1;SSU72;PPP5C;LCK;LRRK2;PPM1L;PPP1CC;PPEF1;PPP6C
prerank,phospholipase binding (GO:0043274),-0.32915948958434715,-0.8091507573443764,0.7278688524590164,0.8790658751215584,1.0,1/13,0.88%,ARHGAP6
prerank,LRR domain binding (GO:0030275),0.3743472793144246,0.8086479949251674,0.6941529235382309,0.914684731571577,1.0,3/14,5.73%,ERC1;PAWR;MRTFA
prerank,proton transmembrane transporter activity (GO:0015078),-0.24338429435634062,-0.807705358333899,0.7810945273631841,0.875535191233895,1.0,8/39,14.21%,NDUFA4;UQCRH;COX4I1;CLCN3;COX5B;UQCR10;UQCRC1;SLC33A1
prerank,protein kinase A regulatory subunit binding (GO:0034237),-0.28648847599444366,-0.8075286378778911,0.7467105263157895,0.869814982466095,1.0,5/21,11.33%,AKAP6;RYR2;WASF3;AKAP1;KCNQ1
prerank,ribosomal large subunit binding (GO:0043023),0.39074500814965685,0.8065298656834022,0.6901408450704225,0.915593118788721,1.0,6/11,25.13%,EIF6;RBM3;NMD3;MRRF;MALSU1;LTN1
prerank,thioesterase binding (GO:0031996),0.3960701619366812,0.8049539955649827,0.6998394863563403,0.9160225713557342,1.0,5/11,21.02%,TRAF2;TRAF6;TRAF5;TRAF4;TRAF3
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.29328273270408034,0.8047181166538321,0.7494145199063232,0.9141561158904432,1.0,15/69,15.52%,SOAT1;ELP3;PLA2G15;CREBBP;ZDHHC2;HHAT;ZDHHC20;ZDHHC12;SOAT2;NAA15;ESCO1;ZDHHC15;ZDHHC13;MOGAT1;KAT6B
prerank,protein phosphatase activator activity (GO:0072542),-0.30932280863140404,-0.8039598252572085,0.7318435754189944,0.8694610190503521,1.0,4/13,15.31%,IGFBP3;CALM1;PPP2R5E;PPP2R5A
prerank,NADPH binding (GO:0070402),0.3823597234338063,0.8007476055942934,0.7001545595054096,0.9181701335929541,1.0,4/13,18.62%,CBR3;DECR1;LBR;HMGCR
prerank,G protein-coupled receptor binding (GO:0001664),0.2744099535086183,0.7995699193404497,0.8251599147121536,0.9177968952969,1.0,8/132,6.17%,WNT9A;LRP6;WNT11;GNAS;FZD1;FZD7;PROK2;MYOC
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.2578108934032896,0.7985390414307214,0.9307228915662651,0.9171452708741302,1.0,83/431,20.30%,ABCD3;RHOJ;MAP3K5;MARK1;SMC4;WNK1;PRPS2;RHOBTB1;N4BP2;ATL3;NRAS;KRAS;TLK1;BMPR1A;ATL2;MRAS;TGFBR1;ABL1;IRAK3;ABCF1;RRAGB;RAD51;RAB6A;ARFIP2;CDK11B;ABCD1;BMS1;RHOQ;PPIP5K1;NOA1;HSPA1L;RND3;NLK;MAST2;TOP1;PTPA;ATP1A3;ATP1A1;RAB35;PFKP;ARL3;RHOA;DHX36;IDE;PDK3;RAP1A;CARS2;ARF4;NMUR2;MARK2;DRG1;ACVR1;RAB21;RAP2C;RAB11B;ATL1;RHEB;TUBE1;RAB28;SMARCA5;P2RX5;PPP5C;SIK1;CHD8;ERN2;PSMA6;P2RX4;LRRK2;STK3;RALB;DHX9;SRR;DAPK1;PEX1;TLK2;RAP2B;EIF4G1;CLP1;ANXA6;CDC42BPA;NEK6;ADSS2;OLA1
prerank,alkali metal ion binding (GO:0031420),0.37755423476055605,0.7964817456273808,0.7048929663608563,0.9180885546736418,1.0,4/13,12.82%,HDAC4;SLC34A2;ATP1A1;DRG1
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.3227101076014337,0.791886519607409,0.7443408788282291,0.9227734460796226,1.0,9/33,21.10%,ERI3;CNOT8;ANGEL2;EXOSC3;REXO2;ERI1;DIS3;EXOSC2;EXOSC7
prerank,cell-cell adhesion mediator activity (GO:0098632),0.30961430411322866,0.791173942602967,0.7532808398950132,0.9216866080109131,1.0,6/42,8.63%,BAIAP2L1;ANXA2;KRT18;ANXA1;STXBP6;EMB
prerank,amino acid binding (GO:0016597),0.32248933374201566,0.7911183907484612,0.7245430809399478,0.9196298601064984,1.0,3/31,4.12%,GCLC;CASR;GLRB
prerank,pentosyltransferase activity (GO:0016763),0.31622432946219475,0.7891344459667116,0.7438551099611902,0.9203274522167817,1.0,12/36,22.84%,LARGE1;SIRT6;PARP3;PARP1;UPP2;SIRT3;PARP6;PARP2;PARP4;LARGE2;UMPS;TNKS2
prerank,cAMP response element binding (GO:0035497),0.3948217457965686,0.7888835892983584,0.7194928684627575,0.9185524381960415,1.0,6/10,21.01%,NR4A3;ATF7;CREB3L1;E4F1;ATF2;CREB1
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.25317013769166785,-0.7847390151512916,0.8114754098360656,0.8940984380321003,1.0,8/30,15.46%,SLC30A10;SLC39A10;SLC39A8;SLC40A1;SLC30A1;SLC39A12;SLC39A1;SLC31A1
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),-0.23830159464251105,-0.784003577914872,0.84688995215311,0.8892361207562163,1.0,6/38,11.47%,SPOCK1;APP;SERPINI1;SERPIND1;TFPI;A2M
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),-0.2918642861043589,-0.7824773902236501,0.7915309446254072,0.8855918441624874,1.0,5/18,20.02%,PIK3R1;PIK3R6;PIK3R5;SOCS5;AGAP2
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.3810145738041542,0.7822916910443047,0.717425431711146,0.9261441677314128,1.0,2/11,13.10%,NUDT5;NUDT1
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),-0.26433076091436647,-0.7800780743208534,0.8007518796992481,0.8833039706839865,1.0,4/24,7.17%,ZDHHC14;ZDHHC1;ZDHHC17;ZDHHC9
prerank,phosphatase activity (GO:0016791),0.2834870561679295,0.7791378742752688,0.8020954598370198,0.9286390532744562,1.0,11/73,12.76%,ALPL;PLPP3;PLPPR2;ACP3;ACP4;DUSP11;LPIN2;SBF1;DUSP28;DUSP5;OCRL
prerank,general transcription initiation factor binding (GO:0140296),0.3279293742903263,0.7783803874356064,0.7385257301808067,0.9275346413487325,1.0,9/25,23.63%,ESR1;PSMC1;GTF2A2;THAP7;TBP;TAF12;YEATS2;TAF13;GTF2B
prerank,histone methyltransferase binding (GO:1990226),-0.32258518581501816,-0.7777115818532855,0.754054054054054,0.8808727808073065,1.0,5/11,15.16%,CBX3;HSP90AB1;LCORL;WIZ;CTNNB1
prerank,MAP kinase kinase activity (GO:0004708),-0.30563385252736885,-0.7766834009995305,0.7624633431085044,0.8765465944547329,1.0,4/15,12.82%,PAK3;MAP2K6;MAP2K1;MAPK10
prerank,gamma-tubulin binding (GO:0043015),-0.2747775422728843,-0.7761730165197482,0.7889273356401384,0.8716092861053546,1.0,7/21,19.45%,PAK1;DIXDC1;CDK5RAP2;DDX3X;BRSK1;ARHGEF7;B9D2
prerank,anion transmembrane transporter activity (GO:0008509),0.3755256924901357,0.7746372512490006,0.7504105090311987,0.9309692483234214,1.0,2/12,4.19%,ABCG2;SLC4A2
prerank,U6 snRNA binding (GO:0017070),0.3614139946677435,0.7726845708421756,0.7377777777777778,0.931673974902133,1.0,8/14,35.87%,LSM8;PRPF8;LSM4;LARP7;METTL16;DDX39B;LSM2;LSM3
prerank,channel activity (GO:0015267),-0.23251914150613873,-0.7703919082526319,0.8868778280542986,0.8742147933159411,1.0,9/41,18.29%,BCL2;AQP11;TRPV2;PDPN;AQP4;KCNK3;TRPV4;SLC14A1;TRPA1
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.33297208311522597,0.7699457195839073,0.7472222222222222,0.9335221346481495,1.0,4/20,8.45%,SLC39A14;SLC39A13;SLC39A11;SLC30A3
prerank,methyltransferase activity (GO:0008168),0.29175755093510325,0.7698177132680198,0.8010012515644556,0.9315704482997157,1.0,8/46,15.93%,NNMT;PRMT8;EHMT1;EEF1AKMT4;PRMT5;RRP8;LRTOMT;TRMT11
prerank,chemokine binding (GO:0019956),0.3076406444160475,0.7697318998056559,0.7635869565217391,0.9295639783955342,1.0,5/30,16.87%,FGF2;ITGB1;ITGAV;ITGB3;CXCR5
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.3306386898847181,0.7672725612205656,0.7606019151846786,0.9309266783916551,1.0,10/22,32.17%,DUSP19;SBF1;DUSP5;CDKN3;DUSP7;DUSP10;DUSP16;DUSP4;DUSP12;DUSP1
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.3787756460532341,0.7670057801064555,0.7432216905901117,0.9292195276832201,1.0,2/12,9.83%,PIK3C2B;PIK3R3
prerank,microtubule minus-end binding (GO:0051011),0.3567707972972969,0.7640998256725229,0.7523219814241486,0.9311483691796697,1.0,6/13,27.89%,TUBGCP6;TUBGCP2;CAMSAP3;CEP290;TUBGCP5;TUBGCP3
prerank,growth factor receptor binding (GO:0070851),0.266667760866873,0.7612920947984446,0.854875283446712,0.9331339397507746,1.0,22/95,22.09%,PGF;FGF2;SNX2;CBLC;VEGFA;PDGFC;SHC1;AGR2;ATXN2;ARF4;ITGB3;CNTF;PLSCR1;EFEMP1;GLMN;ITGA5;JAK2;PIBF1;FER;EGF;ERAP1;IL27RA
prerank,lipase activator activity (GO:0060229),-0.32657401976807776,-0.7595205616367758,0.7675070028011205,0.8837447037787364,1.0,1/10,0.88%,ARHGAP6
prerank,receptor tyrosine kinase binding (GO:0030971),0.28038328831819764,0.7522085985615419,0.8127208480565371,0.9433813825821951,1.0,13/56,17.96%,GAB2;CBLC;IRS1;PTPN2;SHC1;ACP4;MAP3K7;TRAT1;ALKAL2;RNF41;NCK1;CPNE3;TOB1
prerank,ATP binding (GO:0005524),0.24605488564439434,0.7505151522298741,0.9342915811088296,0.94353677855053,1.0,28/266,10.80%,ABCD3;MAP3K5;MARK1;SMC4;WNK1;PRPS2;N4BP2;TLK1;BMPR1A;TGFBR1;ABL1;IRAK3;ABCF1;RAD51;CDK11B;ABCD1;PPIP5K1;HSPA1L;NLK;MAST2;TOP1;PTPA;ATP1A3;ATP1A1;PFKP;DHX36;IDE;PDK3
prerank,mitogen-activated protein kinase binding (GO:0051019),0.30638710295934646,0.7445738819140592,0.8088829071332436,0.9494019286000739,1.0,13/29,28.97%,ABL1;ATF7;DUSP5;NFATC1;NBR1;TNIP1;MAPKAPK2;MAPKAPK5;PPM1D;DUSP7;DUSP10;DUSP16;DUSP4
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.2885873746993487,-0.7438705931824575,0.8112676056338028,0.8989821932454454,1.0,8/14,37.29%,NOX1;NOX4;NCF2;NCF1;MICAL1;NOX3;NCF4;DUOX1
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.36256410165823594,0.7432641051511767,0.7984496124031008,0.9489988703271938,1.0,3/12,21.90%,NQO1;CRYZL1;DHRS4
prerank,fibroblast growth factor receptor binding (GO:0005104),-0.26158166388629667,-0.7419283439209752,0.8235294117647058,0.8957436811363592,1.0,3/21,7.09%,KL;FGF1;FRS2
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.33749810398897045,0.7415967981048202,0.7831149927219796,0.94700603527882,1.0,6/16,27.00%,TCIRG1;ATP6V0A4;ATP6V1A;ATP6V0D1;ATP6V0A2;ATP6V0B
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.33749810398897045,0.7415967981048202,0.7831149927219796,0.94700603527882,1.0,6/16,27.00%,TCIRG1;ATP6V0A4;ATP6V1A;ATP6V0D1;ATP6V0A2;ATP6V0B
prerank,carboxylic ester hydrolase activity (GO:0052689),0.2638650318369171,0.7390545358158837,0.8769751693002258,0.9482536791755005,1.0,14/85,19.06%,MGLL;PLA2G4F;PLA2G15;LYPLA2;PAFAH1B2;PNPLA3;ABHD6;LYPLAL1;PAFAH1B3;PNPLA2;LCAT;CEL;DAGLB;PON2
prerank,aminopeptidase activity (GO:0004177),0.3104466851953033,0.7384530035475907,0.8041095890410959,0.9469178469334082,1.0,4/26,8.49%,XPNPEP3;XPNPEP1;NPEPPS;MMP16
prerank,UDP-galactosyltransferase activity (GO:0035250),0.36448030338432,0.7381431767884291,0.7904,0.9452260252666366,1.0,3/10,15.85%,B4GALT1;B3GALT6;A3GALT2
prerank,phosphate ion binding (GO:0042301),0.3729153844466645,0.7366417636445692,0.7981072555205048,0.9449335127941285,1.0,1/10,2.82%,SLC34A2
prerank,phospholipase activator activity (GO:0016004),-0.3167030810220556,-0.7353098107702226,0.7861111111111111,0.8981934147680665,1.0,1/10,0.88%,ARHGAP6
prerank,four-way junction DNA binding (GO:0000400),0.3252700190274823,0.7308455245323188,0.8117816091954023,0.9502407130751997,1.0,2/17,7.50%,ABL1;WRN
prerank,chemokine receptor activity (GO:0004950),0.30320672839936413,0.7289719308335753,0.8230337078651685,0.9506006080117801,1.0,1/24,2.28%,CMKLR1
prerank,cytokine receptor binding (GO:0005126),0.26012671918122965,0.7288513139550121,0.8808705612829324,0.9486499120606928,1.0,7/83,7.92%,PGF;VEGFA;CLCF1;USP15;SPRED2;KITLG;SMAD2
prerank,Tat protein binding (GO:0030957),-0.32020317391911113,-0.7282066714313482,0.7984293193717278,0.9007999605253579,1.0,3/10,13.43%,ACTB;NPM1;GABARAPL1
prerank,tau protein binding (GO:0048156),0.2867003428738954,0.7249643318125232,0.8342105263157895,0.951354185390628,1.0,9/40,16.61%,MARK1;GSK3B;S100B;SMAD2;CLU;MARK2;MARK3;PPP5C;PIN1
prerank,DNA polymerase binding (GO:0070182),0.3251675707054522,0.7247683288093376,0.7911301859799714,0.9495550344522374,1.0,4/18,17.11%,SMG6;RAD51;NAT10;POLG2
prerank,tubulin binding (GO:0015631),0.23734171422819456,0.7221123720592977,0.9635258358662614,0.9507185275434102,1.0,52/295,16.55%,EZR;FGF13;NLRP5;MAP7D3;UNC5C;MTUS1;MID1;NDRG1;BCAS3;KIF13A;EMD;KATNB1;FMN1;NDEL1;CLIP1;FAM161A;KIF16B;KIF1B;SETD2;MACO1;PAFAH1B1;KIF9;TOGARAM1;MAST2;KRIT1;TTLL2;HOOK3;MAP1B;HDGFL3;ARL3;EML6;GAS2L1;CHP1;KIF3B;TUBGCP6;KIF7;BRCA1;DRG1;KIF1C;MAP6;MAP1S;AGBL5;RABGAP1;TRAPPC14;OFD1;ABRAXAS2;CCT5;KIF5B;RMDN3;CCDC66;TUBGCP2;CRIPT
prerank,nuclear receptor coactivator activity (GO:0030374),0.27225474220901474,0.721375931500646,0.8492462311557789,0.9496015319721599,1.0,11/52,15.51%,FGF2;DCAF6;RBM14;MED13;MED24;THRAP3;KDM1A;PPRC1;NCOA6;SRA1;SLC30A9
prerank,protein phosphatase regulator activity (GO:0019888),0.2698006764425053,0.7171718157560497,0.8557575757575757,0.9526755357583235,1.0,21/53,24.02%,SHOC2;STYXL1;PTPA;PPP2R5C;RCAN1;PPP6R3;EIF2AK2;PPP2R2D;IGBP1;MGAT5;PTN;PPP4R2;ARPP19;PPP1R16A;LGALS3;PPP6R1;CABIN1;PPP6R2;PPP4R1;BOD1L1;CALM2
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.3162568623325555,0.7158526822002853,0.83,0.9500853196373725,1.0,7/21,16.11%,CDK10;CDK12;CDK11B;CDK13;CDKL2;CDK7;CDK2
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.3162568623325555,0.7158526822002853,0.83,0.9500853196373725,1.0,7/21,16.11%,CDK10;CDK12;CDK11B;CDK13;CDKL2;CDK7;CDK2
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.3091138451361008,-0.7092989572596077,0.8166666666666667,0.9153804140187369,1.0,1/10,2.66%,KDM7A
prerank,retinoid X receptor binding (GO:0046965),0.3473581481092795,0.70861821277498,0.8018867924528302,0.956567868124778,1.0,8/11,29.72%,NR4A2;NSD1;NCOA6;PPARG;MED25;HMGA1;RARG;NRIP1
prerank,ubiquitin-dependent protein binding (GO:0140036),0.35338035926927397,0.705345182864901,0.8214285714285714,0.9583447173944217,1.0,2/10,10.56%,USP15;IDE
prerank,palmitoyltransferase activity (GO:0016409),0.2908947484050693,0.7050638841024106,0.8448275862068966,0.9565836689655918,1.0,10/28,22.44%,ZDHHC2;HHAT;ZDHHC20;ZDHHC12;ZDHHC15;ZDHHC13;ZDHHC24;GOLGA7;ZDHHC3;ZDHHC19
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.33879748471822885,0.70275492337362,0.8212634822804314,0.9571379935073091,1.0,3/12,23.87%,TENT2;TENT4B;PAPOLG
prerank,methyl-CpG binding (GO:0008327),0.3072509668606703,0.7021704086832337,0.818830242510699,0.9557365769271629,1.0,5/22,17.18%,MBD1;MECP2;MBD3;PRMT5;CHTOP
prerank,G protein-coupled receptor activity (GO:0004930),0.2299628760708315,0.6980335678003137,0.9582909460834181,0.9583212278793822,1.0,15/239,8.89%,ADGRL2;GPR156;ADRA1B;PDGFRL;CMKLR1;CASR;ADRB2;TAS1R3;NPR3;NTSR1;C5AR2;GPR65;GPR27;MRGPRF;GPR4
prerank,O-methyltransferase activity (GO:0008171),0.35096454835825225,0.6975030903190266,0.8166939443535188,0.9568373486021639,1.0,5/10,27.92%,LRTOMT;ASMT;FTSJ3;CMTR2;CMTR1
prerank,neuropeptide binding (GO:0042923),0.30751148038106324,0.6968190275334927,0.8069164265129684,0.9556081566290013,1.0,3/18,19.53%,NMUR2;SORL1;SSTR2
prerank,glutathione transferase activity (GO:0004364),0.2986751106256451,0.6966409448259442,0.8548621190130624,0.9538029082876657,1.0,7/23,22.91%,GSTT1;GSTA2;GSTT2;GSTM4;LANCL1;GSTO1;PTGES
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.29528998500542186,0.6950835617037987,0.8335588633288228,0.9534520997072182,1.0,8/25,22.84%,SIRT6;PARP3;PARP1;SIRT3;PARP6;PARP2;PARP4;TNKS2
prerank,ATP hydrolysis activity (GO:0140603),0.26810236651488384,0.693372749286209,0.8865336658354115,0.9533168226413046,1.0,9/41,18.46%,VWA8;ABCD1;CHD3;CHD1L;VCP;CLU;TOR1B;MYO1E;DHX9
prerank,syntaxin-1 binding (GO:0017075),0.2993634453745862,0.6872989498557432,0.8465909090909091,0.9577570928903927,1.0,9/22,22.61%,UNC13B;NSF;VAMP2;STXBP1;LRRK2;DAPK1;STXBP5;CPLX2;PRRT2
prerank,endopeptidase activator activity (GO:0061133),0.3407603067216058,0.6865091502615889,0.8190184049079755,0.9566237061314946,1.0,3/10,21.13%,ADRM1;PSMD14;PSME3
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.3315112392501189,0.6859233296732311,0.8265139116202946,0.9552129117250989,1.0,3/11,21.36%,SLC25A45;SLC25A20;SLC22A5
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.299924642049736,0.6831923247889423,0.8497790868924889,0.9559934327340899,1.0,18/18,70.04%,HSD17B2;RDH5;HSD3B7;DHRS11;HSD11B1;HSD3B1;HSD17B10;HSD17B3;HSD17B6;RDH16;DHRS9;AKR1C1;HSD17B14;HSD3B2;SRD5A2;HSD17B8;HSD17B1;HSD17B7
prerank,cGMP binding (GO:0030553),0.32860032780613124,0.6810693984997086,0.8384615384615385,0.9562951873360688,1.0,1/11,3.68%,PDE5A
prerank,semaphorin receptor activity (GO:0017154),0.33350124887764465,0.6804605756027601,0.8042071197411004,0.9549046792817368,1.0,3/11,20.23%,NRP1;PLXNB1;PLXNA4
prerank,glutamate receptor binding (GO:0035254),0.30679481533613956,0.6792202282973915,0.8521229868228404,0.9541635236707916,1.0,5/17,17.48%,GNAS;SHANK1;NSF;HOMER2;HOMER1
prerank,beta-tubulin binding (GO:0048487),0.27590128567929517,0.6759653567299312,0.8909825033647375,0.9555218375223419,1.0,3/31,4.59%,FGF13;BCAS3;EMD
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.32178906625185144,0.6712769548361198,0.8406940063091483,0.9581499080248902,1.0,3/13,13.82%,PIK3C2B;PIP5K1A;PIP4K2A
prerank,phosphoric ester hydrolase activity (GO:0042578),0.2540391311314324,0.6680577656580681,0.9054726368159204,0.9591906248802141,1.0,9/49,12.24%,MPPED2;ACP3;ACP4;APEX1;SMPDL3A;DUSP11;SBF1;DUSP28;DUSP5
prerank,ion gated channel activity (GO:0022839),0.28579998254622846,0.665843845486055,0.8847736625514403,0.9593667827252901,1.0,4/24,12.31%,ANO9;ANO6;TRPM4;NMUR2
prerank,ubiquitin-specific protease binding (GO:1990381),0.3027245600028532,0.6638855624223626,0.8631732168850073,0.9592738020940623,1.0,2/19,9.12%,LCOR;VCP
prerank,MAP-kinase scaffold activity (GO:0005078),0.32900873259646185,0.6600427259240107,0.8540372670807453,0.9610286034457474,1.0,4/11,20.87%,AKAP13;DUSP19;IQGAP1;MAP2K2
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.2670117903030791,0.656530700581557,0.8963660834454913,0.9623816073584818,1.0,13/34,29.04%,UBE2A;UBE2K;UBE2B;UBE2D3;UBE2O;UBE2S;UBE2F;UBE2Z;BIRC6;UBE2R2;UBE2I;UBE2Q2;UBE2N
prerank,RNA methyltransferase activity (GO:0008173),-0.2376805131789364,-0.6548166145680461,0.93,0.959286668003353,1.0,7/19,26.46%,TRMT9B;METTL4;FBL;TRMT5;MRM2;TYW3;METTL8
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.30254098759709164,0.6546638977440783,0.8725637181409296,0.9620226166283845,1.0,3/16,9.58%,SMUG1;DNPH1;NEIL3
prerank,TBP-class protein binding (GO:0017025),0.28306368481031946,0.6514008831831162,0.8969072164948454,0.9629645101013465,1.0,7/21,23.63%,ESR1;PSMC1;GTF2A2;TAF12;YEATS2;TAF13;GTF2B
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.30109290132761307,0.6428650346742936,0.8833333333333333,0.9683875019380831,1.0,2/14,13.66%,AK4;AK1
prerank,death domain binding (GO:0070513),0.3151175526601051,0.6426218694259828,0.8673139158576052,0.9666128290974713,1.0,6/11,27.91%,CRADD;MCL1;DAP;TRADD;DAPL1;BAX
prerank,peptide N-acetyltransferase activity (GO:0034212),0.3166044903640769,0.6406503801559572,0.8866459627329193,0.9663363692715913,1.0,3/10,19.23%,NAA15;NAA80;NAA60
prerank,muscle alpha-actinin binding (GO:0051371),0.29332444640863725,0.6386977259864983,0.8887262079062958,0.965910133419797,1.0,4/15,21.30%,PDLIM7;PDLIM4;PDLIM5;PDLIM2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.31094026000297387,0.6383137443895841,0.8937908496732027,0.9642934452779988,1.0,1/11,8.24%,ARG1
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.2624840095780435,-0.6338990629050173,0.9090909090909091,0.9684153715751299,1.0,5/13,25.56%,SLC38A5;SLC7A7;SLC7A1;SLC3A1;SLC66A1
prerank,RNA stem-loop binding (GO:0035613),0.3108508750689769,0.6332925822627361,0.8983050847457628,0.9664675823574799,1.0,5/12,26.48%,ZC3H12A;EPRS1;DHX9;FMR1;METTL16
prerank,syntaxin binding (GO:0019905),0.23512412689476805,0.6322780217067155,0.9476248477466505,0.9653020655193346,1.0,17/61,23.88%,UNC13B;ABL1;PTPN2;NSF;SCFD2;VAMP2;STXBP1;SNAP23;LRRK2;DAPK1;STXBP5;VPS52;RAB11A;STX8;CPLX2;PRRT2;VPS54
prerank,disordered domain specific binding (GO:0097718),-0.2127751663988103,-0.6227173593320551,0.9407665505226481,0.9696952250291511,1.0,8/23,23.72%,TEAD2;CALM1;HSP90AB1;GAPDH;HSPA1A;KCNA1;BCL2L2;HSPA2
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.2540795234116463,0.6214340142023355,0.9130434782608695,0.9718041821436982,1.0,8/31,21.06%,UBE2A;UBE2K;UBE2B;UBE2D3;UBE2O;UBE2S;UBE2Z;BIRC6
prerank,metalloexopeptidase activity (GO:0008235),0.22794000004400194,0.6098283778878021,0.9578313253012049,0.9781412287024783,1.0,8/51,14.04%,CPQ;XPNPEP3;XPNPEP1;AGBL3;NPEPPS;MMP16;DPEP1;AGBL5
prerank,WW domain binding (GO:0050699),-0.20215918443414746,-0.6069079939734233,0.9671532846715328,0.9729714618777511,1.0,4/26,10.25%,RAPGEF2;LITAF;ENAH;TNK2
prerank,retinoic acid receptor binding (GO:0042974),0.2708378998002412,0.5964962922973026,0.9197080291970803,0.985065830236973,1.0,11/17,31.68%,NR4A2;NSD1;NCOA6;PPARG;MED25;CNOT1;HMGA1;RARG;ASXL1;NRIP1;SNW1
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),-0.2522555368890644,-0.5830504797927833,0.936,0.9791008444839492,1.0,7/11,45.95%,CHRNA4;CHRNB2;CHRNA9;CHRNA5;CHRNA3;CHRNB4;CHRNA1
prerank,ferrous iron binding (GO:0008198),0.25395920194770194,0.5806377779826555,0.934971098265896,0.9926529949150263,1.0,6/21,25.31%,EGLN3;FXN;FTO;HIF1AN;ALKBH1;HEPH
prerank,telomerase RNA binding (GO:0070034),0.24443340504260544,0.5719471691999238,0.958041958041958,0.9953448026357127,1.0,8/22,29.37%,SMG6;DHX36;TENT4B;NAF1;PARN;SNRPB;HNRNPC;GAR1
prerank,nucleosomal DNA binding (GO:0031492),0.2521703708885342,0.5714626117262754,0.9498607242339833,0.9936315026542877,1.0,6/21,29.87%,SMARCC1;MBD3;HDAC2;SMARCA4;HNRNPC;SMARCE1
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.26052079118661897,0.5635915629509882,0.9472049689440993,0.995622535036546,1.0,7/16,28.75%,MTMR12;SYNJ1;MTMR1;SACM1L;MTMR9;MTM1;MTMR11
prerank,neuropeptide receptor activity (GO:0008188),0.22502496753166035,0.5563080981242575,0.9568627450980393,0.997175157443055,1.0,7/29,26.87%,NTSR1;NMUR2;NPSR1;SSTR2;GRPR;NPY2R;GALR1
prerank,neuropeptide receptor binding (GO:0071855),0.25275538845718126,0.5535164175739818,0.9573820395738204,0.9965016613938542,1.0,1/14,7.04%,SHANK1
prerank,protein phosphatase inhibitor activity (GO:0004864),0.22849666161374182,0.5404538361918324,0.9623655913978495,1.0,1.0,7/26,23.18%,STYXL1;MGAT5;PTN;ARPP19;LGALS3;CABIN1;BOD1L1
prerank,motor activity (GO:0003774),0.19727394307991164,0.532982021426369,0.9915764139590855,1.0,1.0,22/60,28.95%,KIF13A;KIF16B;KIF1B;KIF9;KIF3B;KIF7;KIF1C;KLC1;KIF5B;PIN1;MYO1E;DNAH17;DYNC2H1;KIF23;KIF15;APPBP2;SMC3;KIF13B;KIF22;KIF20B;DNAH8;CENPE
prerank,carbohydrate kinase activity (GO:0019200),0.2591657234492565,0.5311307386537821,0.9437037037037037,0.9996044420947799,1.0,3/11,28.42%,GALK2;GALK1;HK1
prerank,alpha-tubulin binding (GO:0043014),-0.1699683578143871,-0.5278788202331569,0.9920634920634921,0.9931563941479743,1.0,8/31,22.48%,TTLL7;EML4;TBCEL;TRPV4;EFHC1;TRIM36;SNCA;DLEC1
prerank,antiporter activity (GO:0015297),0.22777890920848615,0.5278484485393825,0.967741935483871,0.9987365832957896,1.0,5/20,26.40%,SLC35D2;ATP1A3;SLC35D1;SLC35E2B;SLC35E2A
prerank,neuropeptide hormone activity (GO:0005184),0.22066582914572846,0.5193674646543383,0.9723032069970845,0.9996813800887728,1.0,22/22,77.96%,HCRT;SPX;GRP;AGRP;CCK;NMB;NPFF;OXT;CORT;QRFP;GHRH;NPPA;UCN;CALCB;GAL;CRH;VIP;PPY;PNOC;ADCYAP1;NPY;PENK
prerank,Hsp70 protein binding (GO:0030544),-0.1665856376389705,-0.5173470021260306,0.9957264957264957,0.9901758282216219,1.0,7/31,21.84%,RPS3;SACS;HIKESHI;ERN1;NOD2;SNCA;DNAJC2
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.2247455867207362,0.5172715610791374,0.9737226277372263,0.9984487409571267,1.0,4/21,20.52%,GLRB;P2RX5;P2RX4;CHRNB1
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.2590164139977156,0.5118838957930785,0.9445350734094616,0.9979575310798783,1.0,3/10,20.89%,IDE;DNAJB2;PML
prerank,microtubule motor activity (GO:0003777),0.1919739541937722,0.509120076463746,0.9877300613496932,0.9968075681639792,1.0,18/51,28.95%,KIF13A;KIF16B;KIF1B;KIF9;KIF3B;KIF7;KIF1C;KIF5B;DNAH17;KIF23;KIF15;APPBP2;SMC3;KIF13B;KIF22;KIF20B;DNAH8;CENPE
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",-0.1556547431948199,-0.5066157943594872,1.0,0.9868540710407507,1.0,35/35,84.47%,QTRT2;TRMT9B;TARS2;TRMT5;AARS1;AARS2;GATB;TYW3;DTWD1;BCDIN3D;MRPL58;DUS2;PTRH2;PTRH1;LCMT2;NT5C3A;ELAC2;TRMT12;DTWD2;TRIT1;QRSL1;DUS1L;TRPT1;ELAC1;TRMT13;QTRT1;PUS10;DUS3L;GATC;ALKBH1;FTSJ1;TRDMT1;MTFMT;FTO;DUS4L
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.24902252794030885,0.5050640350405996,0.968895800933126,0.995991761882337,1.0,4/12,25.90%,CNOT8;CNOT1;PAN3;PARN
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.2390359448105384,0.503822793507294,0.9765990639625585,0.9943966163534873,1.0,6/14,28.75%,MTMR12;SYNJ1;MTMR1;MTMR9;MTM1;MTMR11
prerank,kinesin binding (GO:0019894),0.20976108496907206,0.4988940912614862,0.9762900976290098,0.9938709864530731,1.0,5/27,24.22%,KIF1B;PLEKHM2;TOR1B;NEK6;KIFAP3
prerank,alanine transmembrane transporter activity (GO:0022858),0.22608740151812134,0.4792737246976215,0.9761904761904762,0.996563240870524,1.0,2/12,20.17%,SLC38A3;SLC36A4
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.20922829760722303,0.458457938686945,0.9802731411229135,0.9984272460377609,1.0,3/16,18.32%,TDO2;ALOX5;IDO2
prerank,hormone activity (GO:0005179),0.16965671249408237,0.45312241039567713,1.0,0.9973752607498052,1.0,9/54,22.48%,PTHLH;INHBA;GNRH1;INHBB;HCRT;EDN3;SPX;GRP;AGRP
prerank,tropomyosin binding (GO:0005523),0.20330465811839854,0.4473124924569122,0.9880774962742176,0.9963809670630892,1.0,1/16,5.56%,CALD1
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.1761438459729684,0.4377823915632178,0.9986979166666666,0.9938336734875673,1.0,8/34,26.55%,NDUFS3;NDUFC2;NDUFB4;NDUFA12;NDUFA9;NDUFB2;NDUFS2;NDUFV1
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.1761438459729684,0.4377823915632178,0.9986979166666666,0.9938336734875673,1.0,8/34,26.55%,NDUFS3;NDUFC2;NDUFB4;NDUFA12;NDUFA9;NDUFB2;NDUFS2;NDUFV1
